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A b s t r a c t  
Listeria monocytogenes is the causative agent of listeriosis, a severe foodborne infection that 
is increasing significantly in Europe and North America. A correlating factor contributing to 
the resurgence of listeriosis is the rise in consumption of cold-stored ready-to-eat (RTE) 
foods.  The steady upsurge in disease requires more focused research to control the pathogen, 
L. monocytogenes.  Currently, there is a plethora of diagnostic methods for the causative 
agent, however, each has limitations, one of which is the inability to correlate results across 
laboratories. This is a particular hindrance to an outbreak investigation in an age when food is 
transported widely across the globe. In this study, proteomic approaches were used to search 
for biomarkers that facilitate rapid characterisation of isolates against a background of 
differentially expressed proteins. A preamble to this investigation necessitated incorporation 
of an efficient lysis procedure to release maximum proteins. This was eventually achieved 
using a Listeria specific enzyme, endolysin, and a disruptive mechanical method. Liquid 
Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS) data showed that 
bead beating and enzymatic lysis were the most efficient methods for analysis of the 
proteome. Dendrogram lineages, derived from MALD-TOF-MS spectra, strongly correlated 
with 16S rRNA analyses. Selective protein capture and analysis by MALD-TOF-MS 
(designated SELDI-TOF-MS) demonstrated considerable intraspecies diversity as revealed 
by dendrograms which were also visualised by „Heat Maps‟. 
 
One-dimensional polyacrylamide gel electrophoresis and LC-MS/MS analysis of seven L. 
monocytogenes isolates, led to the successful identification of two proteins; a hypothetical 
protein, designated lwe06778 and a phosphoribosyl-AMP cyclohydrolase which were 
uniquely present at 4°C. This finding suggests that L. monocytogenes depends on the 
histidine biosynthesis pathway in order to survive at cold temperatures. It is hypothesised that 
the addition of inhibitors, specific to both proteins in RTE cold foods may be a useful means 
for controlling outbreaks of listeriosis in the future. 
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A b b r e v i a t i o n s  
 
°C    Degrees centigrade  
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DBHT    Department for Bioanalysis and Horizon Technologies     
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    zellkulturen (German collection of microorganism 
 and cell cultures) 
EIA    Enzyme-based immunoassay  
ELISA   Enzyme-linked immunosorbant assay 
EVA    Equiphase vertexing alogrithm 
FISH    Fluorescence in situ hybridisation 
FPRU    Foodborne pathogen reference unit 
G    Centripetal force 
GST    Generalised separation transform   
GW    Glycine/tryptophan 
HCCA   Alpha - cyano - 4 hydroxycinnamic acid 
HisA  Phospho-D-ribosyl formimino-5-amino-1- 
  phosphoribosyl-4- imidazole carboxamide isomerase 
HisB  Histidinol phosphatase 
HisC  Histidinol phosphate amino transferase 
HisD  Histidinol dehydrogenase 
HisE    Phosphoribosyl-ATP pyrophosphohydrolase  
HisH    Glutamine imidazole transferase 
HisI    Phosphoribosyl-AMP cyclohydrolase 
HIV    Human immuno-deficiency virus 
HPA    Health protection agency 
HPr    Histidine phosphocarrier 
iap    Invasion associated protein 
IEF    Isoelectric focussing 
IFR    Institute of food research 
IGDP    Imidazole glycerol phosphate dehydratase 
IGP    Imidazole acetol phosphate 
IL    Interleukin 
IMS    Immunomagnetic separation 
INF    Interferon 
inlA    Internalin A gene 
InlA    Internalin A protein 
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InlB    Internalin B protein 
inlB    Internalin B gene 
L    Litre 
LC-MS/MS   Liquid chromatography - mass spectrometry/mass        
spectrometry                                                                                                                                                                                                                        
LIPI-1    Pathogenicity island 1 
LLO    Listerolysin O 
LPXTG   Leucine, proline, any amino acid, tyrosine and  
glycine 
LRR    Leucine rich region 
mA    Milliamp 
Mal    MyD88 adaptor like  
MALDI-TOF-MS  Matrix assisted laser desorption/ionisation - time of  
flight - mass spectrometry 
mg    Milligram 
ml    Millitre  
mM    Millimolar 
Mpl    Metalloprotease 
MRSA   Methicillin resistant Staphylococcus aureus 
MS    Mass spectrometry 
MSSA    Methicillin susceptible Staphylococcus aureus 
MSP    Main-spectrum 
MyD88   Myeloid differentiating factor -88 
m/z    Mass to charge  
NCTC    National collection of typed cultures 
ng    Nanogram 
NLRs    Nucleotide-binding oligomerisation domain (NOD) -  
like receptors 
nm/s    Nanometre per second 
NOD    Nucleotide-binding oligomerisation domain 
NPF    Nucleating promoting factor 
PAGE    Polyacrylamide Gel Electrophoresis 
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PAMPs    Pathogen-associated molecular patterns 
PCR    Polymerase chain reaction 
Pi                                                  Released phosphate 
PI    Phosphatidylinositol 
PFGE    Pulse field gel electrophoresis 
PFO    Perfringolysin 
PLP    Polyproline region 
PM    Plasma membrane 
prfA    Positive regulatory factor A 
PRPP    5-phosphoribosyl 1-pyrophosphate 
PRRs    Pattern recognition receptors  
PTS    Phosphotransferase system 
RNA    Ribonucleic acid 
RNI    Reactive nitrogen intermediate 
ROS    Reactive oxygen species 
SARAMIS   Spectral ARchive and microbial identification system 
SDS    Sodium dodecyl sulphate  
SELDI-TOF-MS  Surface enhanced laser desorption - time of flight –  
mass spectrometry                                                                                                                 
SPA    Sinapinic acid 
TFA    Trifluoroacetic acid  
Thymosine β4  Tβ4 
TLRs    Toll-like receptors 
TNF    Tumour necrosis factor 
TRAM   TRIF-related adapter molecule 
UK    United Kingdom 
V    Volts 
W    Watt 
WASP    Wiskott aldrich syndrome proteins 
Wave    WASP verprolin  
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Chapter 1: General Introduction  
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1.1 Listeria  
1.1.1 Listeria: A brief history 
The earliest record of the isolation of Listeria was in 1926 when Murray et al. isolated an 
organism from a diseased rabbit, which they named Bacterium monocytogenes (Gibbons 
1972). The rabbit was observed to have large mononuclear leucocytosis (Gibbons 1972), and 
therefore the specific epithet monocytogenes was derived from the Greek word meaning, 
“generating monocytes” (Bergey et al. 1939). In 1927, Pirie described a similar organism 
which he named Listerella hepatolytica, but in an addendum to his report he acknowledged 
that the name assigned by Murray et al. (1926) was more appropriate. When the identity of 
the organism isolated by Murray et al. (1926) and Pirie (1927) were confirmed to be 
synonymous, the name Listerella monocytogenes took precedence (Gibbons 1972) and in 
1934, Listerella monocytogenes first appeared in the 4
th
 edition of the Manual of 
Determinative Bacteriology (Bergey 1934). It was later confirmed that the name Listerella 
was in honour of Joseph Lister, a British surgeon who pioneered antiseptic surgery (Breed, 
Murray, and Hitchens 1948; Gibbons 1972) (Bergey 1934).  
 
The name Listerella monocytogenes continued into the 5
th
 edition of the Bergey‟s Manual of 
Determinative Bacteriology, however, in the 6
th
 edition of 1948, the genic Listerella was 
changed to Listeria monocytogenes (Breed, Murray, and Hitchens 1948). This change was 
possibly to avoid confusion as the same genus name was also used to describe Foraminfera 
and Mycetozoa (Gibbons 1972). The new name became accepted after two revisions by 
E.G.D. Murray in 1938 and 1945 (Breed, Murray, and Hitchens 1948), and was adopted in all 
future publications. 
 
In 1961, 1966 and 1971, respectively; Listeria denitrificans, Listeria grayi and Listeria 
murrayi, were identified as new species, and in 1974 were included in the 8
th
 edition of 
Bergey‟s Manual of Determinative Bacteriology (Buchanan and Gibbons 1974), while L. 
monocytogenes continued to be recognised as the type species.  However, from 1966 onwards 
to 1984, morphological, biochemical, serological, chemical and nucleic acid evidence showed 
that L. denitrificans was in compatible with the genus description; and was shown to have a 
closer affinity with the genera Oerskovia, Renibacterium, and Arthrobacter. In each case; 
however, the data was tenuous and the organism therefore retained its status in the genus until 
further studies were carried out (Sneath 1986). Four new species were identified in the late 
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1970‟s to mid-1980‟s: L. innocua was identified by Seeliger and Schoofs in 1979, L. 
welshimeri and L. seeligeri by Rocourt and Grimont in 1983, and, L. ivanovii by Seeliger and 
Rocourt in 1984 (Sneath 1986). During this period, Wilkinson and Jones argued that L. grayi 
and L. murrayi were not sufficiently distinct and that they should be reduced to synonymy as 
L. grayi. Nevertheless they, remained separate while L. dentrificans was transferred to a 
separate genus; Jonesia (Holt et al. 1994). Finally, after much accumulative evidence L. 
murrayi was no longer retained as a separate species. Instead subspecies were defined and L. 
grayi was described as having two subspecies; L. grayi subsp. grayi and L. grayi subsp. 
murrayi.  L. ivanovii was also subdivided and was categorised as L. ivanovii subsp. ivanovii 
and L. ivanovii subsp. londoniensis (De Vos et al. 2009).  
 
In 2009, L. marthii and L. rocourtiae became the most recently discovered species: four L. 
marthii species were isolated from soil, standing water and flowing water systems in Finger 
Lakes National Forest, New York, USA (Graves et al. 2010) and one L. rocourtiae species 
was isolated from pre-cut lettuce in Austria (Leclercq et al. 2010).  In total, the genus is 
currently comprised of 8 species. 
 
1.1.2 Characteristics 
All species are Gram positive bacilli, non-spore forming, facultatively anaerobic, motile with 
peritrichous flagella (if cultured below 30°C), and appear as short rods measuring 0.4-0.5 μm 
in width and 1-2 μm in length (De Vos et al. 2009). The growth and survival of most human 
pathogens are hindered at low temperatures, however, Listeria is capable of slow growth at 
0°C, and can survive temperatures as low as -7°C (De Vos et al. 2009; Ramaswamy et al. 
2007). Growth is optimal between 30°C and 37°C, limited at 45°C, and, Listeria does not 
survive heating above 60°C for 30 minutes (De Vos et al. 2009).  
 
Some phenotypic characteristics which separate Listeria from other genera are: 1) its ability 
to metabolise aesculin and not urea , 2) its ability to catalyse the conversion of hydrogen 
peroxide to hydrogen and oxygen (catalase positive), and 3) its inability to use cytochrome c 
for the production of energy in the electron transport chain (oxidase negative) (De Vos et al. 
2009).  
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1.1.3 Infection 
Of the eight Listeria species, L. monocytogenes and L ivanovii are the most infectious. L. 
monocytogenes is pathogenic to a wide range of animals which include mammals and birds, 
while L. ivanovii primarily affects ruminants (Vazquez-Boland et al. 2001a). Infection by 
either organism may cause listeriosis. Though all other species are described as non-
pathogenic, two exceptional cases of infection caused by L. seeligeri and L. innocua have 
been documented. In 1986, Rocourt and colleagues reported a case of acute purulent 
meningitis due to L. seeligeri infection in an immunocompetent adult male (Rocourt et al. 
1986), while in 1994, Walker and colleagues reported a case of ovine meningoencephalitis, in 
which L. innocua was implicated (Walker et al. 1994). The above mentioned cases are indeed 
extremely rare; however, their occurrence gives support to the view that a small population of 
strains belonging to species described as non-pathogenic, may be capable of causing disease.  
 
1.2 Listeria monocytogenes 
1.2.1 Listeriosis  
A small percentage of the general population (1-6%), are asymptomatic carriers of L. 
monocytogenes (Lamont et al. 2011; Olier et al. 2005; Ramaswamy et al. 2007). However, in 
the majority of other cases, infection by L. monocytogenes in healthy individuals may lead to; 
flu-like symptoms (for example; headache, chills, fatigue, muscular and joint pain (Liu 2006), 
nausea, vomiting, diarrhoea, fever and cramps (Bortollussi 2008). In such cases the infection 
may be self-limited as the immune system of healthy hosts is stimulated to combat and 
eradicate the infection:  only few healthy individuals develop severe listeriosis (Bortollussi 
2008). The more severe and life threatening form of listeriosis includes symptoms such as; 
bacteremia, meningitis and encephalitis; less common manifestations include inflammatory 
gastroenteritis, endocarditis and joint infections (Bortollussi 2008). In pregnant women, 
listeriosis may cause, spontaneous abortion, miscarriages, preterm delivery and still births 
(Lamont et al. 2011). Persons susceptible to the more severe cases of listeriosis (high risk 
individuals) include; the unborn, infants, pregnant mothers, persons over 60 and the 
immunocompromised. Immunocompromised individuals include persons; living with 
HIV/AIDS, cancer, kidney disease and persons receiving immuno-suppressant medication 
(Bortollussi 2008). The approximate L. monocytogenes infection dose sufficient to cause 
listeriosis in healthy and high risk individuals is 10-100 million and 0.1-10 million colony 
forming units respectively (Bortollussi 2008). High risk individuals with signs of listeriosis 
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are given an empiric therapy which includes ampicillin. Infants born to mothers with 
listeriosis are prescribed an antibiotic therapy which includes ampicillin and gentamicin 
(Bortollussi 2008).   
 
Listeriosis, though rare, was in 2006 ranked amongst the fifth most common zoonotic 
infection  in Europe after Salmonella, Campylobacter, Yersinia and VTEC diseases (Denny 
and McLauchlin 2008). Listeriosis has therefore become a very important disease and this is 
attributed to three main factors: 
 
1) the mortality rate associated with listeriosis is 20 - 30%, and at times has been known to 
be 40% (Denny and McLauchlin 2008), this is relatively high in comparison to the 
mortality rate of other common zoonotic infections such as: Salmonella enteriditis 0.38% 
and Campylobacter species 0.02 - 0.1% (Liu 2006).  
 
2) listeriosis carries one of the highest hospitalisation rates amongst known  foodborne 
pathogens with 91% being reported in Europe (Denny and McLauchlin 2008), and 90% in the 
United States (Nightingale 2010).   
 
3) recently, there has been a dramatic rise in the number of listeriosis cases. Trends in 2006 
showed that the number of listeriosis cases have increased for European countries, namely; 
Germany, Netherlands, United Kingdom (UK), Ireland, Spain and Lithuania (Figure 1.1) 
(Allerberger and Wagner, 2010).  
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Figure 1.1. Incidence of listeriosis in Germany, Republic of Ireland, Lithuania, Netherlands, 
Spain and the UK from 1999 - 2007. The graph shows a plot of listeriosis cases/100 000 
between 1999 and 2007. The trends indictate that overall the incidence of listeriosis 
continued to rise during this period (Allerberger and Wagner, 2010).  
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In 2006, the Health Protection Agency (HPA) reported a dramatic rise in sporadic 
nonpregnancy-associated listeriosis cases in England and Wales since 2001. Of the reported 
cases, 97% of patients‟ ages were available and the data showed that between 2001 and 2004, 
the risk of sporadic nonpregnancy-associated listeriosis among persons aged ≥60 increased 
by almost half, compared to 1990 - 2000. Also, a total of 44% of sporadic nonpregnancy-
associated and 10% of sporadic pregnancy-associated cases of listeriosis resulted in mortality 
(Gillespie et al. 2006). Outside of Europe, listeriosis surveillance information seems to be 
lacking. Few countries worldwide collect data regarding the trends associated with foodborne 
pathogen diseases, with the collected data being limited to a few industrialised countries 
(Newell et al. 2010): this may explain the limited amount of surveillance data available 
outside of Europe. However, the data presented in this chapter shows that concerns regarding 
the rise of listeriosis cases are warranted especially among the elderly.  
 
Gillespie and colleagues report that the incidence of listeriosis in England and Wales has 
almost doubled between 2001 and 2007 compared with 1990 and 1999, and that within this 
period, individuals affected were predominantly the elderly aged ≥ 60 (Gillespie et al. 2009). 
The same was also observed in other European countries. In Germany, the number of 
listeriosis case more than doubled between 2001 and 2005 with the increases being 
predominantly associated with persons aged ≥60 (Denny and McLauchlin 2008), while in 
France an upsurge was observed in 2006, predominantly among the same age group. In all 
cases, the rise in listeriosis cases was not associated with foodborne outbreaks and the reason 
for the observed rise particularly among the elderly remains unknown (Denny and 
McLauchlin 2008; Gillespie et al. 2006; Goulet et al. 2008). Therefore, in 2009, Gillespie and 
colleagues conducted a study with the aim of identifying factors that may explain the 
increase. They were able to conclude that the rise in listeriosis among the elderly may have 
occurred in patients with cancer or other conditions which require treatment with acid-
suppressing medication. They therefore suggested that the potential role of proton pump 
inhibitors in human listeriosis be investigated (Gillespie et al. 2009).  
 
1.2.2 Contamination of food 
L. monocytogenes is ubiquitous: it is easily isolated from natural environments such as soil, 
water systems, vegetation and silage (Gray, Freitag, and Boor 2006) and is therefore the 
likely source of the organism in the food chain (Schuppler and Loessner 2010). Foods that are 
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typically contaminated with the organism include raw unwashed vegetables, soft cheeses 
(such as feta, brie and camembert (all made using unpasteurised milk)), paté, deli meats and 
hot dogs (Di et al. 2010; Lamont et al. 2011). In addition to the ability to grow at temperature 
limits mentioned in section 1.1.2, L. monocytogenes is able to tolerate high salt 
concentrations (up to 10%), and a broad pH range (pH 4.0 to 9.0) (Nightingale 2010). The 
organism may also be recovered from high temperature short time pasteurisation after 
exposure to 72°C if originally grown at 39°C and above (Rowan and Anderson 1998). Low 
storage temperatures and high salt are conditions often used to restrict the growth of 
foodborne pathogens in consumable products, while high cooking temperatures and 
pasteurisation are used to kill such organisms. However, the above mentioned features of L. 
monocytogenes facilitate its ability to survive in “ready to eat” (RTE) foods which have been 
properly refrigerated or frozen, foods with a high salt content, and, in foods where heating 
has not been thorough (that is, the product has not been uniformly heated for a substantial 
period, to a temperature which is lethal to the organism).  
 
At present the European Commission‟s food safety criteria limit for L. monocytogenes is ≤ 
100 colony forming units per gram (CFU/g) (Little et al. 2009), at the end of its shelf life. 
The presence of L. monocytogenes in food is constantly being surveyed in various European 
countries to deduce the amount of RTE foods which are beyond this limit, as a means of 
monitoring the food hygiene standards of manufacturers and retailers, for the safety of the 
general public. In 2009, Little and colleagues assessed the prevalence of L. monocytogenes in 
selected retail RTE foods produced in the UK. They showed that the presence of L. 
monocytogenes in selected RTE foods was not exceeded in 99.7% cases. However, the limit 
was exceeded in 0.4% of prepacked sandwiches within their shelf life, and, in 0.7% of sliced 
meats within their shelf life (Little et al. 2009). In 2010, Pinto and colleagues surveyed the 
presence of L. monocytogenes in a selection of RTE foods produced in Southern Italy and 
found that the pathogen was present in 10% of the 1045 tested food items (Di et al. 2010). As 
a result of their findings, they expressed support for the view that L. monocytogenes is a 
priority for risk assessment (according to the Codex Committee on Food Hygiene) for the 
development of an international strategy for the reduction of illnesses that result from the 
consumption of contaminated foods. Generally, European surveillance data show that the 
majority of RTE food items are within the European Commission‟s food safety criteria limit, 
however, it is important that surveillance is continued so that food hygiene standards, as it 
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relates to L. monocytogenes, are improved. Persons more susceptible to listeriosis, may 
benefit from a lowering of the European Commission‟s food safety criteria limit to a zero 
tolerance on the presence of L. monocytogenes in RTE foods because their infection dose is 
lower than an invulnerable population.   
 
1.2.3. Physiopathology 
L. monocytogenes can enter the human body via routes such as; 
a) the epidermis: this is particularly observed among ruminant raring farmers and 
veterinarians exposed to genital secretions following listerial miscarriages, and, is manifested 
as pyogranulomatous skin rashes (Kuhn, Scortti, and Vazquez-Boland 2008). 
 
b) transplacental vertical transmission: from mother to foetus (Lamont et al. 2011). 
c) the mouth, through the consumption of contaminated food  (the main cause of sporadic and 
epidemic listeriosis) (Kuhn, Scortti, and Vazquez-Boland 2008). 
 
Following ingestion of contaminated food, the organism is able to penetrate the body via the 
intestinal mucosa using two mechanisms: one of which involves the phagocytotic uptake by 
M cells of the Peyer‟s patches (Figure 1.2) (Kuhn, Scortti, and Vazquez-Boland 2008; 
Vazquez-Boland et al. 2001b). This is a less efficient method as opposed to translocation of 
the intestinal mucosa, whereby the organism directly invades enterocytes lining the 
absorptive epithelium of the microvilli (Kuhn, Scortti, and Vazquez-Boland 2008; Schuppler 
and Loessner 2010). Subsequent to invasion, the organism is able to replicate in the intestinal 
wall. Essential to these processes are a number of listerial virulence factors, (which will be 
discussed later in detail). The result is a local infection in the intestinal lymphoid structures 
(Vazquez-Boland et al. 2001b).  
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Figure 1.2. Peyers patches, visible as a small bulge on the small intestine. When L. 
monocytogenes is ingested, usually via consumption of contaminated food, the organism is 
able to penetrate the body via the intestinal mucosa using two mechanisms: one of which 
involves the phagocytotic uptake by M cells of the Peyer‟s patches (diagram taken from 
http://www.ppdictionary.com/bacteria/gnbac/enterocolitica.htm, 2011).  
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The infected site appears as a pyogranulomatous and the bacteria are present in mononuclear 
cells. This suggests that the antigen presentation occurs in the intestine and is a site of an 
immunological response to L. monocytogenes infection (Vazquez-Boland et al. 2001b). 
Following entry into the intestinal cells, L. monocytogenes is able to access the mesentric 
lymph nodes, liver, and spleen by blood or lymph (Vazquez-Boland et al. 2001b). This initial 
step of host colonisation is very rapid, and occurs within six hours in experimental mice 
(Kuhn, Scortti, and Vazquez-Boland 2008). The immune system is stimulated during the 
point of ileal gut infection and this is thought to play a major role in developing protective 
immunity against a second infection, as well as the prevention of spread to target organs such 
as; the central nervous system (CNS), where infection may cause meningioencephalitis; the 
blood stream, where it may cause septicaemia; and the uterus, where it may invade the 
placenta and subsequently infect the foetus. A physiopathological summary of L. 
monocytogenes infection is shown as a diagram below (Figure 1.3).  
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Figure 1.3.  Physiopathological summary of L. monocytogenes infection. L. monocytogenes 
present in the environment, for example in soil, is a source of food contamination and enters 
the digestive system through the consumption of such products. Some of the bacteria are 
excreted (“fecal shedding”) and may contaminate food crops which have been exposed to 
untreated or inadequately treated faeces, resulting in a contamination cycle. Non-excreted L. 
monocytogenes translocate into the ileac cells of the digestive system and subsequently into 
the mesenteric lymph nodes, liver and spleen (causing subclinical pyogranulomatous hepatitis 
and splenitis respectively). At this point, a sustained and efficient immune response may 
successfully clear the pathogen from the body. An unsuccessful or impaired immune 
response allows the pathogen to continue replication and spread to target areas such as; the 
CNS, the blood stream and the uterus (taken from Kuhn et al. 2008).  
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1.2.4. Immunity 
1.2.4.1 Innate immunity 
A means by which the body controls microbial infection is through the launch of an innate 
immune response, which is, a non-specific first line of defence against a broad range of 
pathogens. It is short term, yet very effective and important for the control of microbial 
multiplication and growth. Infection by L. monocytogenes through the consumption of 
contaminated food is the most natural and frequent route of infection. The bacteria first 
encounter bactericidal lysozymes secreted by intestinal mucosal cells, stomach gastric acid 
and antibacterial lectins in the intestine. Numerous other microbes symbiotically colonise the 
small intestine, L. monocytogenes is therefore forced to compete with these organisms for 
space and nutrients (Greginat and Grauling-Halama 2008). These conditions culminate to 
make survival of the organism extremely difficult, and few are able to survive in the intestine. 
Some are able to disseminate to other parts of the body via the circulatory system as blind 
passengers of macrophages and dendritic cells (DCs), subsequently decreasing the time spent 
interacting with mucosal environment.  
 
Infected macrophages secrete various cytokines such as interleukin (IL)-1, IL-6, IL-12, IL-18 
and the chemokine-monocyte chemoattractant protein-1 (MCP-1), which activates and 
recruits neutrophils, monocytes, T-cells, natural killer (NK) cells and DCs. IL-12 and IL-18 
stimulates the production of gamma interferon (IFN-γ) and tumour necrosis factor (TNF) by 
T-cells and NK cells. IFN-γ and TNF by positive feedback enhances the bactericidal activity 
of macrophages. The outcome of the interactions amongst these immuno-components 
includes the onslaught of the bacteria by effector molecules such as; lysosyme, antimicrobial 
peptides (such as defensins - an antibacterial peptide), and reactive oxygen species (ROS) and 
reactive nitrogen intermediate (RNI). Only few cells such as Paneth cells (present in the 
intestinal microflora), and a specialised subpopulation of TNF and nitric oxide producing 
DCs have direct bactericidal activity (Greginat and Grauling-Halama 2008). Table 1.1 lists 
the effector molecules produced in L. monocytogenes target organs and the principal immune 
cells responsible for their production.  
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Table 1.1. Effector molecules produced in organs targeted by L. monocytogenes and the 
principal immune cells responsible for their production.  When L. monocytogenes infects 
target organs the principal immune cells of the organ illicits an immune response by 
expressing specific effector molecules such as those listed in this table (adapted from 
Greginat and Grauling-Halama, 2008).  
Abbreviations: ROS, Reactive oxygen species; RNI, Reactive nitrogen intermediate; TNF, 
Tumour necrosis factor; DCs, Dentritic cells; CNS, Central nervous system. 
Target Organ Principal Immune Cell Effector Molecule 
Stomach  Gastric acid 
Intestine Intestinal microflora 
Paneth cells 
Antibacterial lectins, 
lysozyme, α-defensins 
Liver Kupffer cells Defensins, lysozyme 
Spleen Macrophage ROS, lysosyme, RNI 
TNF and inducible  nitric oxide 
synthase producing DCs 
TNF,  RNI 
CNS Neutrophils Defensins, lysozyme 
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The mechanisms involved in the production of effector molecules via cytokines and MCP-1 
are not clearly understood, however, crucial to this overall process is the interaction between 
the invading organism‟s conserved pathogen-associated molecular patterns (PAMPs) and the 
host‟s pattern recognition receptors (PRRs) (Schuppler and Loessner 2010). Toll-like 
receptors (TLRs) and the nucleotide-binding oligomerisation domain (NOD) – like receptors 
(NLRs) are the two PRRs primarily involved in L. monocytogenes innate immunity 
(Schuppler and Loessner 2010). 
 
TLRs are a family of glycoproteins present on the cell surface or within endosomes and are 
expressed on numerous cells, which include; macrophages, dendritic cells, B cells, T cells, 
mast cells and epithelial cells (Torres et al. 2004). To date, 10 human TLRs have been 
described. Their mode of action involves binding extracellular bacterial PAMPs such as 
lipopolysaccharides, lipoproteins, and flagellin, which leads to binding of  four activating 
adaptors: myeloid differentiating factor -88 (MyD88), MyD88 adaptor like (Mal), Toll-
interleukin-1 receptor (TIR) domain-containing adaptor inducing IFN-β (TRIF) and TRIF-
related adapter molecule (TRAM) (Schuppler and Loessner 2010). Binding of activating 
adaptors leads to a cascade of signal transduction events which induces the expression of 
proinflammatory cytokines and interferons (INF) (Schuppler and Loessner 2010). TLR2 is 
one such PRR which interacts with listerial lipoproteins and lipoteichoic acids (Schuppler and 
Loessner 2010).  The involvement of TLR2 in the control of L. monocytogenes infection has 
been described in detail by Torres et al. in 2004. Their results showed that TLR2 
-/-
 knockout 
mice were more susceptible to L. monocytogenes systemic infection than wild type mice, and 
that TLR2 deficient mice had a reduced survival rate, increased bacterial burden in the liver 
and larger hepatic microabscesses. In addition, they observed that production of 
proinflammatory immune system components such as; TNF, IL-12 and nitric oxide, which 
are necessary for infection control, were also reduced in TLR2 deficient macrophages and 
dendritic cells that were challenged by L. monocytogenes (Torres et al. 2004).  
 
While TLR2 has been described as the most relevant TLR for eliciting an innate immune 
response against L. monocytogenes (Torres et al. 2004), other TLR receptors play an active 
role in the inflammatory response. TLR5, for example, has been shown to bind flagellin - a 
structural protein component of L. monocytogenes flagella. The general observation is that L. 
monocytogenes does not produce flagella at 37°C, which is the human body temperature, 
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however ~ 20% of clinical isolates are able to produce flagella at this temperature (Way et al. 
2004). There is evidence that TLR5 receptors are able to bind flagellin and mediate an 
immune response by inducing the expression of nuclear transcription factor-κB and TNF, 
albeit a lower response in comparison to the inflammatory response elicited by TLR2 and 
only in 20% of L. monocytogenes population (Way et al. 2004).  
 
Nucleotide-binding oligermerisation domain (NOD) - like receptors (NLRs), are a family of 
receptors which have either a caspase recruiting N-terminal domain or a pyrin domain. 
Currently, 23 NLRs have been identified in humans, all of which are located in the cytosol of 
mammalian cells where they are responsible for eliciting an innate immune response against 
L. monocytogenes cells that have crossed the membrane barrier to inhabit the host cell 
(Schuppler and Loessner 2010). NLRs mediate a proinflammatory response through the 
activation of caspase I (Schuppler and Loessner 2010): an enzyme that cleaves immunogenic 
proteins such as IL-1β and IL-18 precursors, thus converting them into a mature and active 
form (Cervantes et al. 2008; Walsh et al. 2011).  Of the 23 NLRs, the roles of NOD1 and 
NOD2 have been described in most detail. Lysozyme catalysis of L. monocytogenes 
peptidoglycan produces a diaminopimelic acid containing a di- or tri-peptide which aids in 
activation of NOD1. The function of activated NOD1 is to up-regulate transcription of 
proinflammatory genes and defensins. NOD 2 is also activated by another lysozyme catalytic 
product of L. monocytogenes peptidoglycan: muramyl dipeptide. Activated NOD2 leads to 
the expression of defensins as well as cryptidins (and α-defensin) which aid in disrupting the 
bacteria‟s membrane function (Schuppler and Loessner 2010).   
 
Additional to the role of NLRs in destroying intracellular bacteria, another means by which 
intracellular bacteria are eliminated from the host cell is by autophagy: a term which in the 
context of this discussion, describes the enclosure of intracellular invading organisms in an 
autophagosome and subsequently its destruction while in the enclosure. A number of 
intracellular microorganisms are susceptible to destruction through autophagy; these include 
Salmonella, Group B Streptococcus and Mycobacterium tuberculosis (Schuppler and 
Loessner 2010). In contrast, it has been demonstrated that L. monocytogenes is able to evade 
autophagy due to the essential role of its ActA virulence protein (Yoshikawa et al. 2009).  
When L. monocytogenes invades the host cell, expression of the ActA transmembrane protein 
commences, and, is utilised to recruit host proteins VASP and Arp2/3 (actin-related proteins 
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2 and 3complex) in order for the pathogen to disguise itself as a host organelle.  By doing so, 
L. monocytogenes avoids ubiquitination as well as LC3 and p62 accumulation which are 
essential for the occurrence of autophagy (Figure 1.4) (Schuppler and Loessner 2010; 
Yoshikawa et al. 2009).  
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Figure 1.4. L. monocytogenes host cell entry and encapsulation in an autophagosome. The 
bacterium liberates itself from the membrane enclosure with the aid of its membrane-bound 
listerolysin O (LLO) virulence protein. Expression of membrane bound ActA protein 
facilitates the accumulation of host proteins VASP and Arp2/3 complex which camouflages 
the bacterium as a host organelle. The bacterium is therefore able to freely multiply and 
engage in actin-based motility for cell to cell spread. ActA deficient cells, however, are 
ubiquitinised and subsequently accumulate p62 and LC3 which are cues for entrapment by 
autophagosomes and ultimately cell degradation (taken from Yoshikawa et al. 2009).   
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1.2.4.2 Adaptive immunity 
While the innate immune system is the initial response to L. monocytogenes infection and is a 
means of controlling the spread of the organism, the adaptive immune response, facilitates 
clearance of the organism and is responsible for a more vigorous response, should infection 
re-occur. Briefly, adaptive immunity is shaped by T-lymphocytes which when mature are 
subdivided into either CD8+ (otherwise called cytotoxic or killer cells) or CD4+ cells 
(otherwise called T-helper cells). Any cell infected with L. monocytogenes can present its 
antigens on their cell surface. Such cells are called antigen presenting cells (APC), and these 
antigens are presented via proteins called major histocompatibility complex (MHC). MHC is 
divided into class I and class II molecules. Class I MHC molecules presents cytosolic listerial 
proteins to CD8
+
 T cells while MHC class II molecules present peptides to CD4
+
 T cells 
(Mitsuyama 2008). The role of CD 4 T cells in controlling L. monocytogenes infection is 
unclear, however, the role of CD8
+
 T cells is better understood. Upon antigen presentation 
CD8
+
 T cells respond in two ways:  
 
1) the cells release perforins which function to degrade the cell wall of L. monocytogenes and 
granzymes: a combination of serine proteases, digestive trypsin and chymotrypsin which 
degrade bacterial proteins, and,  
 
2) the cells secrete IFN-γ and TNF which activate macrophages.  IFN-γ plays an important 
role in resistance to L. monocytogenes as it activates resting macrophages which efficiently 
restricts proliferation of the organisms and is responsible for long term immunity (Schuppler 
and Loessner 2010).  
CD8
+
 T cells that persist in the body become stable and long lasting memory cells, which are 
vital to eliciting a more rapid response upon a second infection. Unlike CD8
+
 T cells, CD4
+
 T 
cells do not have a cytotoxic or phagocytic activity. Its roles are centred on facilitating the 
activity of other immune cells and as a result they are also known as T-helper cells. One 
means by which this is accomplished is by promoting the secretion of IFN-γ and TNF which 
maximise the killing efficiency of macrophages and proliferation of CD8
+
 T cells 
(Mitsuyama 2008). Some CD4
+
 T cells promote the production of IL-4, IL-5, IL-6, IL-10 and 
IL-13 which help to stimulate B- cells and increase antibody production (Mitsuyama 2008).  
The basic review of the adaptive immune response, presented here provides an understanding 
of the fact that immuno-compromised persons and persons with an impaired cell-mediated 
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immunity are more susceptible to developing severe listeriosis, as such individuals have a 
diminished ability to produce T-lymphocytes and subsequently the cytokines vital to the 
adaptive immune system. They therefore lack the ability to fully clear the pathogen from host 
cells. 
 
1.2.5 Intracellular life cycle and virulence proteins 
There are a number of genes which are important and vital for the pathogenicity of L. 
monocytogenes and its intracellular life cycle. Some of these genes and protein products have 
been thoroughly characterised, yet, many remain unknown. However, as interest in L. 
monocytogenes’ pathogenicity continues to grow, research is steadily uncovering other genes 
that contribute to virulence. Some of the well understood virulence genes are those located on 
pathogenicity island 1 (LIPI-1) and the internalins. The protein products of these genes 
function to grant L. monocytogenes its characteristic intracellular life cycle which is 
described as follows:  
 
Contact with a potential host cell induces the formation of pseudopod- like structures. 
Progression of this stage results in the organism becoming entrapped in a primary phagosome 
(Kuhn, Scortti, and Vazquez-Boland 2008; Vazquez-Boland et al. 2001a). L. monocytogenes 
is then able to liberate itself from the compartment and into the cytosol where it 
concomitantly replicates and exhibits actin based motility. Propulsion of the bacteria occurs 
in random directions and those that reach the host cell membrane push against it resulting in 
the formation of pseudopod-like structures. As outward movement continues, the pseudo-like 
structure subsequently protrudes into the neighbouring cell where the organism becomes 
entrapped in a secondary phagosome (double membrane vacuole). This is followed by 
liberation of the bacteria from the secondary phagosome and the cycle is re-initiated 
(Vazquez-Boland et al. 2001a).  
 
Pseudopod formation and uptake of the bacteria into a phagosome is as a result of inlA and 
inlB genes which encode internalin A and internalin B membrane bound extracellular 
proteins, respectively. Expression of a number of genes including; inlA, inlB, hpt and genes 
located on LIPI-1 1 are controlled by positive regulatory factor A (PrfA) protein, which is 
encoded by (prfA) (Figure 1.5). Genes downstream of the prfA transcription control site on 
LIPI-1 which facilitate the release of the bacteria from the phagosome are hly, plcA and plcB 
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which encodes listeriolysin O (LLO), phosphatidylinositol phospholipase C (PlcA) and 
phosphatidylcholine phospholipase C (PlcB) respectively. Also downstream are the mpl gene 
which encodes a metalloprotease (Mpl) that assists in the conversion of PlcB to a mature 
state, and, the actA gene which encodes the ActA protein that is vital for actin based motility 
(Gray, Freitag, and Boor 2006). The hpt gene product is a hexose phosphate transporter (Hpt) 
which is required for rapid growth in the host cytosol (Scortti et al. 2007). A schematic 
overview of the intracellular life cycle is depicted in Figure 1.6. 
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 Figure 1.5.  Transcriptional control of L. monocytogenes virulence genes by PrfA. The prfA 
gene product, PrfA, has a number of binding sites on LIPI-I and elsewhere within the genome 
(indicated by curved black arrows). Binding of PrfA switches on expression of downstream 
virulence genes; the transcripts of which may be monocistronic, bicistronic or polycistronic. 
(Virulence genes are depicted in solid grey arrows, except prfA which is depicted as a solid 
black arrow. Promoters are represented by “P” and transcripts by dotted lines) (Scortti et al. 
2007) (taken from Scortti et al. 2007).  
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Figure 1.6. Schematic diagram of L. monocytogenes intracellular life cycle. The transcription 
regulator protein, PrfA, controls expression of the depicted bacterial proteins, (InlA, InlB, 
PlcA, PlcB, Mpl, ActA and Hpt), which are vital for the organism‟s intracellular lifecycle. 
InlA and InlB facilitate the organism‟s entry into the host cell where it is encapsulated in a 
primary phagosome. LLO, PlcA, PlcB and Mpl facilitate the disruption of the phagosome and 
release of the pathogen into the host cytoplasm. Hpt gene enables the pathogen to utilise the 
host cell‟s hexose phosphates as a carbon and energy source to fuel rapid multiplication 
(Chico-Calero et al. 2002). ActA is required for polymerisation of host cell actin which is 
vital for motility. The bacteria are able to propel itself in random directions throughout the 
cytoplasm. Those that move towards the host cell membrane begin to protrude into 
neighbouring cells where InlA and InlB again facilitate entry, and, the organism is 
encapsulated in a secondary phagosome and the life cycle is then re-initiated (taken from 
Scortti et al. 2007).   
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1.2.5.1 Positive regulatory factor A 
PrfA expression is regulated by three promoter regions upstream of the prfA gene, namely; 
PprfAP1 and PprfAP2 which direct a 0.9 kb and 0.8 kb monocistronic prfA mRNA transcript 
respectively, and, the plcA promoter; PplcA which direct a 1.1 kb monocistronic plcA mRNA 
transcript and a 2.1 kb bicistronic plcA-prfA mRNA transcript (Figure 1.7) (Gray, Freitag, 
and Boor 2006). Research has shown that expression of PrfA is temperature dependent, and 
that this is due to the thermosensitive structure of the mRNA transcripts which undergoes 
conformational change at certain temperatures. The structure of the PprfAP1 transcript at 
temperatures lower than 30°C inhibits translation, this however, melts at higher temperatures 
at which translation is unhindered. The bicistronic plcA-prfA transcript, which is dependent 
on PrfA activation, is only produced at high temperatures. In contrast to the PprfAP1 
transcript, the PprfAP2 transcript contains a thermosensitive component and therefore 
transcription has been shown to occur at low temperatures (Gray, Freitag, and Boor 2006). A 
pool of untranslated prfA transcripts are therefore present at low temperatures; however, once 
the organism enters a human host (or other warm blooded hosts), PrfA may be rapidly 
synthesised (Gray, Freitag, and Boor 2006), which may be seen as a mechanism to increase 
survival while in a host system.   
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Figure 1.7. Promoter regions of the prfA gene and their gene transcripts. The bold line 
represents the nucleic acid sequence and boxed areas represent gene coding regions. Arrows 
indicate promoters and the transcription starting point. Lines below represent the mRNA 
transcripts which are labelled according to size (adapted from Gray, Freitag, & Boor 2006).  
PrfA expression is regulated by three promoter regions upstream of the prfA gene, namely; 
PprfAP1 and PprfAP2 which direct a 0.9 kb and 0.8 kb monocistronic prfA mRNA transcript 
respectively, and, the plcA promoter; PplcA which direct a 1.1 kb monocistronic plcA mRNA 
transcript and a 2.1 kb bicistronic plcA-prfA mRNA transcript. 
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1.2.5.2 Listerolysin O 
LLO is described as a cholesterol-dependent pore forming toxin, which is structurally and 
functionally related to cytolysins, another group of pore forming toxins present in some gram 
positive pathogenic bacteria, such as; Bacillus anthracis, Streptococcus pyogenes, 
Streptococcus pneumoniae and Streptococcus suis (Gekara et al. 2010). Structural 
modeling and binding studies have given insight into the likely mechanisms that are involved 
in pore formation. In brief, LLO monomers have 4 domains and are able to bind the 
cholesterol lipid shaft of the primary and secondary phagosome via the tip of domain 4 
(Figure 1.8). In order to form pores, it has been suggested that the monomers diffuse laterally 
to homo-oligermerise into a ring-like pre-pore complex. Subsequently, two α-helices located 
in domain 3, unfurl from domain 2 and become transmembrane hairpins (TMH) called TMH1 
and TMH2. These hairpins are able to insert themselves into the membrane bilayer, where 
they form β-barrels which line the aqueous pore (Schnupf and Portnoy 2007).   
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Figure 1.8. Predicted structure of LLO. The model depicts the 4 LLO domains (D1, D2, D3 
and D4). Undecapeptide and loops are responsible for binding LLO to the phagosome 
membrane at cholesterol lipid shafts. Two sets of α-helices in domain 3 form transmembrane 
hairpins (TMH1 and TMH2), which form the β-barrel pore complex in the phagosome 
membrane bilayer. The acidic triad composed of amino acids D208, E247 and D320 plays a 
role in protein inactivation outside the phagosome and in the host cytoplasm (taken from 
Schnupf and Portnoy 2007). 
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The function of LLO is impaired outside the phagosome and this is due to the cytoplasmic pH 
of the host cell. The pH necessary for optimal activity of LLO is 5.5, while that of the 
phagosome ranges between pH 4.9 and 6.7, and has an average of pH 5.9 (Schnupf and 
Portnoy 2007). The cytoplasmic pH is > 6.0 and LLO therefore becomes denatured and 
functionally hindered within the cytosol. This functional impairment is vital to the pathogenic 
capability of the organism. L. monocytogenes expressing the cytolysin perfringolysin (PFO), 
a protein which is not pH dependent, escapes denaturation by the macrophage phagosomes. 
However, PFO was also active within the host cytoplasm and lysed the plasma membrane. 
This disrupted intracellular replication of the organism and as a result L. monocytogenes 
expressing PFO were avirulent. This provides a possible explanation of the need for a LLO 
pH inactivation mechanism (Schuerch, Wilson-Kubalek, and Tweten 2005). Mutation 
analysis has given insight into the regions vital for pH dependence. In 2005, Schuerch and 
colleagues clearly demonstrated that a LLO
E247M/D320K
 mutant was stable at pH 7.4, while the 
wild type showed reduced haemolytic activity over time at the same pH. The LLO 
D208K
 
mutant had a lethal effect on the E. coli expression cells and therefore could not be studied, 
however the evidence was sufficient to support the hypothesis that the acid triad is 
responsible for LLO pH sensitivity (Schuerch, Wilson-Kubalek, and Tweten 2005). This 
clearly indicated that these juxtaposed amino acids play a role in pH dependence. It has been 
proposed that the three acidic amino acids in D3 become destabilised at cytosolic pH as a 
result of charge repulsion between the three carboxylic groups. However, the pH dependence 
of LLO is not sufficient to drive deprotonation of the carboxylic residues: denaturation is also 
temperature dependent. It has been suggested that > 30°C facilitates the further weakening of 
temperature sensitive interactions such as van der Waal forces, ionic bonds and hydrogen 
bonds (Schuerch, Wilson-Kubalek, and Tweten 2005). As both conditions (> pH 6.0 and > 
30°C) exist in the host cytosol, LLO is readily inactivated outside of the phagosome and 
continues its intracellular cell cycle unhindered. 
 
1.2.5.3 Phospholipases and metalloproteases 
Release from the primary phagosome is also facilitated by the action of two phospholipase 
enzymes, (phosphatidylinositol phospholipase C (PI-PLC; PlcA) and phosphatidylcholine 
phospholipase C (PC-PLC; PlcB)), and a metalloprotease. Phospholipases are dispensable; 
however, they enhance the efficiency of escape from the phagosome. In the absence of PI-
PLC and PC-PLC, the bacterium shows a significant decrease in its ability to escape the 
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primary vacuole and secondary vacuole respectively (Figure 1.9) (Yeung et al. 2007).  
Furthermore it was demonstrated that a mutant lacking both phospholipases was more than 
500-fold less virulent than the wild type strain (Moser et al. 1997; Songer 1997).  
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Figure 1.9. L. monocytogenes intracellular life cycle. plcA mutants are able to enter the cell 
by illiciting phagocytosis. However, unlike the wild type species, they are unable to escape 
the primary vacuole (phagosome) and progress to other stages in the life cycle. plcB mutants 
are unable to escape the secondary vacuole (phagosome) while the wild type is able to 
progress to other stages in the life cycle (taken from Songer 1997). 
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PI-PLC is a ubiquitous enzyme which catalyses the production of D-myo-inositol-1-phosphate 
and diacylglycerol from membrane-bound phosphatidylinositol (PI) by cleavage of its sn3-
phosphodiester bond. The crystal structure of PI-PLC shows that the active site is located at 
the C-terminal and was located by crystallisation with myo-inositol (Moser et al. 1997). The 
enzyme is active between pH 5.5 and pH 7.0 and it is this ability to hydrolyse phagosomal PI 
in an acidic environment which supports evidence that it aids in phagosome lysis (Kuhn, 
Scortti, and Vazquez-Boland 2008). Unlike PI-PLC, PC-PLC is a broad range phospholipase 
(Yeung et al. 2007), which hydrolyses phosphatidylcholine, phosphatidylethanolamine, 
phosphatidylserine and spingomyelin (Kuhn, Scortti, and Vazquez-Boland 2008). PC-PLC is 
expressed as an inactive proenzyme, and activation is dependent on the cleavage of a 24 
amino acid residue by Mpl. The enzyme is also active in the same pH range as PI-PLC and 
while L. monocytogenes is within the cytoplasm, the enzyme is maintained as an inactive 
pool at the membrane-cell wall interface. Once compartmentalised in a phagosome the pool 
of inactive enzyme is activated and translocated across the bacterial cell wall (Yeung et al. 
2007). 
 
Mpl is a member of the thermolysin family, a group of proteins capable of hydrolysing N-
terminal bonds of hydrophobic amino acid residues in some proteins (Forster et al. 2011). 
This property accounts for its ability to cleave the PC-PLC proenzyme. It is also categorised 
as a zymogen, and is therefore expressed as an inactive enzyme. It has been suggested that 
Mpl is a 55 kDa protein composed of a 20 kDa propeptide domain and a 35 kDa catalytic 
domain. Activation of Mpl is an autocatalytic reaction and research carried out by Forester 
and colleagues in 2011 demonstrated that this is pH dependent. They demonstrated that the 
enzyme primarily remains associated with the bacterium at a cytosolic pH, and that upon a 
decrease in pH (a condition found in the phagosome), autocatalysis occurs resulting in release 
of the propeptide and catalytic domain across the bacterial cell wall (Forster et al. 2011).  
Other processes involving the role of Mpl in L. monocytogenes intracellular life cycle has 
been hypothesised. This includes 1) Mpl targets secondary molecules whose degradation is 
required to efficiently transport PC-PLC across the bacterial cell wall, and 2) the protein may 
function as a chaperone by assisting with PC-PLC folding (Yeung, Zagorski, and Marquis 
2005). Exploration of these hypothesises may reveal other roles of Mpl. 
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1.2.5.4 ActA 
When released from the phagosome, the extracellular membrane-bound ActA, is free to 
interact with host cell cytosolic proteins which have an affinity to its protein motifs (Figure 
1.10) (Lambrechts et al. 2008). This interaction is not only led by protein affinity, but also by 
the host mimicry features of ActA.  The N-terminal site constitutes regions A (acidic region), 
AB (actin-binding region) and C (cofilin homology region), all of which mimic the binding 
activity of the Wiskott Aldrich Syndrome Proteins (WASP) and WASP verprolin (Wave) 
protein family. WASP and Wave are activators of actin related proteins 2 and 3 (Arp2/3 
complex) which initiates the growth of a branching network of actin filaments (Bompard and 
Caron 2004). Region AB is a short actin monomer binding motif which putatively contains 
two WASP homology 2 domains. These are short actin binding motives, which, depending on 
the sequence variation are involved in monomer binding, nucleation, or filament elongation. 
In L. monocytogenes, this region binds G-actin, however, it has been reported that this region 
is not essential for L. monocytogenes motility (Lambrechts et al. 2008).  
The central region of ActA is a polyproline region (PLP) containing FPPP or FPPIP motifs. 
The proline rich stretches mimic host cell cytoskeletal proteins such as zyxin, vinculin and 
palladin which are associated with focal adhesion and stress fibres. The proline rich region of 
these proteins and ActA bind host cell Ena-Vasp protein family. Actin-profilin complexes 
interact with Ena-Vasp and may increase the pool of actin monomers, as well as, bind to the 
N-terminal AB region and facilitates shuttling of the G-actin to the growing end of the actin 
filament. 
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Figure 1.10. ActA protein motifs and interacting host proteins involved in actin tail 
formation. The N-terminal site (NH2), is comprised of regions; AB which binds G-actin, and, 
regions A and C which bind Arp2/3 complex. Together this section of ActA mimics the host 
cell‟s WASP/wave protein family, facilitating the recruitment of WASP proteins and 
subsequently more Arp2/3 complex binding. The central site mimics Zyxin/vinculim host 
proteins and is comprised of polyproline region (PLP) which binds Ena-Vasp. Actin-profilin 
protein complexes interact with Vasp proteins, and therefore increase the pool of actin 
polymers (taken from Lambrechts et al. 2008). 
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Other proteins essential to actin tail formation are; cofilin which is involved in filament-
severing and depolymerising, and, capping proteins which regulate barbed end elongation of 
growing filaments. The barbed end is described as the growing end or the point at which the 
actin filament is elongated (Figure 1.11a). The growing actin filament potentially becomes 
branched, forming a network of cross-linked actin filaments (Figure 1.11b). The network of 
branched actin filaments are polarised into a filopodia (Figure 1.11c).  
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Figure 1.11. Components of L. monocytogenes flagella. (a) Formation of actin filament in 
equilibrium, and regulation by actin binding proteins. ATP-actin monomers are shuttled to 
the barbed end as profilin-actin, and, cofilin removes ADP-actin from the pointed end. ADP-
actin are re-phosphorylated and are either stored in complex with thymosine β4 (Tβ4) or 
reused at the barbed end. (b)   The network of actin filaments is comprised of branched and 
elongating filaments and is driven by a number of host cell actin binding proteins.  
Nucleating promoting factors (NPFs) such as WASP, recruit and activates Arp2/3 complex 
which initiates a new starting point for actin filament formation.  Capping proteins terminate 
barbed end filament extension, cofilin re-introduces new actin monomers and α-actinin 
stabilises the network of filaments. (c) A simple representation of filament bundles in 
filapoda. Formin or Ena-VAsp facilitates continuous filament elongation which are bundled 
by fascin and fimbri (adapted from Lambrechts et al. 2008). 
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Initially the network of actin filaments are visible as actin clouds, however, this is eventually 
rearranged into a comet-shaped tail at one pole of the cell. The constant nucleation of actin at 
the barbed end provides the propulsive force which allows the organism to move in the host 
cytoplasm at a speed of up to 30nm/s. It has been proposed that this movement gives the 
added advantage of protection against host cell clearance (Lambrechts et al. 2008).   
 
1.2.5.5 Internalins 
The internalins are a multigene family exclusive to Listeria. This multigene family is present 
in L. monocytogenes and L. ivanovii, and has even been in the nonpathogenic species, L. 
innocua (Vazquez-Boland et al. 2001a). Of this group of proteins, internalin A and internalin 
B (InlA and InlB respectively) were the first to be discovered. Characteristic of the internalin 
protein family is a 20-22 leucine-rich repeat domain (LRR) at their N-terminal domain 
(Figure 1.12) (Seveau, Pizarro-Cerda, and Cossart 2007). Of the 24 proteins known in L. 
monocytogenes, 19 members including internalin A have an LPXTG motif, where X can be 
any amino acid. The motif facilitates adhesion of the protein to the peptidoglycan of the 
bacterial cell wall via covalent bonds (Seveau, Pizarro-Cerda, and Cossart 2007). InB is the 
sole member which has no LPXTG motif. Instead, the protein is bound to the bacterial cell 
wall by glycine/tryptophan-rich (GW) repeat modules which bind cell wall lipoteichoic acid 
by electrostatic force. Representation of this internalin family is shown in Figure 1.12. The 
remaining proteins are all secreted and therefore contain no LPXTG or GW motifs (Seveau, 
Pizarro-Cerda, and Cossart 2007). InlA and InlB have been demonstrated to be involved in 
uptake of the pathogen by non-phagocytic cells. InlA facilitates entry into epithelial cells 
while InlB facilitates invasion of a broader range of cells including; epithelial cells, 
endothelial cells, hepatocytes and fibroblasts (Seveau, Pizarro-Cerda, and Cossart 2007).  
 
InlA is able to facilitate entry into cells via interaction with E-cadherin, an intercellular 
adhesion protein which ensures that cells within tissue are bound together. Interaction with E-
cadherin is due to the specificity of InlA interaction with the proline amino acid at position 16 
of the molecule.   
 
InlB is able to interact with a number of receptor proteins in order to facilitate cell invasion. 
Of the numerous receptors, the c-Met receptor has been described as playing a key role. The 
c-Met receptor is a hepatocyte growth factor with cytoplasmic tyrosine kinase activity. Upon 
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binding of InlB to the receptor, phosphorylation of the cytoplasmic domain is induced and 
this leads to a cascade of signal transduction events which conclude with activation of the 
Arp2/3 complex, cortical actin cytoskeleton rearrangement and phagocytosis of the pathogen.    
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Figure 1.12. Internalin protein family. All the proteins have a signal peptide and the 
characteristic 20-22 leucine rich repeat. The LPXTG motif, where X can be any amino acid, 
anchors the protein in the bacterial cell wall. LPXTG is absent from InlB which uses its GW 
module to anchor itself in the bacterial cell wall. Secreted proteins have no LPXTG motif and 
lack a sorting signal (taken from Seveau et al. 2007). 
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1.2.5.6 Other virulence proteins 
Although the genes located on LIPI-1 and the internalins tend to be the main focus of 
discussion when referring to virulence genes, it is important to note that there are other genes 
which play a key role in pathogenicity of the organism. One of the more frequently 
documented genes include: bsh which allows the organism to survive the acid condition in 
the small intestine caused by the release of bile. Bsh encodes bile salt hydrolases which 
hyrolyses the amide group adjacent to the steroid core, resulting in liberation of the glycine 
and taurine amino acid side chains thus rendering it less toxic to the pathogen (Begley, Hill, 
and Gahan 2006; Zhang et al. 2011). As research in this area increases, virulence-associated 
genes which play a role in the pathogenicity of L. monocytogenes are likely to be uncovered, 
which will ultimately provide clearer understanding of the numerous mechanisms involved in 
host infection. 
 
1.2.6 Identification methods 
Due to the severity of L. monocytogenes infection in high risk individuals, and the observed 
rise in the number of listeriosis cases, there has been an important need to improve techniques 
which offer rapid and discriminatory identification of the organism in order to help improve 
patient care. In the past, identification of the organism was based solely on certain phenotypic 
characteristics; such as motility, Gram stain, haemolysis and the Christie, Atkins, Munch-
Petersen (CAMP) test; however, they are now being superseded by DNA-based methods. 
Although the latter have gained popularity, traditional methods remain valuable for the 
identification of L. monocytogenes, and as such, a brief description is given below, in 
addition to the more recent methods.  
 
1.2.6.1 Phenotypic 
1.2.6.1.1 Christos, Atkins, Munch-Petersen test 
All Listeria species are Gram positive and motile with peritrichous flagella at < 30ºC and 
therefore these tests cannot be used to distinguish L. monocytogenes from other species of the 
same genus. However, the CAMP test, originally designed by Christie et al. in 1944 for the 
detection of group B streptococci, went through an evolutionary period over the years and 
was first described by Fraser in 1962, for the purpose of distinguishing L. monocytogenes 
from other hemolytic Listeria species (McKellar 1994). Briefly, the test is carried out by 
parallelly streaking Staphylococcus aureus and Rhodococcus equi on a rabbit or sheep blood 
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agar plate. The Listeria species to be identified is perpendicularly streaked on the same plate 
but not touching S. aureus and R. equi. Haemolysis by L. monocytogenes is enhanced in the 
vicinity of S. aureus while haemolysis by L. ivanovii is enhanced in the vicinity of R. equi. L. 
seeligeri also displays haemolysis in the vicinity of   S. aureus, but to a lesser extent than L. 
monocytogenes (Figure 1.13) (Gasanov, Hughes, and Hansbro 2005). The remaining Listeria 
spp.: L. grayi, L. innocua, L. marthii, L. rocourtiae and L. welshimeri, are non-haemolytic 
and are therefore CAMP negative.  It is worth noting that there are some L. innocua strains 
that are haemolytic (Liu 2008) as well as L. monocytogenes that are non-hemolytic (for 
example the type strain NCTC 10357 (Jones and Seeliger 1983). Such isolates would 
therefore not be correctly identified using the CAMP test. 
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Figure 1.13. Listeria spp. CAMP Test. The diagram illustrates the type or result expected 
when performing a CAMP test to identify L. monocytogenes, L. ivanovii and L. seeligeri.  
The red circled area is representative of a blood agar plate. Lines represent bacterial growth; 
SA = S. aureus, RE = R. equi, 1 = L. monocytogenes, 2 = L. seeligeri, 3 = L. ivanovii and 4 = 
L. innocua. Arrows indicate areas where β-haemolysis is heavily present. The Listeria species 
to be identified are perpendicularly streaked on the same plate but not touching S. aureus and 
R. equi. Haemolysis by L. monocytogenes is enhanced in the vicinity of S. aureus while 
haemolysis by L. ivanovii is enhanced in the vicinity of R. equi. L. seeligeri also displays 
haemolysis in the vicinity of   S. aureus, but to a lesser extent than L. monocytogenes. 
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1.2.6.1.2 Immunological methods 
Immunological methods used for identification are often available as commercial kits and are 
usually for the identification of Listeria spp. or L. monocytogenes. Immunological methods 
can be divided into four categories; visual immunoprecipitation, latex agglutination, 
immunomagnetic separation (IMS) and enzyme-based immunoassay (EIA). Identification is 
generally base on the simple but effective mechanism of using matrix bound Listeria antisera 
to bind Listeria antigens (Gorski 2008). Briefly, in visual immunoprecipitation, a lateral flow 
cassette is used. The enriched test sample is spotted onto a nitrocellulose membrane and it 
flows to a region of the membrane where gold or other visual detection chemistry is 
conjugated to Listeria antibodies.  Depending on the kit, the appearance of a coloured line is 
indicative of a positive reaction (Gorski 2008). In latex agglutination procedures, a Listeria 
enrichment culture is added to Listeria antiserum bound to latex particles. The reaction is 
carried out on a dark coloured surface and agglutination is visible as white cloudy clumps. 
IMS involves the use of Listeria antibodies bound to magnetic beads. The beads are mixed 
with a contaminated microflora or enrichment culture, and incubated briefly (Gorski 2008). 
The organism is therefore sequestered and concentrated when the beads are washed and 
placed in a smaller volume (Mercanoglu et al. 2003). The beads are plated on a Listeria 
selective medium and identification is based on the appearance of Listeria colonies (or by 
further analysis such a colony immunoblotting (Gorski 2008). Finally, enzyme linked 
immunosorbent assay and enzyme linked immunosorbent fluorimetric assay are forms of 
EIA. Both are methods in which Listeria antisera is bound to a matrix such as a well of a 
microtitre plate. Briefly, an enrichment culture is added, followed by a brief incubation and 
washes. A solution containing another Listeria antiseria conjugated to an enzyme is added 
followed by an enzyme substrate. Listeria is confirmed by presence of colourimetric or 
fluorimetric change that is detected by visual inspection or a microplate reader. An advantage 
of using EIA is that detection is high throughput due to work being carried out in a multiwell 
plate (Gorski 2008).  
 
The disadvantages associated with the use of most kits are: 1) they are often compromised by 
components of enrichment media such as high salt and (2) as they mostly identify Listeria 
spp., further tests are necessary for identification to the species level. This method is 
therefore mostly suitable as a screening tool (Gorski 2008). 
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1.2.6.1.3 Biochemical and API Listeria tests 
 In the past, biochemical tests have been routinely used to differentiate L. monocytogenes 
from other Listeria species, based on differences in abilities to ferment certain sugars (Table 
1.2). However, disadvantages associated with biochemical methods are monetary cost and 
time as confirmation of results can take up to 6 days (Liu 2006). The use of biochemical tests 
remain valuable today, though it has been modified and offered as a small and easy to use 
collection of tests known as API Listeria (BioMérieux) (McLauchlin 1997). The API Listeria 
is inexpensive and offers considerable reduction in identification time as results are available 
in 18- 24 hours. It is offered as 10 individual tests located on a single strip, and are as 
follows; DIM  test (based on the presence or absence of arylamidase), aesculin hydrolysis, 
presence of α-mannosidase and acidification of: D-arabitol, D-xylose, L-rhamnose, α-methyl-
D-glucoside, D-ribose, glucose-1-phosphate and D-tagatose (Table 1.3).  The results are easily 
interpreted by colour changes as detailed by the manufacturer (Bille et al. 1992).  
 
Previously a haemolysis test was required in order to distinguish L. monocytogenes from L. 
innocua as both could at times produce the same identification results (Table 1.2). However, 
the API Listeria negates the need for this as the incorporation of the DIM allows clear 
separation of both species (Table 1.3).  
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Table 1.2. Biochemical test outcomes used to differentiate Listeria spp.. The fermentation 
results of each sugar; L-rhamose, D-mannitol, D-xylose and A-methyl mannoside may be 
positive, negative or variable and the combination of results provides the basis of the 
identification(adapted from Gassanov et al. 2005).  
Key: +, positive reaction; -, negative reaction; and V, variable reaction. 
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D-mannitol - - - - - + 
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Table 1.3. API Listeria test outcomes used to differentiate Listeria spp.. The API is offered as 
10 individual tests located on a single strip, and are as follows; DIM  test (based on the 
presence or absence of arylamidase), aesculin hydrolysis, presence of α-mannosidase and 
acidification of: D-arabitol, D-xylose, L-rhamnose, α-methyl-D-glucoside, D-ribose, glucose-
1-phosphate and D-tagatose (Table 1.3).  The results are easily interpreted by colour changes 
as detailed by the manufacturer. The results may be positive, negative or variable and the 
combination of results provides the basis of the identification (adapted from Bille et al. 1992). 
Key: +, positive reaction; -, negative reaction; and V, variable reaction. 
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DIM - + V V + V + 
Aesculin  
hydrolysis 
+ + + + + + + 
α-
Mannosidase 
+ + - - - + V 
D-Arabitol + + + + + + + 
D-Xylose - - + + + + - 
L-Rhamnose + V - - - V - 
α-Methyl-D-
glucoside 
+ + + + + + V 
D-ribose - - + - - - + 
Glucose-1-
phosphate 
- - + V - - - 
D-Tagatose - - - - - + - 
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As is often the case with most identification methods, API Listeria at times has to be used in 
conjunction with other tests in order to attain confident identification as in a very small 
number of cases it may result in no identification or misidentification. This was reported in 
1992 by Bille et al. who tested a total of 646 Listeria strains (Table 1.4). They tested 258 
strains of L. monocytogenes, 176 L. innocua, 75 L. ivanovii, 76 L. seeligeri and 47 L. 
welshimeri and found that 2.3%, 0.6%, 10.7%, 100% and 6.4% respectively, required 
additional tests for correct identification. A total of 1.3% and 4.3% of L. ivanovii and L. 
welshimeri were not identified while 2.1% of L. welshimeri were misidentified (Table 1.4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
66 
 
Table 1.4. Identification results of 646 Listeria isolates using API Listeria. A total of 258 
strains of L. monocytogenes, 176 L. innocua, 75 L. ivanovii, 76 L. seeligeri and 47 L. 
welshimeri were tested. Results showed that 2.3%, 0.6%, 10.7%, 100% and 6.4% 
respectively, required additional tests for correct identification. A total of 1.3% and 4.3% of 
L. ivanovii and L. welshimeri were not identified while 2.1% of L. welshimeri were 
misidentified. This data shows that API Listeria at times has to be used in conjunction with 
other tests in order to attain confident identification as in a very small number of cases it may 
result in no identification or misidentification (taken from Bille et al. 1992). 
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1.2.6.2 Genotypic 
Genotypic identification methods fall into two main categories; non amplification methods 
and amplification methods. Among the non-amplification methods are DNA-DNA 
hybridisation, gene probe hybridisation, southern blot and fluorescence in situ hybridisation 
(FISH). Amplification methods include traditional PCR, reverse transcription PCR, real time 
PCR and quantitative PCR.  
 
1.2.6.2.1 DNA-DNA hybridisation 
In DNA-DNA hybridisation, the DNA from the type strain is sheared and mixed with the 
radiolabelled DNA of the test isolate. The mixture is heated at 100°C for 3-4 minutes, and 
maintained at 60°C for 16 hours. The DNA is passed through a hypoxyapatite column which 
has the ability to retain double stranded DNA. The column is washed followed by elution of 
DNA. Radioactivity is measured and is commensurate to the amount of Listeria present (Liu 
et al. 2008). The use of radioactive labelling was later replaced with safer and equivalently 
sensitive options such as; biotin, enzymes and SYBR green which has a great affinity for 
dsDNA (Gasanov, Hughes, and Hansbro 2005). 
 
1.2.6.2.2 Gene probe hybridisation, southern blot and fluorescent in situ 
hybridisation  
DNA-DNA hybridisation was later replaced by various probe based detection methods which 
overall offered a reduction in identification time.  A probe is a short stretch of single stranded 
nucleic acid sequence which is specific to a particular gene target and is labelled with an 
enzyme, biotin, fluorescence or a radio isotope. Probe-base detection methods include; gene 
probe hybridisation, southern blot and FISH. Briefly, for gene probe hybridisation, a number 
of targets are available for detection of L. monocytogenes. These mostly include virulence 
genes such as: prfA, hly, inlA, inlB, inlC, inlD, plcA, plcB, mpl, actA, flagellin (fla) and  
invasion-associated protein (iap) (Gasanov, Hughes, and Hansbro 2005).  The overall 
principle involves hybridisation of the probe to test strain isolated DNA which is bound to a 
surface such as: nitrocellulose or nylon membrane or a microtitre plate. This method has been 
useful for the differentiation of Listeria spp. The disadvantage associated with this method is 
poor sensitivity, as a result of low copy number, (usually a minimum of 10
4
 target copy 
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number is required for adequate detection) (Liu et al. 2008). For this reason PCR based 
methods have superseded gene probe hybridisation amplification. 
 
Southern blot is similar to gene probe hybridisation in that a probe is used for detection.  The 
method involves restriction enzyme digestion of test isolate DNA followed by separation of 
the resulting DNA fragments on an agarose gel. The gel is treated with alkali in order to 
produce single stranded fragments. This aids transfer and binding of the nucleic acid onto a 
nitrocellulose or nylon membrane and ultimately probe hybridisation. The membrane is 
baked or exposed to ultraviolet light (in the case of nitrocellulose and nylon, respectively), in 
order to affix the nucleic acid. This is followed by hybridisation of the nucleic acid with a 
fluorescent, chemogenic or radio labelled DNA or RNA probe. Unbound probe is 
subsequently removed by washing and hybridisation is visualised by colourimetric 
development (chemogenic probe), or auto radiography (fluorescent and radio labelled probe). 
This method has been used to differentiate Listeria species and also extends to differentiation 
of serotype 4b strains belonging to lineages I and II as well as further discrimination of IIIA, 
IIIB and IIIC subgroups (Liu et al. 2008). Serotyping will be discussed in more detail in 
section  
 
FISH is another variant of probe gene probe hybridisation and is based on labelling a specific 
sequence in the chromosome so that it becomes visible under a microscope. It involves fixing 
test whole bacteria cells to a glass slide or to the well of a microtitre plate. The cells are 
permeabilised by incubation with proteinase K. This is followed by addition of a 
fluorescently labelled probe specific for 16S rRNA genes.  The cells are then visualised under 
a microscope. All species of Listeria are identifiable using (Liu et al. 2008). 
1.2.6.2.3 PCR amplification based methods 
The polymerase chain reaction (PCR), a method developed by Kary Mullis in 1983, allows 
the exponential amplification of a gene target using key reaction components such as; primers 
which flank the nucleic acid target of interest and a heat stable polymerase necessary 
enzymatic amplification. It is widely applied for identification of L. monocytogenes and 
distinguishing the organism from other Listeria species. Targets genes commonly used for 
identification include, (but are not limited to), virulence genes. In its traditional and simple 
form, amplified gene target products are visualised by separation on an agarose gel, followed 
69 
 
by staining with a DNA chelating compound such as ethidium bromide. The presence of a 
DNA band of expected size is indicative of positive identification. This method has been 
employed over decades by numerous researchers: In 1991, Thomas et al. were able to 
distinguish L. monocytogenes from other Listeria species by the amplification of the 
listerolysin O genes regions unique to the organism (Thomas et al. 1991).  
 
A number of PCR variants have also been implemented for identification, some of which 
include nested PCR, multiplex PCR, real time PCR and reverse transcriptase PCR. Briefly, 
nested PCR is used in instances where increased sensitivity is required, normally due to a low 
number of target organisms. It requires the use of two sets of primers, used in separate 
amplification rounds. In the first amplification, a larger target area is amplified. The PCR 
products are transferred to a second reaction tube where the second set of primers are used to 
amplify a region within the PCR products.  Disadvantages associated with nested PCR are 
that it requires more time than conventional PCR and there is a chance of introducing 
contaminants  in the process of transferring PCR products from the first PCR round to the 
second (Liu et al. 2008). Multiplex PCR permits simultaneous amplification of more than one 
gene. One of the first multiplex PCR assays designed for detection of L. monocytogenes was 
described by Furrer et al. in 1991, which based identification on the amplification of unique 
hly and iap gene regions (Furrer et al. 1991). Amplification of both genes is distinguishable 
by the visualisation of bands of different and expected sizes. A real time PCR assay involves 
the use of a fluorescent, DNA intercalating dye, such as SYBR green or EVA green, during 
the amplification process. The dye is introduced to the reaction mixture, and is less 
fluorescent in its unbound state. As the sequence is amplified, the dye binds to the double 
stranded DNA and fluoresces. The fluorescence is therefore at its highest when the number of 
amplicons is at its highest. This signal is detected by an optical sensor which monitors the 
process in real time. The advantage associated with this method is that it negates the need to 
separate the amplified fragments on an agarose gel. The results are therefore available shortly 
following the PCR. Additionally, multiplex real time PCR is possible provided that melt 
curve analysis is performed after PCR amplification is complete. This involves melting the 
dsDNA by a gradual increase in temperature. As the temperature is increased, the dsDNA is 
denatured and the dye is released, resulting in a decrease in fluorescence. The decrease in 
fluorescence is continuously detected in order to deduce the melting temperature (Tm).  The 
Tm is defined as the point when 50% of the amplicons are double stranded and 50% are 
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single stranded and the resulting melt curve data are plotted as fluorescence versus time. This 
is known as melt curve analysis and is useful provided that the melting temperatures of each 
set of PCR products are sufficiently different (Liu et al. 2008). Unlike the methods previously 
described which requires DNA, reverse transcription PCR involves the use of mRNA from 
which complementary DNA is synthesised by a reverse transcriptase. This can be followed 
by the traditional PCR reaction and can be performed in the same reaction mixture. The 
advantage of this method is that it is highly sensitive, as it allows identification from a sample 
with a low copy number of mRNA molecules (Liu et al. 2008).     
 
1.2.6.3 Outbreak investigation 
Though useful, species level identification of L. monocytogenes is not sufficient for control of 
outbreaks in the human populations as it is not discriminatory. Discriminatory methods are 
valuable in efforts to control outbreaks as the information allows us to distinguish outbreak 
strains as well as provide a link to the source of contamination. Outbreak investigation 
methods therefore probe the organism even further than the phenotypic and genotypic 
identification methods previously discussed, providing a means of characterising the 
organism in greater detail.  
1.2.6.3.1 Serological serotyping 
Isolates that have been identified as L .monocytogenes can be further subdivided into 
subtypes by serotyping. Serotyping is a once widely used traditional phenotypic method 
which involves agglutination of the somatic (O) and flagella (H) proteins with corresponding 
antibodies. There are 15 Listeria somatic (O) antigens subtypes (I-XV) and 4 flagella (H) 
subtypes (A-D). Serotypes are determined by unique combinations of O and H antigens 
(Table 1.5), and based on the agglutination pattern L. monocytogenes is divided into at least 
13 serotypes (Kerouanton et al. 2010; Liu 2006; Ragon et al. 2008). 
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Table 1.5. List of O and H antigens that agglutinate to form serotypes of Listeria. There are 
15 Listeria somatic (O) antigens subtypes (I-XV) and 4 flagella (H) subtypes (A-D). 
Serotypes are determined by unique combinations of O and H antigens, and based on the 
agglutination pattern L. monocytogenes can be divided into at least 13 serotypes(taken from 
Liu 2006). 
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There are a number of  limitations associated with the use of this assay; (1) the high cost of 
obtaining antisera, (2) the inability to correlate serotype with species, a problem in the case of 
L. monocytogenes and L. seeligeri as both species contain serotypes 1/2a, 1/2b, 3b, 4a, 4b, 4c, 
and 6b, (3) the technical expertise required, (4) the difficulty in conclusively determining 
different serotypes and (5) discrepancies in results due to changes in the phenotypic 
characteristics of the bacteria. For these reasons, alternative methods have been explored 
which has seen serological serotyping being replaced by molecular serotyping. 
1.2.6.3.2 Molecular serotyping 
A number of molecular serotyping assays have been developed and includes methods 
designed by; Doumith and colleagues, 2004: Doumith and colleagues, 2005; Zhang and 
Knabel, 2005; and De Santis and colleagues, 2007 (Kerouanton et al. 2010). The technique 
involved in all methods revolve around the same principle, which is the use of a multiplex 
PCR assay for amplification of genus-specific, species-specific, and serotype-specific genes. 
Doumith and colleagues designed primers to amplify L. monocytogenes gene targets 
lmo0737, lmo1118, ORF2819, ORF2819, ORF2110 and prs. These gene targets are present 
in specific serotypes of the organism and based on the presence or absence of certain bands, 
L. monocytogenes can be differentiated into sero-specific groups (Table 1.6) (Doumith et al. 
2004).  
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Table 1.6. Gene targets which distinguish major L. monocytogenes serotypes. Doumith and 
colleagues designed primers to amplify L. monocytogenes gene targets lmo0737, lmo1118, 
ORF2819, ORF2819, ORF2110 and prs. These gene targets are present in specific serotypes 
of the organism and based on the presence or absence of certain bands, L. monocytogenes can 
be differentiated into sero-specific groups (adapted from Doumith et al. 2004). 
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A limitation to this method is its inability to discriminate: serotype 1/2a from 3a, serotype 
1/2b from 3b and 7, serotype 1/2c from 3c and serotype 4b from serotype 4d and 4e. 
However, serotypes 3a, 3b, 7, 4d and 4e are infrequently isolated from food and rarely 
implicated in disease (Doumith et al. 2004; Kerouanton et al. 2010), hence the method still 
remains valuable. 
 
In a more recent study Kérouanton colleagues (2010) published an alternative multiplex PCR 
assay for L. monocytogenes serotyping. This simply incorporated all targets designed by 
Doumith and colleagues in 2004 and included a prfA gene target designed by D‟Agostino and 
colleagues in 2004, for species-specific recognition (Kerouanton et al. 2010). Similar to the 
method described by Doumith and colleagues, this method fails to discriminate certain 
serotypes. Nevertheless, there are a number of merits associated with using both multiplex 
PCR assays, such as; (1) results are available quickly (within 1 day instead of 5 days as is the 
case with serological serotyping), (2) PCR patterns are easier to interpret than agglutination 
patterns (Kerouanton et al. 2010), (3) little expertise is required (relative to serological 
serotyping), (4) results are reproducible (as opposed to serological serotyping) and (5) the 
method is cheaper.  It must however be mentioned that, serotyping is a first level of 
discrimination and that subtyping methods such as; pulse field gel electrophoresis (PFGE), 
amplified fragment length polymorphism (AFLP), (multilocus sequence typing) MLST and 
(variable number tandem repeats) VNTR, are required for epidemiological monitoring of 
food and human isolates in the event of an outbreak (Kerouanton et al. 2010). 
 
1.2.6.3.3 Pulse field gel electrophoresis 
Pulse field gel electrophoresis (PFGE), is widely known as the international gold standard for 
L. monocytogenes subtyping (Kerouanton et al. 2010). The method involves extraction and 
digestion of L. monocytogenes DNA with a rare cutting restriction enzyme, yielding 8-25 
large fragments ranging in size from 20kb to over 20Mb (Nightingale 2010). Following 
restriction, the DNA is slowly separated on an agarose gel (for 30-50hrs) by applying 
alternating currents, which cause the DNA to move back and forth, resulting in higher 
resolution. This method has been used to divide L. monocytogenes into four lineages, and to 
discriminate isolates belonging to the same serotype, therefore allowing the differentiation of 
strains which are implicated in outbreaks. While PFGE is more discriminatory, there are 
limitations associated with its use, such, as; (1) it is time consuming - requiring up to 
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approximately 2 days for completion (Liu 2006), (2) it requires expertise and (3) the results at 
times do not translate across other laboratories, as different restriction enzymes are often 
used, therefore producing profiles that are not comparable. Due to these limitations PFGE is 
therefore not widely used (Liu 2006).  
 
1.2.6.3.4 Amplified fragment length polymorphism 
In 2002, an amplified fragment length polymorphism (AFLP) method was designed by 
Guerra and colleagues for L. monocytogenes subtyping. This proved to be quicker than PFGE 
(Guerra, Bernardo, and McLauchlin 2002) and was later, further developed and has been 
adopted as a molecular subtyping method by the Foodborne Pathogen Reference Unit 
(FBPRU), Heath Protection Agency (HPA), London, (Corcoran et al. 2006). This involved 
digestion of extracted DNA with a frequent cutting and a rare cutting restriction enzyme. 
Adaptors were ligated to complimentary ends of the restriction site and primers 
complementary to the adaptors were used to PCR amplify selected fragments (Parisi et al. 
2010). The targets were separated by agarose gel electrophoresis and banding patterns 
recorded. Both AFLP and PFGE may vary between laboratories due to the use of different 
restriction enzymes. 
 
1.2.6.3.5 Multilocus sequence typing  
Multilocus sequence typing (MLST) relies on variation in nucleic acids sequence among 
seven chromosomal loci (usually 450 - 600 bp) (Nightingale 2010).  A number of MSLT 
typing schemes have been designed for L. monocytogenes subtyping, which target 
housekeeping genes, virulence genes, or a combination of both (Nightingale 2010). The 
method involves PCR amplification of each sequence, followed by DNA sequencing. Using 
bioinformatics tools, the sequences of each loci are aligned and polymorphic sites identified. 
Allelic types are assigned based on polymorphisms and MLST types are assigned based on 
unique combinations of polymorphisms (Nightingale 2010; Parisi et al. 2010).  MLST has 
become a robust tool for global epidemiological survey of microbial populations (Parisi et al. 
2010), with a web-based database existing for L. monocytogenes 
(http://www.pasteur.fr/recherche/genopole/PF8/mlst/Lmono.html). Such a database enables 
inter-laboratory sequence data to be compared (Parisi et al. 2010). Other advantages include 
its potential to provide evolutionary information. For example, in 2008, Ragon and 
colleagues analysed MLST data and were able to suggest that serotype 4b and 1/2c diverged 
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from 1/2b and 1/2a respectively (Ragon et al. 2008).  However, as the method is costlier and 
time consuming relative to AFLP (Parisi et al. 2010) and PFGE, it therefore has not 
superseded PFGE as the gold standard.  
 
1.2.6.3.6 Multilocus variable number tandem repeat analysis  
Multilocus variable number tandem repeat analysis (MLVA) is based on detection of a 
number of tandem repeat sequences (TRs) at specific loci in the chromosome. Mutations in 
TRs can occur during events such as DNA replication and recombination, leading to size 
changes and thus giving rise to the name variable number tandem repeats (VNTR) 
(Nightingale 2010). Recently, VNTR detection at multiple L. monocytogenes loci has been 
proven as a simple and reproducible subtyping method which is more discriminatory than 
PFGE (Chen et al. 2011). Briefly, in 2011 Chen and colleagues designed an MLVA method 
which involved amplification of the VNTR in a multiplex PCR. The products were resolved 
by capillary electrophoresis and fragment sizes determined using software analysis. The 
number of fragments was also determined and an allele numbering system assigned based on 
the number of TRs at each locus (Chen et al. 2011). In 2010, Nightingale speculated that, in 
future, a standardised MLVA protocol using well-characterised VNTR, may replace or 
complement PFGE, and subsequently, in 2011 Chen and colleagues have demonstrated the 
possibility of this occurrence.    
 
1.3 Proteomics: A new approach to identification, diagnosis and 
characterisation 
1.3.1 Matrix Assisted Laser Desorption/Ionisation - Time of Flight - Mass Spectrometry 
(MALDI-TOF-MS) 
 
Matrix Assisted Laser Desorption/Ionisation - Time of Flight - Mass Spectrometry (MALDI-
TOF-MS) is an analytical method used to measure the mass-to-charge (m/z) ratio of a range 
of macromolecular ions. It has a vast number of applications which include; the 
characterisation of synthetic polymers, the analysis of peptides and proteins, DNA and oligo 
nucleotide sequencing and the characterisation of recombinant proteins (Bucknall et al. 
2002). The method typically involves applying the analyte to a target plate followed by 
mixing of the analyte with a matrix solution which is then allowed to air dry. The purpose of 
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the matrix is to co-crystalise with the sample and allow ionisation of the macromolecular ions 
upon exposer to laser energy in the proceeding step. Once the target plate is loaded into the 
MALDI-TOF Mass Spectrometer pulses of laser energy are fired onto the sample. This 
causes excitation of the molecules and their conversion into gaseous phase ions, which travel 
through a vacuum flight tube. Each ion travelling through the flight tube has a specific m/z 
ratio. The mass of each ion is determined by their time taken to reach a detector. Smaller ions 
will travel faster and reach the detector more quickly than larger ions. The masses detected 
are compiled to give a spectral fingerprint (mass spectrum) (Emonet et al. 2010). This 
spectral fingerprint provides a means of detecting molecules based on their size. Over the 
years this technology has been interfaced with software analysis so that the spectral 
fingerprints of numerous samples can be compared reliably. An initial step in this procedure 
is the generation of a superspectrum which is a composite mass spectrum of peaks shared by 
replicates of similar samples. The result of generating a number of superspectra is the 
generation of a database of various samples. The overall aim is to allow identification of an 
unknown sample by comparing its mass spectrum with known samples in the database. This 
is simply described as pattern matching.  
 
This pattern matching principle can be applied to various areas of research. A survery of the 
literature shows that it is gradually being implemented in environmental, food and clinical 
microbiology research laboratories. Companies such as BioMérieux have developed the 
Shimadzu Launchpad software to compare the spectral profile to the superspectra in the 
Spectral ARchive And Microbial Identification System (SARAMIS) database. The MALDI 
BioTyper (software and database) is utilised by Brucker. The result of comparisons made by 
Brucker‟s MALDI Biotyper and Shimadzu Launchpad is the determination of the closet 
possible match and is the basis of identification (Emonet et al. 2010). 
 
SARAMIS uses a linear confidence level score which is expressed as a percentage. This is 
equal to one-tenth of the accumulation points of matching with an upper cut-off of 999 
points. On the other hand the MALDI Biotyper classifies results using a coefficient score 
which is the alogortihm of the points calculated by a different algorithm (Khöling et al. 
2012). 
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As MALDI-TOF-MS is a sensitive method, it is currently being explored by other researchers 
as a method for the rapid identification of microorganisms directly from blood and urine 
samples without the need to isolate colonies. In 2010 Ferrieria et al. tested 238 urine samples 
and 68 blood culture samples using conventional methods and MALDI-TOF-MS (Ferrieria et 
al. 2010). Sample preparation involved two brief centrifugation steps in order to retrieve the 
bacteria. Results showed that, using MALDI-TOF-MS, 91.8% of urine isolates were 
identified at the species level and 92.7% were identified at the genus level, while 76% of 
blood culture isolates were identified to the species level and 96% were identified to the 
genus level. All results were confirmed using conventional biochemical tests. 
 
Recently, in 2013 Leli et al. used MALDI-TOF MS to identify bacteria present in 109 blood 
cultures. They obtained correct identification for 57/62 (91.9%) aerobic/facultative anaerobic 
Gram-positive isolates, 53 (85.5%) at species level, and 4 (6.4%) at the genus level; 32/32 
(100%) aerobic/facultative anaerobic Gram-negative isolates, 31 (96.9%) at species level, and 
1 (3.1%) at the genus level; 7/7 (100%) obligate anaerobes, all at the genus level isolates. 
They found that the results were comparable to standard reference or automated methods. 
They also found that overall, the median identification time of MALDI-TOF MS vs reference 
standard methods was significantly shorter (Leli et al. 2013). Publications such as these 
continue to highlight the value of MALDI-TOF-MS. 
 
 
1.3.2 Surface Enhanced Laser Desorption/Ionisation - Time of Flight - Mass 
Spectrometry (SELDI-TOF-MS) 
 
Surface Enhanced Laser Desorption/Ionisation Time of Flight Mass Spectrometry (SELDI-
TOF-MS) is a variation of MALDI-TOF-MS. The technology utilises ProteinChip arrays 
with a variety of surface chemistries that facilitate the capture and detection of a specific 
category of proteins prior to mass spectral analysis. SELDI-TOF-MS is a valuable tool for 
biomarker discovery and characterisation of microbes (Shah et al. 2005). A biomarker is 
molecule found in an organism and is a sign of a normal or an abnormal process. It can be a 
variety of molecules such as DNA, RNA, protein and other metabolites (Paul et. al. 2013). 
Chip arrays that are frequently used include Q10 (strong anion exchange) which captures 
negatively charged proteins, CM10 (weak cation exchange) which captures positively 
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charged proteins, IMAC30 (immobilized metal affinity capture) which captures proteins that 
bind polyvalent metal ions, as well as, H50 and H4 ( hydrophobic) which captures large and 
small proteins respectively through hydrophobic interactions. Captured low molecular weight 
proteins which are not visible by sodium dodecyly (SDS)-polyacrylamide gel electrophoresis 
(PAGE) are usually resolved by SELDI-TOF-MS. This is evident upon converting the spectra 
into a gel view and comparing the images (Figure 1.14). 
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Figure 1.14. Comparison of a bacterial cell extract separated by SDS-PAGE and visualised 
using Coomassie Brilliant Blue (Top). Several peptides/proteins not seen by the SDS-PAGE, 
particularly the low molecular weightmolecules are resolved by SELDI-TOF-MS (bottom 
spectrum). The intensities of the mass ions in the spectrum are represented as a „Gel View‟ 
image (middle) for comparison (taken from Shah et al. 2005) 
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Since then, data emerging within the field of microbiology continue to highlight the value of 
SELDI-TOF-MS. In 2011 Shah and colleagues used the technology along with software 
analysis to trace the transition of methicillin resistance in sub-populations of Staphylococcus 
aureus (Shah et al. 2011). Also, in 2011 Kiehntopf and colleuages used SELDI-TOF-MS to 
differentiate Campylobacter species (Kiehntopf et al. 2011).  
 
While the analysis of spectra generated by MALDI-TOF-MS has been standardised, the 
analysis of SELDI-TOF-MS data are not yet standardised and various alogarithms are utilised 
by different laboratories. Shah and colleagues used artificial neural network (Shah et al. 
2011) while Kientopf and colleagues used ProteinChip Data Manager (Bio-rad) (Kiehntopf et 
al. 2011). However, analysis of SELDI-TOF-MS data using various logarithms makes it 
difficult to compare results across laboratories.  
 
1.3.3 Diagnostic use of proteomic techniques 
 
As mentioned in section 1.3.1 proteomic techniques such as MALDT-TOF-MS have been 
successfully introduced in microbiology diagnostic laboratories with results comparable to 
traditional biochemical tests. The added advantage of this approach is a drastic reduction in 
identification time. The technique also has diagnostic value in identifying biomarkers of 
human diseases and is being used to identify clinically diverse diseases such as cancer. In 
2013, Paul and colleagues published a review which detailed the application of mass 
spectrometry based proteomics in molecular diagnostics, with particular reference to 
discovery of cancer biomarkers (Paul et. al. 2013). According to their review, almost all 
proteomic biomarker discovery platform use mass spectrometry as the central technique in 
asscociation with other proteomic approaches. These approaches can either be gel based 
(such as 2-dimensional (2-D) gel electrophoresis and 2-D Differential in gel electrophoresis) 
or gel free (such as Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) or 
Isobaric Tag for Relative and Absolute Quantitation (iTRAQ)).  
 
A survey of the literature continues to show the diagnostic value of proteomic techniques 
across various diseases. In 2013, Di Domenico and colleagues used gel-based method, 2-D-
PAGE coupled to mass spectrometry to identify high levels of several proteins indicative of 
Brugada Syndrome, a polygenic inherited cardiac disease characterised by life-threathening 
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arrhythmias and a high coincidence of sudden death. They hypothesised that the proteins 
which include apolipoprotein E, thrombin and vitamin D binding protein are potential 
markers for identification of the disease status (Di Domenico et al. 2013). In 2013, 
Kroksveen and colleagues, used iTRAQ and Orbitrap MS to discover cerebrospinal fluid 
proteins with significant difference between early multiple sclerosis patients and controls.  
They reported a significant abundance of alpha-1-antichymotrypsin, contactin-1, 
apolipoprotein D, clusterin, and kallikrein-6 and suggested that they may serve as diagnostic 
or prognostic biomarkers for multiple sclerosis. A survey of the literature also reveals that use 
of these mass spectrometry coupled techniques in diagnostic investigation is increasing 
across a vast number of diseases.  
 
1.3.4 Listeria monocytogenes proteomics 
 
As discussed previously proteomic approaches to diagnosis of diseases now frequently 
involves the use of mass spectrometry based approaches. The same appears to be true for L. 
monocytogenes proteomic investigations. As L. monocytogenes is capabable of surving 
adverse conditions such as freezing tempeartures, high salt and a broad pH range relative to 
other foodborne pathogens (see section 1.2.2), and since these factors contribute to its 
persistence in food and subsequently its ability to cause listeriosis, survival under these 
conditions continue to be the focus of proteomic studies. This is the case as proteins are the 
driving force of metabolic functions that enable the organism to survive these conditions, and 
in the case of virulence proteins (section 1.2.5) enables the organism to evade the host‟s 
physical and immune defence system. One metabolic ability which to date is not fully 
understood is the organism‟s ability to evade a valuable host defence measure, which is the 
high bile-salt condition throughout the gastro intestinal tract. In 2013, using multidimensional 
protein identification technology coupled with electrospray ionisation tandem mass 
spectrometry, Payne and colleagues were able to identify significant alterations in the 
presence of cell-wall-associated proteins, DNA repair proteins, protein folding chaperones 
and oxidative stress-response proteins. They report that using the type strain, 6 cell-envelop-
associated proteins showed an increase in expression greater than 1-fold, 5 proteins 
associated with metabolic functions showed an increase in expression greater than 2-fold, 
whilst 11 proteins associated with information pathways, such as DNA repair, showed an 
increase in expression greater than 3-fold (Payne et al. 2013). This publication is one of many 
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highlighting that the fact that knowledge regarding L. monocytoegenes proteomics is 
expanding tremendously, with protein expression at various growth conditions and amongst 
various virulent and non-virulent strains being tested and compared. This view is further 
supported by the evidence provided in this study. The evidence presented in  the results and 
discussion chapters expands our knowledge regarding L. monocytogenes proteomics by 
indicating a number of proteins differentially expressed at cold and ambient temperatures.   
 
1.3.5 Lysis of cells 
 
A preamble to proteomic analysis necessitates efficient extraction of proteins that are 
representative of the entire cell. However, complete lysis of Listeria spp. is very difficult. 
Isolated dry cell walls of Listeria strains are compose of about 30-40% peptidoglycan and the 
bulk of the wall is a carbohydrate of teichoic acids (Fielder 1988). The multilayered network 
of the peptidoglycan polymer and the extension of the cell wall by teichoic acids accounts for 
the robustness and difficulty in cell lysis. Lysostaphin, lysozyme and achromopeptidase are 
effective in lysing some Gram positive bacteria, however, Listeria in particular appears to be 
resistant (Fliss et al. 1991; Kämpfer et al. 1995.  In 1991 Fliss and colleagues, and 1995 
Kämpfer and colleagues reported successful lysis of the bacteria with enzymes such as 
mutanolysin (Fliss et al. 1991 and Kämpfer et al. 1995). This enzyme was originally purified 
from Streptomyces globisporous, and is recommended for lysis of a variety of Gram positive 
organisms (Fliss et al. 1991). However, recent developments show that endolysin, a Listeria 
specific enzyme, is more efficient in lysis of the organism.  Endolysin is a term used to 
describe a broad range of bacteriophage lysins which are expressed by phages for the purpose 
of aiding their escape from their host cells (Loessner, M., et al., 2005; Courchesne, et al., 
2009). These enzymes show extraordinary substrate specificity and high activity when added 
to Listeria cells, leading to the rapid degradation of the murein layers (Korndörfer et al. 
2006). In 1995, Loessner and colleagues showed that 10 units of the enzyme was sufficient to 
clear a suspension of L. monocytogenes which was grown to the end of log phase, in a 10 ml 
volume of tryptose broth (Figure 1.15).  
 
The enzyme is not commercially available. However, the use of the phage was recently 
approved by the United States Food and Drug Administration as an ingredient in Listex 
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P1000, a product for control of Listeria sp. in both raw and ready to eat products (Sonia et al 
2010).  
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Figure 1.15.  Lysis of L. monocytogenes WSLC1001 cells by bacteriophage endolysin. The 
plot of absorbance (y-axis) vs time (x-axis) shows that after 8 minutes the density of L. 
monocytoegenes present in the cell suspension decreased from 2.5 to ~0.1 A600 in 8 minutes. 
This data shows the efficiency of endolysin in lysing the species (taken from Loessner et al 
1995). 
 
The use of this enzyme may be valuable in Listeria proteomics research, facilitating greater 
amount of cytosolic protein for investigative studies. The conserved size of the Listeria 
genome is 2.8 - 3.2 Mb (den Bakker et al. 2010). Therefore theoretically the amount of 
protein that may be expected following efficient cell lysis would be 28 - 32 mg/ml. However, 
in reality, this figure is expected to decrease as a result of various factors such as the presence 
of introns, and changes in expression due to environmental conditions such as media and pH. 
Nevertheless, use of this enzyme may allow access to proteins which are not affected by these 
conditions. 
   
1.4 Hypotheses 
 
There is a large body of published data concerning the use of MALDI-TOF-MS for the rapid 
identification of bacterial species including L. monocytogenes, as detailed by Barbuddhe and 
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colleagues (Barbuddhe et al. 2008). By contrast, SELDI-TO-MS has received less attention, 
but has the potential to characterize microbial species at a higher resolution. The output of the 
data from these instruments are complex and represent mass ions derived mainly from 
proteins. Numerous mathematical approaches suach as dendrograms, heat maps, artificial 
neral networks are used to group isolates by similatity of their mass ion profiles into species, 
subspecies and types. It is envisaged that the generation of heat maps will be another 
approach to revealing the diversity to the Listeria species.   
 
In common with other soil-derived human pathogens, L. monocytogenes has the capacity to 
grow over a wide temperature distribution. Consequently, there has been significant research 
into the molecular mechanisms that enable this organism to survive under these conditions. A 
review of the literature show that most of these investigations are carried out using the type 
strain which appears to be atypical of the species. It is envisaged that analysis of clinical and 
food isolates will show that that there are proteins which may be expressed in these isolates 
which are not present in the type strain. Should these proteins be present, they may serve as 
biomarkers of the L. monocytogenes presence at 4°C.        
 
 
1.5 Aims and Objectives 
The overall aim of this thesis was to use proteomic approaches to further characterise L. 
monocytogenes and subsequently assess the applicability of the information for tracing 
outbreak investigations. 
 
The project had two specific aims:  
 
1) to investigate the potential of proteomic-based platforms such as mass spectrometry to 
further characterise isolates of this Listeria. 
 
2) to use proteomic tools to analyse proteins which may be differentially expressed at two 
selected temperatures, 4°C and 37°C. 
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Chapter 2: Materials and Methods 
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2.1. Selection of isolates for entire study 
Clinical and food isolates were obtained from the FPRU, and the HPA identification number, 
serotype, source and AFLP profile of each isolate was recorded. Isolates were also obtained 
from DBHT which were originally obtained from NCTC and DSMZ (Table 2.1). Isolate were 
kept at - 80°C on storage beads (Pro-Lab Diagnostics), and when required, were cultured on a 
blood nutrient (BN) (HPA media department) agar plate and incubated overnight under 
aerobic conditions at 37°C. The exception was Brochothrix spp. which was cultured on APT 
(HPA media department) plates and incubated at 30°C. Purity was verified by visual 
inspection before use. To replenish stocks, each isolate was sub-cultured from a single colony 
and grown under the previously stated conditions. Purity was verified as before and isolates 
stored on - 80°C storage beads for later use in this study.  
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Table 2.1. List of isolates used in this study. If available information on strain number, 
serotype, source and AFLP pattern was also tabulated.  
Organism  Isolate 
Identification  
Number 
Serotype Source AFLP 
L. monocytogenes H10 162 0552 4b Human I 
L. monocytogenes H08 446 0286 4b Food I 
L. monocytogenes H09 012 0053 1/2b Food II 
L. monocytogenes H08 490 0250 1/2c Food VII+1 
L. monocytogenes H10 146 0091 1/2a Food IX 
L. monocytogenes H08 074 0271 1/2a Human IX 
L. monocytogenes F2365 4b Human - 
L. monocytogenes H08 162 0317 1/2a Human III 
L. monocytogenes H08 126 0107 4b Human XV 
L. monocytogenes H09 088 0603 4b Human V 
L. monocytogenes H08 180 0412 1/2a Human XI+1 
L. monocytogenes H08 520 0220 1/2b Human IIa 
L. monocytogenes H08 352 0191 1/2b Human IV-1 
L. monocytogenes  H08 282 0003 1/2a Food VI 
L. monocytogenes H08 156 0404 1/2a Food XII 
L. monocytogenes H08 224 0145 1/2c Food VIIf 
L. monocytogenes H08 382 0048 4b Food V 
L. monocytogenes H08 454 0569 4b Human V+2 
L. monocytogenes H08 136 0109 1/2c 1/2c VII 
L. monocytogenes H08 164 0195 1/2a Food XI-1 
L. monocytogenes H08 344 0402 1/2a Human VIIh 
L. monocytogenes H08 374 0182 4b Human IV-1 
L. monocytogenes H08 384 0314 1/2a Human XI+1 
L. monocytogenes H09 052 0645 1/2a Food XVI 
L. monocytogenes H09 112 0012 1/2a Food IV 
L. monocytogenes H09 224 0336 1/2a Food XIVd 
L. monocytogenes H09 224 0355 4b Human V 
L. monocytogenes H09 232 0063 4b Human  I 
L. monocytogenes H09 094 0336 4b Human V 
L. monocytogenes H09 296 0322 1/2a Human IX 
L. monocytogenes H08 396 0517 1/2a Human IX 
L. monocytogenes H09 354 0308 4b Human I 
L. monocytogenes H09 404 0479 4b Human I 
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L. monocytogenes H09 314 0192 1/2a Human IX 
L. monocytogenes H09 420 0585 4b Human I 
L. monocytogenes H09 066 0222 1/2a Human IX 
L. monocytogenes H09 400 0324 4b Human I 
L. monocytogenes H09 062 0066 1/2a Human IX 
L. monocytogenes H09 364 0232 4b Human  I 
L. monocytogenes H08 360 0121 1/2a Human  IX 
L. monocytogenes H09 392 0041 1/2c Food VII-1 
L. monocytogenes H10 172 0401 1/2a Human VII 
L. monocytogenes H10 170 0375 1/2a Food VII 
L. monocytogenes H10 126 0369 1/2a Food IX 
L. monocytogenes H10 074 0236 1/2b Human II 
L. monocytogenes H09 406 0833 1/2c Human VII 
L. monocytogenes H10 044 0420 1/2c Food IV 
L. monocytogenes H08 262 0274 1/2b Human IV 
L. monocytogenes H09 076 0244 1/2c Food VII 
L. monocytogenes H10 046 0271 1/2c Food VII 
L. monocytogenes H09 510 0595 1/2a Human IIIa 
L. monocytogenes H10 112 0014 4b Food IV 
L. monocytogenes H10 1780389 4b Human IV 
L. monocytogenes H09 348 0558 4b Human V 
L. monocytogenes H08 476 0100 4b Food  V 
L. monocytogenes H10 202 0622 1/2c Human VII 
L. seeligeri H09 032 0787 - Food - 
L. innocua H09 304 0186 - Human - 
L. ivanovii H09 032 0783 - Food - 
L. welshimeri H09 032 0784 - Food - 
L. grayi H09 032  7077 - Food - 
L. monocytogenes NCTC 10357 1/2c Rabbit - 
L. monocytogenes NCTC 4883 4c Bird - 
L. monocytogenes NCTC 10888 4d Sheep - 
L. monocytogenes NCTC 5214 4a Sheep - 
L. monocytogenes NCTC 12426 4bX - - 
L. monocytogenes NCTC 4885 4b Human - 
L. monocytogenes NCTC 12480 4b - - 
L. monocytogenes NCTC 11994 4b Food - 
L. monocytogenes NCTC 5348 1/2c Mammal  
L. monocytogenes NCTC 7974 1a Human - 
L. monocytogenes NCTC 10890 7 Human - 
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L. grayi subsp.  
grayi 
NCTC 10815               - Plant - 
L. grayi subsp. 
murrayi 
NCTC 10812 - Plant  
L. grayi subsp. 
murrayi 
NCTC 10813 - Plant - 
L. grayi subsp. 
murrayi 
NCTC 10814 - Plant - 
L. ivanovii subsp. 
londoniensis 
NCTC 12701 - - - 
L. innocua NCTC 11288               6a Cow - 
L. ivanovii subsp. 
ivanovii 
NCTC 11846               - Sheep - 
L. seeligeri NCTC 11856     - Soil - 
L. seeligeri NCTC 10889  Human - 
L. seeligeri NCTC 11289 - Human - 
L. welshimeri NCTC 11857               - Compost - 
L. welshimeri DSM 15452 - - - 
B. thermosphacta DSM 20171 - - - 
B. thermosphacta DSM 20599 - - - 
B. campestris DSM 4712 - - - 
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2.2. Purification of LM4 Endolysin  
2.2.1 Culture growth conditions  
Two strains of Lactococcus lactis were used; 
1) FI 10544: which was transformed with a pUK200 vector and lacked the LM4 endolysin 
gene and His tag (negative control). 
2) FI 1066: which was transformed with a pUK200 vector containing the endolysin gene 
(Figure 2.1). 
 
 
 
 
 
 
 
 
93 
 
 
Figure 2.1. Vector map of pUK200_6His_LM4. The plasmid is 4062 bp in size with various 
restriction sites. The plasmid codes for the endolysin gene (LM4) which under the control of 
PnisA produces the Listeria specific lytic enzyme. (Diagram obtained from Nikki Horn, 
Institute of Food Research, 2010). 
 
Separate starter cultures of L. lactis FI10544 and FI1066 were prepared by using 100 µl of 
50% glycerol stock to inoculate 10 ml of GM17 media containing 5 µg/ml chloramphenicol, 
followed by overnight incubation at 30°C. A 2.5 ml volume of L. lactis FI10544 starter 
culture was used to inoculate 100 ml of GM17 (IFR media deparment) and 5 ml of L. lactis 
FI1066 starter culture was used to inoculate 200 ml of GM17. Chloramphenicol was added to 
both cultures to give a final concentration of 5 µg/ml followed by incubation at 30°C. The 
LM4 gene was induced at approximately 0.5 optical density 600 (OD600) units by adding 
nisin to both cultures to a final concentration of 1ng/ml. The gene was induced for two hours. 
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2.2.2 L. lactis protein extraction  
L. lactis FI10544 and FI1066 cultures were harvested by centrifugation at 6100g (J2 HS 
Beckman) for 5 minutes at 4°C. The supernatant was removed and each pellet was 
resuspended in 40 ml of PBS followed by centrifugation as before. This was repeated twice 
giving a total of three washes. 
 
For each 100 mg of pelleted cells, 180 µl of lysis buffer (from QIAexpress Ni-NTA Fast Start 
kit) and 250 µl of glass beads were added. The samples were vortexed briefly and processed 
in a Fast Prep® (MP Biomedicals) (glass bead beating) at speed setting 6.0, for 30 seconds, 
followed by 10 minutes on ice. This was repeated 3 times.  An extra 150 µl of lysis buffer 
was added per 100 mg of cell pellet. The samples were briefly vortexed, then centrifuged at 
maximal speed in a microcentrifuge for 5 minutes, to pellet glass beads and cell debris. A 5 
μl sample of supernatant (soluble protein), was set aside for separation by one dimensional 
sodium dodecyl sulphate polyacrylamide gel electrophoresis (1-D SDS PAGE). The 
remaining supernatant was decanted by pipette, made up to 10 ml with lysis buffer and 
purified immediately. 
 
2.2.3 His tag purification and 1-D SDS PAGE analysis of endolysin from L. lactis 
protein extracts 
The protein was purified according to instructions in the QIA express Ni-NTA Fast Start 
handbook (procedures 1 and 2 were eliminated). A 5 μl sample of; flow through, first wash, 
second wash and eluent were set aside for analysis by 1-D SDS PAGE. The eluted protein 
was dialysed into a buffer containing: 50 mM phosphate pH 8.0 and 300 mM NaCl. The 
protein concentration was measured using a nanodrop 2000 (Thermo Scientific) and was 
stored in 50% sterile glycerol at - 20°C.  
 
Loading buffer (Invitrogen) was added to each 5 μl sample that was set aside and proteins 
were separated on a Nupage® 10% Bis-Tris gel (Invitrogen), at 200V in MOPS buffer 
(Invitrogen) for 1 hour. The gel was washed three times in 50 ml sterile water for 5 minutes 
with shaking, then stained at room temperature with shaking using 20 ml of colloidal 
coomassie (Invitrogen) for 1 hour. After staining, the gel was left shaking in 50 ml sterile 
water overnight. The gel was imaged using Alpha imager (Genetic Research 
Instrumentation). 
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2.3 L. monocytogenes  growth curve at 4°C and 37°C 
NCTC 10357 and H101620552 were cultured separately on blood nutrient (BN) agar plates 
from beads stored at - 80°C. Each culture was incubated overnight under aerobic conditions 
at 37°C. Purity was verified by visual inspection before use. Each isolate was sub-cultured 
from a single colony and grown under the previous conditions. Purity was verified as before. 
A starter culture for each isolate was prepared by inoculating 5 ml of brain heart infusion 
(BHI) broth (HPA media department) with the growth from four colonies, followed by 
overnight incubation at 37°C. 
 
Both isolates were grown in 50 ml BHI broth at 4°C and 37°C by inoculating 50 ml  pre-
chilled (4°C) and 50 ml pre-warmed (37°C) BHI broths with 1μl starter culture.  
For each isolate a 50 ml 4°C pre-chilled BHI broth and a 50 ml pre-warmed (37°C) BHI 
broth was inoculated with 1 μl starter culture. Both were re-incubated at their corresponding 
temperatures. In order to obtain 4°C and 37°C  growth curves, absorbance readings were 
recorded at OD600 (Biophotmeter, Eppendorf), daily and hourly respectively.  Cultures 
incubated at 37°C and 4°C were recorded hourly and every 24 hours respectively. Both 
cultures were monitored until the readings were relatively constant. Growth curves at 4°C 
and 37°C were deduced by plotting absorbance at OD600 against time.  
2.4 Growth and harvest of Listeria spp.  
Isolates were cultured from - 80°C beads, starter cultures were prepared and used to prepare 
50ml BHI broth cultures as previously detailed (section 2.3). Cultures were maintained until 
late exponential growth phase, that is, cultures incubated at 4°C and 37°C were harvested at 
OD600
 
of 0.65 - 0.75 and 0.8 - 1.0 respectively.  
 
Cells were harvested by centrifugation (Z36HK, Hermle) at 6100 g for 5 minutes at 4°C. The 
supernatant was removed and each pellet was resuspended in 40 ml of PBS followed by 
centrifugation at 6100 g for 5 minutes at 4°C. This was repeated twice giving a total of three 
washes. Each pellet was resuspended in 1 ml of PBS and dispensed into a screw cap 
microfuge tube (eppendorf). The samples were centrifuged at maximal speed in a 
microcentrifuge (Heraeus Fresco 21 Centrifuge, Thermo Electron Corporation) for 10 
minutes, the supernatants were decanted and the pellets weighed. The pellets were stored at - 
80°C until required.  
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2.5 Efficient lysis of Listeria spp  
2.5.1 Determination of minimum amount of endolysin required for complete lysis of 
Listeria spp. 
Using 37°C growth condition, a total of 12 pellets of a L. monocytogenes H10 162 0552 were 
prepared using starter culture conditions described in section 2.3 and growth and harvest 
conditions described in section 2.4.  Each pellet was resuspended in 180 μl lysis buffer per 
100 mg of pellet. (Lysis buffer: 2% Chaps, 50mM NaCl, 20mM Tris-HCl pH 8.0, 1mM 
EDTA, protease inhibitor cocktail (Roche) and 5mM DTT). Different amounts of endolysin 
were added to individual suspensions as follows; 0.0, 2.0, 2.2, 2.4, 2.6, 2.8, 3.0, 3.4, 3.8, 4.0, 
4.5 and 5.0 μg per 100 mg pellet. Each suspension was vortexed briefly and incubated on ice 
of 30 minutes. Approximately 250 µl of blass beads (Sigma) was added per 100mg of cell 
pellet. The samples were then processed, in the Fast-Prep®-24 (MP Biomedicals) for 1 
minute at speed setting 6.0 and incubated on ice for 10 minutes. This was repeated three 
times followed by the addition of a further 150 µl of lysis buffer per 100 mg pellet. The 
samples were vortexed briefly, then centrifuged at maximal speed in a microcentrifuge for 10 
minutes to pellet the cell debris. The supernatant was removed, and the quality of the protein 
assessed using 1-D SDS PAGE. Briefly, a 1 μl volume of each sample supernatant was 
combined with 1 μl loading dye and 1 μl reducing agent (Invitrogen) followed by separation 
on Nupage® 4 - 12% Bis-Tris gel (Invitrogen), at 125V in MES buffer (Invitorgen) 
containing 500 ml antioxidant for 35 minutes. After electrophoresis, the proteins were fixed 
by incubating the gel in 50 ml 40% methanol and 10% acetic acid for 1 hour at room 
temperature. The proteins were stained overnight using 20 ml colloidal coomassie 
(Invitrogen) and the background destained by incubation in 25% methanol at room 
temperature. The gel was visualised using a Propic II instrument (Digilab).  
 
The cell debris from each supernatant was visualised using a light microscope at x 1000 
magnification (Nikon Labophot). 
 
2.5.2 Lysis of a range of Listeria spp.  
Cell pellets for each of the following isolates were prepared: L. monocytogenes F2365, 
NCTC 10888 - L. monocytogenes, NCTC 10357 - L. monocytogenes, NCTC 5348 - L. 
monocytogenes, NCTC 04883 - L. monocytogenes, NCTC 05124 - L. monocytogenes,  NCTC 
10815 - L. grayi subsp grayi, NCTC 10813 - L. grayi subsp murrayi, NCTC 11288 - L. 
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innocua, NCTC 11846 - L. ivanovii subsp. ivanovii, NCTC 12701 - L. ivanovii subsp. 
londoniensis, NCTC 11856 - L. seeligeri, and NCTC 11857 - L. welshimeri. This was 
achieved using 37°C growth condition, starter culture conditions described in section 2.4 and 
growth and harvest conditions described in section 2.5.   
 
Pellets and protein extracts were processed as detailed in section 2.5.1. Modifications to the 
protocol include:  
1) Duplicate pellets were prepared for each isolate one of which was lysed without endolysin 
and the other was lysed by adding 5.0 μg of endolysin per 100 mg of pellet. 
2) The protein extract was quantified using Bradford assay and 5 μg of protein was analysed 
using 1-D SDS PAGE. 
3) The cell debris of each sample was visualised using a light microscope (Nikon Eclipse Ti) 
and photographed Nikon Digital Sight camera unit. 
 
2.5.3 Lysis of L. monocytogenes F2365 using endolysin, glass bead beating and pressure 
cycling 
Three L. monocytogenes F2365 cell pellets were prepared. This was achieved using 37°C 
growth condition, starter culture conditions described in section 2.3 and growth and harvest 
conditions described in section 2.4.   
Pellets and protein extracts were processed as detailed in section 2.5.1. Modifications to the 
protocol include:  
 
1) The first pellet was lysed without endolysin and the second was lysed by adding 5.0 μg of 
endolysin per 100 mg of pellet, and the third pellet was lysed using the pressure cycler 
(Barocycler ® NEP2320, Pressure Biosciences Inc.) as follows. Briefly, the pellet was 
resuspended in 180 μl of buffer per 100 mg of pellet and cycled at 35 kpsi for 1 minute 
followed by atmospheric pressure for 1 minute for 30 cycles. 
 
2) The protein extract was quantified using Bradford assay.  
 
3) A volume containing 100 μg of protein was set aside for 2-D SDS PAGE analysis as 
detailed in section 2.6. A volume containing 5 μg of protein was set aside for 1-SDS PAGE 
analysis (as detailed in section 2.5.1), followed by Liquid Chromatography - Mass 
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Spectrometry/Mass Spectrometry (LC-MS/MS) analysis. The experiment was repeated twice 
equaling a total of three biological replicates. 
 
 4) The cell debris of each sample was not photographed. 
 
2.6. 2-D SDS PAGE 
2.6.1 Rehydration of Immobiline DryStrip gels and Isoelectric focussing (IEF) 
Three lanes of an Immobiline DryStrip reswelling tray (GE Healthcare), were each filled with 
340 μl of rehydration solution (7M urea, 2M thiourea,  2% CHAPS w/v, 2% IPG buffer (GE 
Helathcare) and 2μl of 1% w/v bromophenol blue) which contained; 2.8 mg DTT and 20 μl 
IPG buffer pH 4 -7 (GE Healthcare) per ml. An 18 cm, Immobiline DryStrip gel pH 4 - 7 (GE 
Healthcare), was placed gel side down in each lane containing rehydration solution. Care was 
taken to ensure air was not trapped under the strips. Each strip was covered with 2 ml of 
Immobiline DryStrip Cover Fluid (GE Healthcare). The strips were allowed to rehydrate 
overnight for 10 - 20 hours. 
 
The protein extracts were spun in a microcentrifuge at 13,100g in order to pellet insoluble 
matter. A volume of supernatant containing 100 μg of protein was transferred to a microfuge 
tube. Rehydration solution containing 2.8 mg DTT and 20 μl IPG buffer pH 4 - 7 (GE 
Healthcare) per ml was added to the supernatant to give a total volume of 150 μl. The 
isoelectric focussing apparatus was set up according to instructions stated in the GE 
Healthcare 2-D Electrophoresis Principles and Methods handbook. The following Ettan 
IPGphor conditions were applied for protein focussing: 
 
S1 Step-n-hold     300V      3:00 hours 
S2 Gradient          100V      6:00 hours 
S3 Step-n-hold     8000V    9:00 hours 
 
After IEF, the gel strips were stored at - 80°C until ready for second dimension separation. 
 
2.6.2 Preparation of 12.5% acrylamide gel cassettes 
The gels were prepared by combining 31.21 ml of chromosolve water, 23.45 ml of 40% 
acrylamide, 18.75 ml of 1.5M Tris-HCl pH 8.8, 750 µl of 10% SDS, 833 µl of 10% APS and 
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20.83 µl of TEMED, and casting between glass plates according to instructions stated in the 
GE Healthcare 2-D Electrophoresis Principles and Methods handbook. An amendment to the 
instructions was the use of 80% isopropanol instead of 1-butanol to overlay the gels after 
casting. 
 
2.6.3 Equilibration of gel strips and 2-D electrophoresis 
Focused gel strips were removed from - 80°C storage and thawed at room temperature. 
Each gel strip was placed in a separate well of an IPG DryStrip gel holding tray. A 4 ml 
volume of equilibration buffer (6M urea, 1.5M Tris-HCl pH 8.8, 28.6% v/v of 85% w/w 
glycerol, 29% w/v SDS and 2μl of 1% w/v bromophenol blue) containing 40 mg DTT was 
placed in each well and gel strips were equilibrated by gentle shaking for 15 minutes. The 
equilibration buffer was decanted by pipette and 4 ml of equilibration buffer containing 100 
mg of idoacetamide was added to each well. The strips were equilibrated by gentle shaking 
for 15 minutes. Each strip was fixed on top of a 12.5% acrylamide gel using molten agarose 
sealing solution (0.5g agarose dissolved in 100 ml of 1X TGS buffer (Bio-Rad) and 2μl of 
1% w/v bromophenol blue). Gel electrophoresis was carried out in an Ettan DALT six 
electrophoresis unit (GE Healthcare) as follows. The lower chamber was filled with 4.5 L of 
1 X TGS buffer (Bio-Rad) and each gel cassette was slotted into a cassette carrier. 
Unoccupied gel cassettes were filled with blank cassettes. The upper buffer chamber was 
seated over the gels and the upper chamber was filled with 2 X TGS buffer.  The unit was 
closed and electrophoresis was carried out at 10 mA/gel, 1W/gel and 80 V for 24 hours. 
Proteins were fixed by shaking in 200 ml 40% methanol for 1 hour and stained in sypro ruby 
protein gel stain (Invitrogen) overnight. The gels were destained in 200 ml 10% methanol for 
1 hour and imaged with an Ettan™ DIGE Imager.  
2.7 In-gel tryptic digestion of proteins for LC-MS/MS and data analysis  
2.7.1 Destaining 
Each lane of a 1-D SDS gel containing a protein sample was cut into 12 pieces, using a clean 
scalpel. Each gel piece was transferred into a well of a 96-well low-bind microtitre plate. 
Each gel piece was destained by incubation at room temperature with 500 μl of solution 
containing 25 mM ammonium bicarbonate and 50% methanol for 20 minutes. The solution 
was decanted by pipette and the process of destaining was repeated three times. A final 500 
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μl volume of solution was added and incubated with the gel pieces overnight to ensure 
complete removal of the colloidal coomassie stain. 
 
2.7.2 Drying 
The 25 mM ammonium bicarbonate/50% methanol solution was decanted by pipette and 500 
μl of acetonitrile was added to each well. The microtitre plate was incubated at room 
temperature for 10 minutes. The acetonitrile was removed and this step was repeated. The gel 
pieces were allowed to air dry. 
 
2.7.3 Reduction and alkylation 
A 50 μl volume of 10 mM DTT in 25 mM ammonium bicarbonate was added to each gel 
piece and incubated at 60°C for 30 minutes. The excess was removed and 50 μl of 55 mM 
iodoacetamide in 25 mM ammonium bicarbonate was added to each piece and incubated for 
45 minutes at room temperature in the dark. The excess was removed and the gel pieces were 
washed three times for 5 minute in 500 μl of 25 mM ammonium bicarbonate. The gel pieces 
were dehydrated as described in section 2.7.2. 
 
2.7.4 Trypsinisation 
Trypsin (Promega, mass spectrometry grade) was resuspended in 25 mM ammonium 
bicarbonate to a concentration of 10 ng/μl. A 40 μl volume was added to each gel piece. The 
plate was sealed and incubated at 37°C overnight for 16 hours. 
 
2.7.5 Extraction 
A 40 μl volume of 0.1% Trifluoroacetic acid (TFA) was added to each well and incubated for 
60 minutes at room temperature. The plate was centrifuged at 3,000g for 5 minutes and the 
supernatants were transferred to a clean microtitre plate. The samples were stored at - 80°C 
until ready for analysis. 
 
2.7.6 LC-MS/MS analysis 
LC-MS/MS analysis relating to the efficient lysis of Listeria spp. (section 2.5) was carried 
out by Min Fang of Department of Bioanalysis and Horizon Technology (DBHT), HPA, 
using the Ultimate 3000 Dionex nano/capillary HPLC system coupled to a LTQ Orbitrap 
mass spectrometer (Thermo Scientific). 
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2.7.6 Database search 
The MS data was generated as .RAW files. A database search alogarithm, Mascot (Matrix 
Science UK), was used to identify the peptides detected by LC-MS/MS. Parameters selected 
for peptide identification were: enzyme - trypsin, fixed modification - carbamidomethlylation 
of cysteine, variable modifications - oxidation of methionine, missed cleavage sites - 2 and 
peptide mass tolerance - +/- 10ppm. The results were imported into Scaffold 3 (Proteome 
Software, Inc). The analysis parameters selected in scaffold were; minimum protein = 20% 
and minimum number of peptides = 2. 
 
2.8 Characterisation of L. monocytogenes  using Matrix Laser Assisted 
Desorption/Ionisation - Time of Flight - Mass Spectrometry (MALDI-TOF-
MS)  
2.8.1 Target plate preparation using direct colony smears for the AXIMA CFR Plus 
MALDI-TOF-MS instrument (Shimadzu Corporation, UK) and data acquisition 
A total of 23 isolates were analysed. Of these isolates, 17 were obtained from FPRU; 13 - L. 
monocytogenes and 1 isolate of each of the following species; L. innocua, L. grayi, L. 
ivanovii, L. seeligeri and L. welshimeri. The remaining 5 samples were NCTC isolates; L. 
grayi subsp. grayi - NCTC 10815, L. innocua - NCTC 11288, L. ivanovii subsp. ivanovii - 
NCTC 11846, L. seeligeri - NCTC 11856 and L. welshimeri - NCTC 11857. 
 
Sub-cultures were prepared as detailed in section 2.1. and surface growth of one colony was 
evenly spread over a well of a 48 spot target plate (Shimadzu Corporation, UK) using a 
pipette tip. Wells G3 and G4 remained empty. Each isolate was applied in duplicate. One 
microlitre of 2, 5-dihydroxybenzoic acid (DHB) matrix was applied to each spot and mixed 
with the sample using a pipette tip. A second target plate was prepared using alpha-cyano-4-
hydroxy cinnamic acid (HCCA) as an alternate matrix. The plates were air dried for 
approximately 10 minutes and sent to AnagnosTec, Germany, by courier. In order to 
minimise sample degradation, the plates were scheduled for arrival within 48 hours of 
preparation. The plate numbers and sample details were entered into a software template 
called Target Manager of the SARAMIS Satellite. The file was electronically transferred to 
AnagnosTec as a text file. Escherichia coli whole cell standards were applied to wells G3 and 
G4 of the target plates by an AnagnosTec staff. All reagents were supplied in the 
SARAMIS
TM
 Runit Box (AnagnosTec). 
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MS analysis was performed by AnagnosTec and results were updated remotely in the 
SARAMIS system available at the DBHT (Department of Bioanalysis and Horizons 
Technologies), HPA. The results appeared in the SARAMIS status bar where the each isolate 
present on the target plate was assigned a confidence coefficient. The results were copied and 
presented in table format. As mentioned earlier (section 1.31) the confidence coefficient is 
assigned during analysis by the Shimadzu Launchpad software. It is expressed as a 
percentage which is equal to one-tenth of the accumulation points of matching with an upper 
cut-off of 999 points. 
 
2.8.2 Target plate preparation using direct colony smears for the Microflex LT MALDI-
TOF-MS instrument (Bruker UK, Ltd)  
A total of 89 Listeria isolates were analysed. Of these, 84 were obtained from FPRU; 78 -  L. 
monocytogenes,1 -  L. grayi, 2 -  L. innocua, 1 -  L. ivanovii, 1  - L. seeligeri and 1 - L. 
welshimeri.  The remaining 5 samples were NCTC isolates; NCTC 10815 - L. grayi subsp. 
grayi, NCTC 11288 - L. innocua, NCTC 11846 - L. ivanovii subsp. ivanovii, NCTC 11856 - 
L. seeligeri and NCTC 11857 - L. welshimeri. Also, 1 - Brochothrix campestris and 1 - 
Brochothrix thermosphacta were analysed.  
 
All sub-cultures were prepared as detailed in section 2.1 and the surface growth of a colony 
was evenly spread over a well of a 96 spot target plate. Each isolate was applied in duplicate. 
Staphylococcus aureus was used to smear two wells on the target plate and extracted and E. 
coli protein extracts called Biological Test Standard (BTS) (Bruker UK, Ltd.) was also 
spotted in duplicate on to the target plate. The spots were allowed to air dry. One microlitre 
of HCCA matrix was applied to each spot and allowed to air dry. The target plate was loaded 
into the Microflex LT MALDI-TOF-MS instrument and analysed as detailed in section 2.8.4.  
 
2.8.3 Target plate preparation using formic acid extracted proteins for the Microflex LT 
MALDI-TOF-MS instrument (Bruker UK, Ltd) 
Sub-cultures were prepared as detailed in section 2.1. Using a 1µl loop, single visibly pure 
colonies were scrapped from a plate until the loop was at full capacity. The cells were 
thoroughly resuspended into a 1.5 ml microfuge tube containing 300 μl of molecular grade 
water. A 900 µl volume of absolute ethanol was added and the cell suspensions were mixed 
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by inverting 6 times. The tubes were spun in a microcentrifuge at top speed for 2 minutes, 
supernatants were decanted completely and the pellets resuspended in 50 µl of 70% formic 
acid followed by addition of 50 µl acetonitrile. The suspensions were mixed by inverting 6 
times, incubated at room temperature for 2 minutes, then spun in a microcentrifuge at top 
speed for 2 minutes.     
 
A 2 μl volume of cell extract was applied to a spot on the target plate and allowed to air. One 
microlitre of HCCA matrix was applied to each spot and allowed to air dry. The target plate 
was loaded into the Microflex LT MALDI-TOF-MS instrument and analysed as detailed in 
section 2.8.4  
 
2.8.4 Data acquisition from the Microflex LT MALDI-TOF-MS (Bruker) instrument 
Briefly, the software used included MALDI Biotyper Real Time Client, Flex control and 
MALDI biotyper sample sheet. The name and position of each isolate on the target plate was 
entered into the MALDI biotyper sample sheet. The details entered were copied and pasted 
into the analyte placement window of the MALDI Biotyper Real Time Client. The “MALDI 
biotyper standard processing” option was selected for the data processing and identification 
method. The BDAL database was selected for spectral comparison with test isolate spectra.  
The instrument vacuum was allowed to reach 3e
-6
 and was verified by viewing the flex 
control software. Spectra generation was commenced by selecting “finish” in the MALDI 
Biotyper Real Time Client window. The real time window displayed the quality of the 
spectrum and classification of each sample. At the end of the run the results were made 
available in a new internet explorer window.  
 
 
 
2.8.5 Construction of Listeria spp. main-spectrum (MSP) Dendrogram using MS profiles 
acquired by MALDIbiotyper 
MS files for a total of 78 Listeria isolates were used for cluster analysis. Of the 78 isolates, 54 
L. monocytogenes were obtained from the FPRU. The remaining isolates were NCTC and 
DSMZ isolates: NCTC 04885, 04883, 10888, 12426, 05214, 07973, 10890, 10357, 12480, 
11994, 05348, 10887- L. monocytogenes; NCTC 10812 - L. grayi subsp. murrayi; NCTC 
10813 and 10815 - L. grayi subsp. grayi, NCTC 10815 - L. grayi subsp. grayi, NCTC 11288 
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- L. innocua, NCTC 11846 - L. ivanovii subsp. ivanovii, NCTC 11856 - L. seeligeri, NCTC 
11857 - L. welshimeri, NCTC 12701 - L. ivanovii subsp. londoniensis, NCTC 10889 - L . 
seeligeri, NCTC 11289 - L. seeligeri,   and DSMZ 15452 - L. welshimeri.  The isolates and 
target plate was prepared as detailed in section 2.8.3.  
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Table 2.2 List of 78 Listeria isolates used to generate the MSP Dendrogram shown in Figure 
3.25. For simplicity, each isolate was assigned a number from 1-78 which can be used to 
identify its position on the dendrogram. 
 
 
 
 
MSP 
Dendrogram 
number
HPA Sample 
Number Isolate
MSP 
Dendrogram 
number
HPA Sample 
Number Isolate
1 NCTC 10357 L. monocytogenes 40 NCTC 11856 L. seeligeri
2 H08 136 0109 L. monocytogenes 41 NCTC 11857 L. welshimeri
3 H08 156 0404 L. monocytogenes 42 H09 420 0585 L. monocytogenes
4 H08 162 0317 L. monocytogenes 43 H09 066 0222 L. monocytogenes
5 H08 164 0195 L. monocytogenes 44 H09 400 0324 L. monocytogenes
6 H08 224 0145 L. monocytogenes 45 H09 062 0066 L. monocytogenes
7 H08 180 0412 L. monocytogenes 46 H09 364 0232 L. monocytogenes
8 H08 282 0003 L. monocytogenes 47 H08 360 0121 L. monocytogenes
9 H08 344 0402 L. monocytogenes 48 NCTC 05214 L. monocytogenes
10 H08 352 0191 L. monocytogenes 49 NCTC 07973 L. monocytogenes
11 H08 374 0182 L. monocytogenes 50 NCTC 10890 L. monocytogenes
12 H08 382 0048 L. monocytogenes 51 NCTC 10357 L. monocytogenes
13 H08 348 0314 L. monocytogenes 52 NCTC 10814 L. grayi
14 H08 446 0286 L. monocytogenes 53 NCTC 12480 L. monocytogenes
15 H08 454 0569 L. monocytogenes 54 NCTC 12701 L. ivanovii
16 H08 520 0220 L. monocytogenes 55 NCTC 11994 L. monocytogenes
17 H09 052 0645 L. monocytogenes 56 NCTC 10889 L. seeligeri
18 H09 112 0012 L. monocytogenes 57 NCTC 11289 L. seeligeri
19 H09 126 0107 L. monocytogenes 58 NCTC 10812 L. grayi
20 H09 224 0336 L. monocytogenes 59 NCTC 05348 L. monocytogenes
21 H09 224 0355 L. monocytogenes 60 NCTC 10887 L. monocytogenes
22 H09 232 0063 L. monocytogenes 61 H09 392 0041 L. monocytogenes
23 H09 088 0603 L. monocytogenes 62 F2365 L. monocytogenes
24 H09 094 0336 L. monocytogenes 63 DSM 15452 L.welshimeri
25 H09 224 0145 L. monocytogenes 64 H08 490 0250 L. monocytogenes
26  H08 180 0412 L. monocytogenes 65 H10 172 0401 L. monocytogenes
27 H09 296 0322 L. monocytogenes 66 H10 170 0375 L. monocytogenes
28 H08 396 0517 L. monocytogenes 67 H10 162 0369 L. monocytogenes
29 H09 354 0308 L. monocytogenes 68 H10 162 0552 L. monocytogenes
30 H09 404 0479 L. monocytogenes 69 H10 074 0236 L. monocytogenes
31 H09 314 0192 L. monocytogenes 70 H08 074 0271 L. monocytogenes
32 NCTC 04885 L. monocytogenes 71 H09 012 0053 L. monocytogenes
33 NCTC 04883 L. monocytogenes 72 H09 406 0833 L. monocytogenes
34 NCTC 10888 L. monocytogenes 73 H10 146 0091 L. monocytogenes
35 NCTC 10813 L. grayi 74 H10 044 0420 L. monocytogenes
36 NCTC 12426 L. monocytogenes 75 H08 262 0274 L. monocytogenes
37 NCTC 10815 L. grayi 76 H09 076 0244 L. monocytogenes
38 NCTC 11288 L. innocua 77 H10 046 0271 L. monocytogenes
39 NCTC 11846 L. ivanovii 78 H09 510 0595 L. monocytogenes
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MSP Dendrograms were constructed using the MALDI Biotyper 3 Bruker software.  
 
2.9 Characterisation of L. monocytogenes  using Surface Enhanced Laser 
Assisted Desorption/Ionisation - Time of Flight - Mass Spectrometry SELDI-
TOF-MS  
2.9.1 Bacterial culture and protein extraction 
L. monocytogenes F2365 and L. monocytogenes NCTC 10357 cell pellets were prepared. 
This was achieved using 37°C growth condition, starter culture conditions described in 
section 2.3 and growth and harvest conditions described in section 2.4. 
Pellets and protein extracts were processed as detailed in section 2.5.1. Modifications to the 
protocol include:  
1) Pellets were lysed using the Fast Prep and endolysin was not used.  
2) Protein was quantified using Bradford assay  
3) Proteins were not separated on Nupage® 4 - 12% Bis-Tris gel (Invitrogen).  
4) Cell debris was not visualised. 
 
2.9.2 Preparation of ProteinChip CM10 Array 
Two ProteinChip CM10 arrays (Bio-Rad) were placed in a bioprocessor. The arrays were 
washed by adding 250 μl of buffer: 50 mM Tris-HCl pH 8.4, to each well and shaking 
vigorously at approximately 200 rpm for 5 minutes. The buffer was decanted and the wash 
step was repeated. 
 
L. monocytogenes F2365 and L. monocytogenes NCTC 10357 protein extracts were 
processed on separate arrays. A 150 μl volume of protein was added to each well, (wells A-
G). The amount of protein in each 150 μl volume varied from 150 μg to 750 μg for L. 
monocytogenes F2365 and from 250 μg to 1200 μg for L. monocytogenes NCTC 10357. 
Wells H were loaded with 150 μl buffer. The arrays were incubated at room temperature for 
30 minutes with shaking at approximately 200 rpm. 
 
The protein extracts were decanted and each well was washed with buffer as before for a total 
of three washes. The buffer was decanted and 250 μl of distilled water was added to each 
well, followed by immediate decantation. The arrays were removed from the bioprocessor 
and allowed to air dry. Sinapinic acid (SPA) matrix (Bio-Rad) was resuspened in 400 μl of 
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solution containing 50% acetonitrile and 0.5% trifluoroacetic acid by vigorous vortexing. 
Undissolved particles were allowed to sediment and 0.5 μl of matrix solution was added to 
spots A-G of both arrays, and on spot H of the array used for processing L. monocytogenes 
NCTC 10357 protein extracts. The spots were allowed to air dry and another 0.5 μl of the 
matrix solution was added.  A 0.5 μl volume of protein standard (Protein All-In-One Standard 
II (Bio-Rad)) was added to spot H of the array used for processing L. monocytogenes F2365 
protein extracts. The spot was allowed to air dry and another 0.5 μl of the protein standard 
was added. 
 
2.9.3 Preparation of ProteinChip H50 Array 
Two ProteinChip H50 arrays were placed in a bioprocessor. The arrays were prewashed by 
adding 50 μl of buffer: 50% methanol, to each well and shaking vigorously at approximately 
200 rpm for 5 minutes. The solution was decanted and the prewash step was repeated. 
 
The arrays were washed by adding 50 μl of 50% methanol containing 0.1% TFA to each well 
and shaking vigorously for 5 minutes. The solution was decanted and the wash repeated. 
 
L. monocytogenes F2365 and L. monocytogenes NCTC10357 protein extracts were processed 
on separate arrays. A 150 μl volume of protein was added to each well, (wells A - G). The 
amount of protein in each 150 μl volume varied from 200 μg to 546 μg for L. monocytogenes 
F2365 and from 150 μg to 984 μg for L. monocytogenes NCTC 10357. Wells H were 
occupied with 150 μl buffer. The arrays were incubated at room temperature for 30 minutes 
with shaking at approximately 200 rpm. 
 
The protein extracts were decanted and each well was washed with 50% methanol containing 
0.1% TFA for a total of three washes. The buffer was decanted and 250 μl of distilled water 
was added to each well, followed by immediate decantation. 
 
SPA and protein standard were applied to spots as described in section 2.9.2. 
This experiment was repeated on a separate occasion with the following modifications: 
 
a)  50% methanol containing 1% TFA was substituted by 10% acetonitrile containing 0.1% 
TFA. 
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b)  The amount of protein in each 150 μl volume varied from 200 μg to 450 μg for L. 
monocytogenes F2365 and from 150 μg to 984 μg for L. monocytogenes NCTC 10357. 
 
2.9.4 Preparation of ProteinChip Q10 Array 
Two ProteinChip Q10 arrays were placed in a bioprocessor. The arrays were washed by 
adding 250 μl of buffer: 20mM Tris-HCl, pH 7.4 containing 1% Triton, to each well and 
shaking vigorously at approximately 200 rpm for 5 minutes. The buffer was decanted and the 
wash step was repeated. 
 
L. monocytogenes F2365 and L. monocytogenes NCTC10357 protein extracts were processed 
on separate arrays. A 150 μl volume of protein was added to each well, (wells A-G). The 
amount of protein in each 150 μl volume varied from 200 μg to 546 μg for L. monocytogenes 
F2365 and from 150 μg to 984 μg for L. monocytogenes NCTC 10357. Wells H were 
occupied with 150 μl buffer. The array was incubated at room temperature for 1 hour with 
shaking at 200 rpm. 
 
The protein extracts were decanted and each well was washed as before for a total of three 
washes. The buffer was decanted and 250 μl of distilled water was added to each well, 
followed by immediate decantation. 
 
SPA and protein standard were applied to spots as described in section 2.9.2. 
 
2.9.5 SELDI-TOF-MS analysis of prepared ProteinChip Arrays 
All ProteinChip array spots were completely dry before being analysed individually. Each 
array was loaded into a PBS II MALDI-TOF Mass Spectrophotometer (Ciphergen 
Biosystems). Spectral profiles were collected in the mass range 3000 - 50,000 kDa. The laser 
energy used was 220V. The resulting data was displayed in the programme window as a plot 
of abundance against mass/charger (m/z). 
 
2.9.6 SELDI-TOF-MS analysis of a selection of isolates using ProteinChip H50 Arrays  
A total of 30 isolates were analysed on ProteinChip H50 Arrays These included 21 L.  
monocytogenes isolates obtained from FPRU; 6 NCTC isolates; NCTC 10815 - L. grayi 
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subsp. grayi, NCTC 11288 - L. innocua, NCTC 11846 - L. ivanovii subsp. ivanovii, NCTC 
11856 - L. seeligeri, NCTC 11857 - L. welshimeri and NCTC 10890 - L. monocytogenes; and 
2 DSMZ isolates DSMZ 4712 - Brochothrix campestris and DSMZ 20171 -  Brochothrix 
thermosphacta.  
 
Cell pellets were prepared using 37°C growth condition, starter culture conditions described 
in section 2.3 and growth and harvest conditions described in section 2.4. Brochothrix spp. 
were cultured at 30°C on APT agar plates, in APT broths where appropriate, and harvested at 
approximately OD600 of 1.0. 
 
Pellets and protein extracts were processed as detailed in section 2.5.1. Modifications to the 
protocol include:  
1) Pellets were lysed using the Fast Prep and endolysin was not used.  
2) Protein was quantified using Bradford assay and a volume containing 5 μg of protein 
separation on Nupage® 4 - 12% Bis-Tris gel (Invitrogen).  
3) Cell debris was not visualised. 
4) When lysates were obtained directly from sub-cultures 200 μl of lysis buffer was added to 
a microfuge tube and growth from 2 - 3 plates was removed using a 10 μl loop and 
resuspended in the lysis buffer by thoroughly swivelling the loop.  Glass beads were added to 
occupy 1/3 of the tube contents volume.  
 
2.9.7 SELDI-TOF-MS analysis of a selection of isolates using ProteinChip CM10 Arrays 
using (manual spotting protocol)  
As an alternative to using the bioprocessor, samples were spotted manually. Briefly, 5 µl of 
buffer: 25 mM ammonium acetate/0.01% Triton, was added to each spot and incubated at 
room temperature for 5 minutes. The buffer was removed by pipetting and another 5 μl of 
buffer was added. This was removed following incubation at room temperature for 5 minutes. 
The protein extracts from section 2.10.6 were diluted to 2 mg/ml and 3 μl of extract (6 μg of 
protein) was added to individual spots. The arrays were incubated for 1 hour after which the 
samples were removed by pipette. The arrays were washed twice with 5 μl buffer as 
described earlier. The arrays were allowed to air dry. A 1 μl volume of standard was added to 
an empty spot and allowed to air dry before adding another 1 μl volume. A 0.75 μl volume of 
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SPA was added to each spot including an empty spot. The matrix was allowed to air dry and 
a further 0.75 μl SPA was added and allowed to air dry.  
 
Each array was analysed as detailed in section 2.9.5. An amendment to the protocol included 
the increase of laser energy form 220V to 235V.  
 
2.10 Differentially expressed L. monocytogenes  proteins 
2.10.1 Growth  
Cell pellets for each of the following isolates were prepared: NCTC 10357, H101620552, 
H084460286, H090120053, H084900250, H101460091 and H080740271. One pellet was 
obtained from a 4°C culture and the other a 37°C culture. This was achieved using starter 
culture conditions described in section 2.3 and growth and harvest conditions detailed in 
section 2.4. 
 
2.10.2 Protein extraction quantification and separation by 1-D SDS PAGE  
Pellets were processed as detailed in section 2.5.1.  
Modifications to the protocol include: 
1) All pellets were lysed using the Fast Prep and endolysin was not used.  
2) Protein was quantified using Bradford assay and a volume containing 5 μg of protein 
separation on Nupage® 4 - 12% Bis-Tris gel (Invitrogen).  
3) Proteins were stained overnight using Simply Blue Safe Stain (Invitrogen) and background 
destained by incubation in 25% methanol at room temperature for 2 hours.  
4) The gels were visualised using a Bio-Rad Gel Doc 
TM
 EZ Imager.  
5) Cell debris was not visualised. 
 
2.10.3 Proteins band intensity measurement 
This was achieved using the Bio-Rad Image Lab 4.0 software. 
 
2.10.4 deltaDOT analysis of differentially expressed proteins 
Peptides generated from L. monocytogenes H101620552 protein extracts which were 
expressed at 4°C and 37°C were analysed by Deepika Devanur (deltaDOT). Briefly, the 
samples were de-salted using Pierce desalting columns prior to analysis.   
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Separation was carried using deltaDOT‟s proprietary capillary gel electrophoresis protocols 
using the PEREGRINE I system. 
 
 The data was analysed using both deltaDOT‟s Equiphase Vertexing Alogrithm (EVA) and 
Generalised Separartion Transform (GST) algorithm by Deepika Devanur (deltaDot). 
 
2.10.5 Analysis of differentially expressed bands 
Bands which appeared to have different intensities were excised and subject to in-gel tryptic 
digestion as detailed in section 2.7.1 - 2.7.5. 
 
LC-MS/MS analysis was carried out by Jenny Cho of ThermoScientic in Hemel Hemstead, 
using the Easy nLC 1000 (Thermo Scientific) coupled on-line to a Q Exactive mass 
spectrometer (Thermo Scientific).  
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Chapter 3: Results 
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3.1 Efficient lysis of Listeria spp. 
Efficient cell lysis is a necessity to proteomic investigations. Therefore in the early stage of 
this study, considerable time was spent to attain efficient lysis of Listeria species. This 
preliminary measure was important in order to ensure that the proteins being investigated 
were reproducible and representative of the entire cell, and subsequently allow a great level 
of confidence regarding experimental findings. Efficient lysis experiments commenced with 
the construction of L. monoctogenes growth curves in order to deduce the optimal point at 
which cells should be harvested for further study. Following this accomplishment 
characterisation studies were pursued using tool MS tool and these results are presented in 
sections 3.2 - 3.4. 
 
3.1.1 Growth curve at 4°C and 37°C 
It was decided that cells used in this study should be harevested at their exponential growth 
phase. This decision was taken as it is a widely helf view that cells are metabolically most 
active at this phase while the integrity of the cell is better retained. Growth curves were 
constructed in order to determine the exponential phase. The 4°C and 37°C growth curves for 
L. monocytogenes NCTC 10357 showed that when grown in BHI broth, cells harvested 
between OD600 0.5 and 0.7 and between OD600 0.8 and 1.0 respectively, are at their 
exponential phase (Figure 3.1 and Figure 3.2 respectively).  
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Figure 3.1. L. monocytogenes NCTC 10357 4°C growth curve. A plot of absorbance at OD600 
(y-axis) versus days (x-axis). The curve shows that at an absorbance between OD600 0.5 and 
0.7 cells were in their exponential growth phase.  
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Figure 3.2. L. monocytogenes NCTC 10357 at 37°C growth curve. A plot of absorbance at 
OD600 (y-axis) versus days (x-axis). The curve shows that at an absorbance between OD600 0.8 
and 1.0 cells were in their exponential growth phase. 
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3.1.2 Purification of endolysin 
A survey of the literature shows that endolysin is an efficient Listeria specific lytic enzyme. 
The enzyme is not commercially available hence it was necessary to undertake protein 
expression of the cloned endolysin gene and purification of the enzyme for subsequent use.  
 
A stained image of the gel (on which L. lactis extracts reserved at every stage of the 
purification process) showed the presence of a number of bands (Figure 3.3). A comparison 
of the negative control soluble fraction (lane 1) and the induced expression strain (lane 2 and 
3) showed the presence of a unique band in the induced expression strain. The predicted 
molecular weight of endolysin is 34044.3 Da, which is the approximate mass of the unique 
band, according to the protein marker (lane M). Addition of Ni-NTA (nickel nitrilotriacetic) 
facilitated in removal of the His-tagged endolysin proteins from the solution as Ni-NTA has 
an affinity for the 6x Histidine located at the N-terminal of the protein. The flow through 
shown in lanes 4 - 5 therefore lacked the unique band.  Absence of the protein from the Ni-
NTA wash buffer (lanes 6 and 7), showed that the protein remained bound to the beads. The 
protein was eluted from the Ni-NTA beads by washing with a high concentration of 
imidazole which has a greater affinity to Ni-NTA than 6x Histidine. The protein was 
successfully purified as the band in lane 8 represented the eluted protein. 
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Figure 3.3. One-Dimensional SDS PAGE analysis of protein at each stage of endolysin 
purification. Lane; M- Marker, 1 - Soluble negative control, 2 and 3 - Soluble protein, 4 and 5 
- Flow through, 6 and 7- First and second wash respectively, lane 8- Elution (endolysin). The 
gel shows the presence of a dense band in the 35 - 55 kDa marker region of lanes 2 and 3 
(indicated by black arrow). This band is absent from negative control in lane 1 and was 
indicative of the presence the endolysin protein which is approximately 34 kDa. The same 
band was absent from the flow through and wash samples as a result of being bound to the 
Ni-NTA beads. Presense of the band in the eluate indicated that the endolysin was 
successfully removed from the Ni-NTA beads and that purification was successful (indicated 
by black arrow in lane 8). 
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3.1.3 Lysis of Listeria spp. using endolysin 
A serotype 4b clinical isolate was lysed using various amounts (0.0, 2.0, 2.2, 2.4, 2.6, 2.8, 
3.0, 3.4, 3.8, 4.0, 4.5, and 5.0 µg) of the purified endolyisn. Analysis on a 1-D protein gel 
showed that the enzyme did not cause protein degradation, which was indicated by the 
absence of smearing in each lane (Figure 3.4).  
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Figure 3.4. One-Dimensional SDS PAGE separation of protein extracted from L. 
monocytogenes, serotype 4b clinical isolate obtained from FPRU. Lanes 1- 12 are protein 
extracts obtained using 0.0 (negative control), 2.0, 2.2, 2.4, 2.6, 2.8, 3.0, 3.4, 3.8, 4.0, 4.5, and 
5.0 µg of endolysin respectively. The image show that the use of endolysin in various 
amounts did not affect the integrity of the L. monocytogenes protein extracts as the protein 
profile of the negative control was similar to that of the other extracts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
120 
 
Light microscopic examination of the cell debris was used to determine the minimum amount 
of enzyme required for complete lysis. In the negative control sample, consisting of unlysed 
L. monocytogenes, all cells appeared intact. Some intact cells were visible in samples to 
which 2.0 - 3.4 μg of endolysin was added. Observations showed that the amount of lysed 
cells increased as the amount of enzyme increased. More lysis was achieved when 3.8 - 4.5 
μg of enzyme was used; however, a few cells appeared to be intact. There were no visibly 
intact cells when 5.0 μg of enzyme was used and lysis appeared to be complete. Based on 
these results, it was deduced that 5 μg of endolysin was sufficient to lyse a 100 mg pellet of 
this isolate, and was used to test lysis efficiency of other L. monocytogenes lineages and 
Listeria species. A total of 13 isolates were tested. These included, L. monocytogenes F2365, 
NCTC 10888, NCTC 10357, NCTC 5348, NCTC 04883, NCTC 05124, NCTC 10815, 
NCTC 10813, NCTC 11288, NCTC 11846, NCTC 12701, NCTC 11856 and NCTC 11857. 
Light microscopic examination showed that the enzyme efficiently and reproducibly lysed all 
other Listeria species (Figure 3.5) (two isolates shown). However, L. grayi subsp grayi 
(NCTC 10815) appeared to be less susceptible as some of the cells appeared to be intact. L. 
rocourtiae and L. marthii were not tested as the isolates were not part of the NCTC collection 
at the time of study. 
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Figure 3.5. Gram stain images of L. monocytogenes F2365 and L. innocua cells (x 1000 
magnification). Images (a) and (d) depicts L. monocytogenes F2365 and L. innocua 
respectively as unlysed small clustered rods. Images (b) and (e) show the cell debris post lysis 
by bead beating. The cells are no longer clustered, however, they appear to be intact, an 
indication that lysis is not complete. Images (c) and (f) show the cell debris post lysis with 
endolysin and bead beating. The absence of rod shaped cells indicated that complete cell lysis 
occured. 
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Separation of all 13 protein extracts on a 1-D gel also showed no evidence of smearing and 
this suggested that endolysin did not cause degradation of protein extracted from all Listeria 
species (Figure 3.6). The figure also revealed the similarities between the protein profiles of 
all the species. For example, protein bands at 160, 40 and 30 kDa (indicated by arrows) are 
consistenly seen across all profiles. 
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Figure 3.6. One-Dimensional SDS PAGE separation of Listeria protein extracts obtained 
from lysis with endolysin. M - Marker,  1- L. monocytogenes F2365,  2 -  NCTC 10888,  3 - 
NCTC 10357,  4 - NCTC 5348,  5 - NCTC 04883,  6 - NCTC 05124,  7 - NCTC 10815,  8 - 
NCTC 10813,  9 - NCTC 11288,  10 - NCTC 11846,  11 - NCTC 12701,  12 - NCTC 11856,  
13 - NCTC 11857,  14 - endolysin. The gel shows that endolysin did not affect the integrity 
of the various species of Listeria used in this experiment. It also emphasised the close 
similarity among Listeria by virtue of their similar protein profiles. 
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Protein concentrations were compared using a bar chart (Figure 3.7). The result also showed 
that overall, the use of endolysin facilitated in the release of more protein from Listeria spp. 
cells in comparison to lysing with glass beads or the barocycler. Furthermore, the data 
showed reproducibility across the methods as consistently, extraction with the barocycler 
yielded the least amount of protein, while extraction with endolysin liberated the highest 
amount of protein with the exception of L. monocytogenes F2365, NCTC 5348, NCTC 
05214, and NCTC 11857 (4 of 13 isolates). A reason for this exception could be that errors 
occurred while simultaneously processing a large number of samples. In order to investigate 
whether this was the case, protein was extracted from L. monocytogenes F2365 (1 of the 4 
samples in which an increase was not apparent), in three biological replicates. The results of 
all three experiments showed that the amount of protein extracted was highest when 
endolysin was used and least when the barocycler was used (Figure 3.8). This demonstrated 
that extraction of higher amounts of protein was reproducible when endolysin was used. 
 
Analysis of these extracts on a 2-D gel showed that extracts obtained using endolysin 
contained more proteins (Figure 3.9), as assessed visually by 2-D gel electrophoresis. The 
experiment was carried out in three biological replicates (one replicate shown). The result 
was reproducible and the image showed that protein extraction using the barocycler leads to 
the least number of protein spots, whilst extraction with endolysin leads to the most number 
of protein spots evident on the gel. 
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Figure 3.7. Amounts of protein (mg/ml) extracted from Listeria spp by lysis using barocycler, 
glass bead beating only and endolysin incubation followed by glass bead beating. Strains 
F2365, NCTC 10888 and NCTC 10357 were not tested. Overall, the data showed 
reproducibility across the methods as consistently, extraction with the barocycler yielded the 
least amount of protein, while extraction with endolysin liberates the highest amount of 
protein with the exception of F2365, NCTC 5348, NCTC 05214, and NCTC 11857.  
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Figure 3.8. Amounts of protein (mg/ml), extracted from Listeria monocytogenes F2365 using 
barocycler, glass bead beating and endolysin incubation followed by glass bead beating. As 
above, data showed that lysis using the barocyler yields the least amount of protein across all 
biological replicates (< 2mg/ml) whereas lysis using endolysin liberates the highest amount 
of protein. Glass bead beating yielded 1mg/ml - 2.25mg/ml protein. 
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Figure 3.9. Two-dimensional SDS PAGE analysis of L. monocytogenes F2365 protein 
extracts obtained using a barocycler, glass bead beating and endolysin and glass bead beating. 
Protein molecular weights are indictated on the y-axis whilst charge is indicated on the x-
axis. The “+” sign indicates the anodic side and the gel and the “-” sign indicates the cathodic 
side of the gel. The experiment was carried out in three biological replicates (one replicate 
shown). The result was reproducible and the image shows that protein extraction using the 
barocycler leads to the least number of protein spots, whilst extraction with endolysin leads to 
the most number of protein spots evident on the gel. 
 
LC-MS/MS analysis of the extracts consistently showed that the number of proteins 
identified was higher when endolysin was used during extraction as opposed to glass bead 
beating only; this was verified by comparing each biological replicate (Figure 3.10), and by 
comparing both extraction methods (Figure 3.11). A comparison of each biological replicate 
showed that a difference of 14, 7 and 5 extra proteins were identified from extracts produced 
using endolysin, (Figures 3.10 a, b, and c respectively).  A comparison of the extraction 
methods showed that 12 extra proteins were identified from extracts produced using 
endolysin (Figure 3.11).  However, the lists of proteins identified showed that only 2 proteins 
(Table 3.1) were consistently present in extracts produced by incubation with endolysin, and 
which were  absent from extracts produced using glass bead beating only. A list of all 
proteins identified can be found in Table A1 (see appendix). 
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Figure 3.10. Venn diagram showing the number of proteins identified from L. monocytogenes 
F2365 cell extracts; a) first biological replicate shows that no unique proteins were produced 
using  glass bead beating, 14 proteins were unique to extracts produced using endolysin and 
416 proteins were found in both extracts; b) second biological replicate shows 2 proteins 
unique to extracts produced using glass bead beating, 9 proteins were unique to extracts 
produced using endolysin and 420 proteins were found in both extracts; c) third biological 
replicate shows that 21 proteins were unique to extracts produced using glass bead beating, 
26 proteins were unique to extracts produced using endolysin and 347 proteins were found in 
both extracts. 
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Figure 3.11. Venn diagram of number of proteins identified from L. monocytogenes F2365 
cell extracts; a) a comparison of number of  proteins identified in extracts produced using 
glass bead beating; b) a comparison of number of  proteins identified in extracts produced 
using endolysin. Using the endolysin extraction method, a total of 368 proteins were 
consistenly identified across all 3 replicates. Using the glass beating method a total of 356 
proteins were consistently identified across all 3 replicates. 
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Table 3.1. List of proteins uniquely and consistently present among all protein extracts 
produced using endolysin (replicates1, 2 and 3), the accession number and number of unique 
peptides found. 
Protein name  
 
Accession  
Number 
 
 
Number of Unique Peptides 
 
Replicate 1 Replicate 2 Replicate 3 
ISPC  gi126143318 5 7 5 
RNA 
Methyltransferase 
gi 116871624 1 1 2 
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 The accession number corresponding to ISPC was searched against the NCBI database and 
results showed that it is an immunogenic surface protein: a 86 kDa protein target of the 
humoral immune response to infection with L. monocytogenes serotype 4b.  RNA 
Methyltransferase is a 51 kDa protein involved in the conversion of primary RNA transcript 
to mature RNA molecules. As the endolysin extraction method did not yield a great number 
of consistently identified proteins, the extraction method applied to all future experiments 
was glass bead beating only which proved to be sufficiently efficient. 
3.2 Characterisation of L. monocytogenes  using MALDI-TOF MS 
Characterisation of L. monocytogenes using MALDI-TOF-MS was undertaken using direct 
smears of the organisms as well as by using formic acid protein extracts. Mass spectra 
analysis of Listeria spp. from direct smears using the AXIMA CFR Plus MALDI-TOF-MS 
instrument (Shimadzu Corporation, UK) and DHB matrix showed that protein mass ions of 
up to 16 kDa were detected; however, most peaks were up to 10 kDa (Figure 3.12). This data 
provided the first indication that in this study, MALDI-TOF-MS would be more effective for 
the characterisation of smaller molecular weight proteins, whereas SELDI-TOF-MS, is 
capable of detecting larger molecular weight proteins. Analysis using HCCA matrix showed 
a similar result (data not shown), therefore the focus was placed on inspecting ions up to 10 
kDa.  
 
Visual inspection of mass spectra profiles consistently showed that the major high intensity 
peaks detected were 4325 and 5301 kDa, while lower intensity peaks included 7591 and 9752 
kDa (Figures 3.13). The occurrence of these peaks in multiple spectra of various L. 
monocytogenes species shows that these ions are consistently present within the species. It 
was therefore envisaged that in this study, the consistent detection of a number of protein ions 
amongst isolates would be the basis through which the species could be further characterised. 
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Figure 3.12. Mass spectrum of NCTC 10357 obtained using a direct colony smear. Ion 
abundance (y-axis) and ion mass (x) axis. Blue peaks represent ions detected in the isolate 
and red peaks represent ions in the SARAMIS Listeria superspectrum. The spectrum shows 
that using the AXIMA CFR Plus MALDI-TOF-MS instrument (Shimadzu Corporation, UK) 
and DHB matrix, protein mass ions of up to 16 kDa can be detected; however, most peaks are 
up to 10 kDa. 
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Figures 3.13. Mass spectra of (A) L. monocytogenes NCTC 10357 isolate and (B) L. 
monocytogenes NCTC 10890 isolate. Ion abundance (y-axis) and ion mass (x) axis. Blue 
peaks represent ions detected in the isolate and red peaks represent ions in the SARAMIS 
Listeria superspectrum. Visual inspection of the profiles consistently shows that the major 
high intensity peaks detected were 4325 and 5301 kDa (indicated by red arrows), while lower 
intensity peaks included 7591 and 9752 kDa (indicated by green arrows).   
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Though the quality of spectra obtained using SARAMIS MALDI-TOF-MS instrument was 
good (that is, ions detected were reproducible with consistent intensities), identification was 
predominantly genus level identification of all Listeria species. Of the 23 isolates analysed 
using DHB matrix 19 were positively identified as belonging to the genus Listeria, 1 was 
identified to the correct species level and the remaining 4 isolates yielded no identification 
results (Table 3.2). Analysis using HCCA yielded similar results and therefore did not appear 
to impact identification result. Of the 23 isolates tested, 18 were identified to genus level, 2 
were identified to the species level and 4 were not identified (Table 3.3). This was an 
unexpected result as there are superspectra in the SARAMIS database representing each 
species of Listeria, which should have therefore facilitated species level identification.  
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Table 3.2. List of microorganisms smeared on the bioMérieux MALDI target plate, the HPA 
Sample Identification code, the identification confidence scores and the Taxnonmic Rank 
assigned by the SARAMIS analysis. The matrix used was DHB. Each isolate was tested in 
duplicates. The results showed that of the 23 isolates, 18 were identified to the genus level, 1 
was identified to the species level and 4 were not identified. 
HPA Sample 
Identification  
Isolate Identification 
Confidence 
Score (%) 
Results 
EGD-e L. monocytogenes 99.9 Listeria spp. 
EGD-e L. monocytogenes 99.9 Listeria spp. 
NCTC 10815 L. grayi subsp grayi 0 no identification 
NCTC 10815 L. grayi subsp grayi 0 no identification 
NCTC 11846 L. ivanovii subsp 
ivanovii 
94.6 Listeria spp. 
NCTC 11846 L. ivanovii subsp 
ivanovii 
99.9 Listeria spp. 
NCTC 11288 L. innocua  79.5 Listeria spp. 
NCTC 11288 L. innocua  99.9 Listeria spp. 
NCTC 11857 L. welshimeri 86.4 Listeria spp. 
NCTC 11857 L. welshimeri 99.9 Listeria spp. 
NCTC 11856 L. seeligeri 99.9 Listeria spp. 
NCTC 11856 L. seeligeri 99.9 Listeria spp. 
H09 032 787 L. seeligeri 99.9 Listeria spp. 
H09 032 787 L. seeligeri 99.9 Listeria spp. 
H09 304 0186 L. innocua  90.1 Listeria spp. 
H09 304 0186 L. innocua  77.4 Listeria spp. 
H09 032 0783 L. ivanovii  79.5 Listeria spp. 
H09 032 0783 L. ivanovii  79.5 Listeria spp. 
H09 032 0784 L. welshimeri 0 no identification 
H09 032 0784 L. welshimeri 0 no identification 
H09 0327 077 L. grayi  0 no identification 
H09 0327 077 L. grayi  0 no identification 
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H08 162 0317 L. monocytogenes 90.3 Listeria spp. 
H08 162 0317 L. monocytogenes 94.6 Listeria spp. 
H09 126 0107 L. monocytogenes 99.9 Listeria spp. 
H09 126 0107 L. monocytogenes 99.9 Listeria spp. 
Control Escherichia coli 99.9 Escherichia coli 
Control Escherichia coli 99.9 Escherichia coli 
H09 088 0603 L. monocytogenes 90.3 Listeria spp. 
H09 088 0603 L. monocytogenes 94.6 Listeria spp. 
H08 180 0412 L. monocytogenes 99.9 Listeria spp. 
H08 180 0412 L. monocytogenes 99.9 Listeria spp. 
H08 520 0220 L. monocytogenes 81 Listeria spp. 
H08 520 0220 L. monocytogenes 75.6 Listeria spp. 
H08 352 0191 L. monocytogenes 99.9 Listeria spp. 
H08 352 0191 L. monocytogenes 99.9 Listeria spp. 
H08 446 0286 L. monocytogenes 99.9 Listeria spp. 
H08 446 0286 L. monocytogenes 94.6 Listeria spp. 
H08 382 0003 L. monocytogenes 91.8 Listeria spp. 
H08 382 0003 L. monocytogenes 99.9 Listeria spp. 
H08 156 0404 L. monocytogenes 91.8 Listeria spp. 
H08 156 0404 L. monocytogenes 97.2 Listeria spp. 
H08 224 0145 L. monocytogenes 97.2 Listeria spp. 
H08 224 0145 L. monocytogenes 91.3 Listeria 
monocytogenes 
H08 382 0048 L. monocytogenes 0 no identification 
H08 382 0048 L. monocytogenes 86.4 Listeria spp. 
H08 454 0569 L. monocytogenes 0 no identification 
H08 454 0569 L. monocytogenes 0 no identification 
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Table 3.3. List of microorganisms smeared on the bioMérieux MALDI target plate, the HPA 
Sample Identification code, the identification confidence scores and the Taxnonmic Rank 
assigned by the SARAMIS analysis. The matrix used was HCCA. Each isolate was tested in 
duplicates. The results show that of the 23 isolates, 19 were identified to the genus level, 2 
was identified to the species level and 3 were not identified. 
 
HPA Sample 
Identification  
Isolate Identification 
Confidence 
Score (%) 
Results 
EGD-e L. monocytogenes 87.6 Listeria spp. 
EGD-e L. monocytogenes 98.9 Listeria spp. 
NCTC 10815 L. grayi subsp grayi 0 no identification 
NCTC 10815 L. grayi subsp grayi 98.9 no identification 
NCTC 11846 L. ivanovii subsp 
ivanovii 
99.9 Listeria spp. 
NCTC 11846 L. ivanovii subsp 
ivanovii 
99.9 Listeria spp. 
NCTC 11288 L. innocua  94.6 Listeria spp. 
NCTC 11288 L. innocua  86 Listeria spp. 
NCTC 11857 L. welshimeri 86.4 Listeria spp. 
NCTC 11857 L. welshimeri 86.4 Listeria spp. 
NCTC 11856 L. seeligeri 99.9 Listeria spp. 
NCTC 11856 L. seeligeri 99.9 Listeria spp. 
H09 032 787 L. seeligeri 91.8 Listeria spp. 
H09 032 787 L. seeligeri 91.8 Listeria spp. 
H09 304 0186 L. innocua  0 no identification 
H09 304 0186 L. innocua  0 no identification 
H09 032 0783 L. ivanovii  99.9 Listeria spp. 
H09 032 0783 L. ivanovii  0 no identification 
H09 032 0784 L. welshimeri 0 no identification 
H09 032 0784 L. welshimeri 0 no identification 
H09 0327 077 L. grayi  0 no identification 
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H09 0327 077 L. grayi  0 no identification 
H08 162 0317 L. monocytogenes 99.9 Listeria spp. 
H08 162 0317 L. monocytogenes 99.9 Listeria spp. 
H09 126 0107 L. monocytogenes 98.9 L. monocytogenes 
H09 126 0107 L. monocytogenes 84.8 Listeria spp. 
Control Escherichia coli 99.9 Escherichia coli 
Control Escherichia coli 99.9 Escherichia coli 
H09 088 0603 L. monocytogenes 81.7 Listeria spp. 
H09 088 0603 L. monocytogenes 0 no identification 
H08 180 0412 L. monocytogenes 94.6 Listeria spp. 
H08 180 0412 L. monocytogenes 94.6 Listeria spp. 
H08 520 0220 L. monocytogenes 98.9 Listeria spp. 
H08 520 0220 L. monocytogenes 81.7 Listeria spp. 
H08 352 0191 L. monocytogenes 81.7 Listeria spp. 
H08 352 0191 L. monocytogenes 98.9 Listeria spp. 
H08 446 0286 L. monocytogenes 81.7 Listeria spp. 
H08 446 0286 L. monocytogenes 98.6 Listeria spp. 
H08 382 0003 L. monocytogenes 99.9 Listeria spp. 
H08 382 0003 L. monocytogenes 99.9 L. monocytogenes 
H08 156 0404 L. monocytogenes 97.2 Listeria spp. 
H08 156 0404 L. monocytogenes 97.2 Listeria spp. 
H08 224 0145 L. monocytogenes 98.9 Listeria spp. 
H08 224 0145 L. monocytogenes 99.9 L. monocytogenes 
H08 382 0048 L. monocytogenes 94.6 no identification 
H08 382 0048 L. monocytogenes 90.3 Listeria spp. 
H08 454 0569 L. monocytogenes 90.3 Listeria spp. 
H08 454 0569 L. monocytogenes 0 no identification 
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As species level identification was not attainable, the Microflex LT MALDI-TOF-MS 
instrument (Bruker UK, Ltd) was investigated as an alternate approach. In the first instance 
this was investigating from direct smears. Good quality spectral profiles were obtained using 
HCCA matrix. The profiles were also similar to those obtained using the SARAMIS MALDI-
TOF-MS instrument.  Mass ions of similar sizes were detected (4322 and 5803 kDa), and the 
majority of peaks detected were up to ~10 kDA (Figure 3.14a and Figure 3.16a). These 
results provided confidence that the Micro LT MALDI-TOF-MS instrument could be used to 
accomplish the same goals which were set out earlier. Of the 89 Listeria isolates investigated, 
57 (64%) were given secure genus identification, 31 isolates (35%) were high probable 
species and 1 isolate (1%) was probable genus (Figure 3.15). Of the 31 high probable species 
2 isolates were assigned conflicting species identification: NCTC 10813 - L. grayi subsp 
grayi and NCTC 11289 - L. seeligeri were both identified as L. monocytogenes. All 57 
isolates which were assigned secure genus score were correct and the isolate which was given 
a high probable genus score was also correct. 
 
Species level identification was improved using the Microflex LT MALDI-TOF-MS 
instrument; however, there was a need to vastly improve the number of isolates identified to 
the species level prior to ascertaining its value for further discrimination. Barbuddhe et al. 
(2008) demonstrated that formic acid extraction improved L. monocytogenes identification 
results (Barbuddhe et al. 2008). Formic acid extraction was performed on 33 of the 89 
Listeria isolates used in direct smear analysis, and visual inspection of mass spectral profiles 
showed that the number of mass ions detected had increase (Figures 3.14b and 3.16b). The 
spectra shows that relative to direct smears (Figure 3.14a and 3.16a), formic acid extraction 
resulted in the detection of a larger number of ions with ions such as 3702, 4325, 4698, 4878, 
6364, 7402, 9340 and 9747 Da being consistently detected in other L. monocytogenes 
species. A total of 30 (94%) Listeria isolates were correctly identified to the species level 
while 3 isolates (6%) were assigned conflicting species identification (Figure 3.17). 
Discrepant identification included: NCTC 11289 - L. seeligeri which was identified as L. 
monocytogenes, NCTC 10813 - L. grayi subsp grayi which was identified as L. innocua and 
an isolate which was identified by the FPRU as L. innocua was identified as L. grayi. 
 
A comparison of the pie charts in Figure 3.15 and Figure 3.17 shows that when the formic 
acid extraction method was used the percentage of isolated identified to the species level 
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increased by 69%. Also by, comparing the resulting score values it is evident that formic acid 
extraction facilitates better identification results. A sample of the compared score values are 
illustrated in Table 3.4. The data shows that the score values increased as a result of 
performing formic acid extraction. This subsequently let to a larger number of isolates being 
identified to species level.  
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Figure 3.14a. Mass spectrum of L. monocytogenes NCTC 10357 derived directly from 
smeared cell preparations that were overlaid with HCCA matrix. Ion abundance (y-axis) and 
ion mass (x) axis. The spectrum was obtained using ths Microflex LT MALDI-TOF-MS 
instrument (Bruker UK, Ltd). The 4322 and 5303 Da ions which were detected using 
SARAMIS MALDI-TOF-MS instrument (Figure 3.13) were also detected here (indicated by 
arrows).  
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Figure 3.14b. Mass spectrum of L. monocytogenes NCTC10357 derived from formic acid 
extracts of cell that were overlaid with HCCA matrix. Ion abundance (y-axis) and ion mass 
(x) axis. The spectrum was obtained using ths Microflex LT MALDI-TOF-MS instrument 
(Bruker UK, Ltd). The spectrum shows that relative to direct smears (Figure 3.14a), formic 
acid extraction results in the detection of a larger number of ions. The arrows indicate some 
of the major peaks which are consistently detected in other L. monocytogenes species. 
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Figure 3.15. Pie chart showing the percentage of Listeria isolates identified using the 
MALDIbiotyper description; highly probable species, secure genus and probable genus. Of 
the 89 Listeria isolates investigated, 57 (64%) were given secure genus identification, 31 
isolates (35%) were high probable species and 1 isolate (1%) was probable genus.  
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Figure 3.16a. Mass spectrum of L. monocytogenes NCTC 10890 derived directly from 
smeared cell preparations that were overlaid with HCCA matrix. Ion abundance (y-axis) and 
ion mass (x) axis. The spectrum was obtained using ths Microflex LT MALDI-TOF-MS 
instrument (Bruker UK, Ltd). The 4322 and 5303 Da ions which were detected using 
SARAMIS MALDI-TOF-MS instrument (Figure 3.13) were also detected here (indicated by 
arrows).  
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Figure 3.16b. Mass spectrum of L. monocytogenes NCTC 10890 derived from formic acid 
extracts of cell that were overlaid with HCCA matrix. Ion abundance (y-axis) and ion mass 
(x) axis. The spectrum was obtained using ths Microflex LT MALDI-TOF-MS instrument 
(Bruker UK, Ltd). The spectrum shows that relative to direct smears (Figure 3.16a), formic 
acid extraction results in the detection of a larger number of ions. The arrows indicate some 
of the major peaks which are consistently detected in other L. monocytogenes species. 
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Figure 3.17. Pie chart showing the percentage of Listeria isolates identified in the 
MALDIbiotyper description; highly probable species and secure genus. A total of 30 (94%) 
Listeria isolates were correctly identified to the species level while 3 isolates (6%) were 
assigned conflicting species identification. 
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Table 3.4. Comparison of Listeria spp. score values whole cell smears and formic acid 
extracted proteins. The data shows that the score values increased as a result of performing 
formic acid extraction. This subsequently led to a a larger number of isolates being identified 
to species level. 
  
Isolate 
HP Sample 
Identification 
Code 
Score (whole 
cell smears) 
Score (formic acid 
extracted proteins) 
L. monocytogenes EGD-e 2.147 2.466 
L. monocytogenes NCTC 04885 2.174 2.337 
L. monocytogenes NCTC 04883 2.179 2.428 
L. innocua NCTC 11288 2.267 2.51 
L. ivanovii subsp. 
ivanovii 
NCTC 11846 2.167 2.336 
L. grayi subsp murrayi NCTC 10814 1.773 2.444 
L. seeligeri NCTC 11856 1.178 2.367 
L. welshimeri NCTC 11857 2.011 2.296 
 
 
key: 
 high probable species 
identification 
score 2.300-3000 
secure identification score 2.000-2.299 
probable genus identification 1.700-1.999 
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As satisfactory species level identification was achieved, an attempt to further characterise L. 
monocytogenes strains was undertaken. An MSP dendrogram was generated using the MS 
profiles obtained from formic acid extractions. The result showed that Listeria isolates 
separated into two main clusters (Figure 3.18). The turquoise cluster contained L. grayi 
species only, while the red cluster contains all other species tested; L. monocytogenes, L. 
innocua, L. grayi, L. ivanovii, L. seeliegeri and L. welshimeri (a list of all isolates used to 
generate the MSP dendrogram can be found in section 2.8.5 of the Material and Methods 
section). The dendrogram in Figure 3.18 provided strong evidence to support the the use of 
MALDI-TOF-MS data for the further characterisation of Listeria. There was good 
congruence between the MSP dendrogram and the one generated using 16S rRNA data. 
Those species belonging to the red main cluster were further differentiated into 5 major 
clusters which will be further referred to as phena (Figure 3.19). Each phenon contained a 
mixture of isolates, that at this stage, did not cluster into separate phena. This suggests a large 
number of conserved ribosomal proteins amongst the species.  
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Figure 3.18. MSP Dendrogram of Listeria spp. obtained using MALDI-TOF-MS. The 
distance level is on the x-axis and isolates are on the y-axis. The dendrogram was generated 
by analysing the spectra of 78 isolates; L. monocytogenes, L. ivanovii, L seeligeri, L. 
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welshimeri, L. innocua and L. grayi. Each isolate is numbered for simplicity and the 
corresponding species name is recorded in Table 2.2. The turquoise cluster contained L. grayi 
species only, while the red cluster contains all other species. The dendrogram shows that 
whilst all species show correlation, L. grayi form a separate cluster at a distance level of 100.  
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Figure 3.19. MSP Dendrogram of Listeria spp. obtained using MALDI-TOF-MS spectra 
(zoomed image of Figure 3.18), with distance level on the x-axis and isolates on the y-axis. 
The dendrogram was generated by analysing the spectra of 78 isolates; L. monocytogenes, L. 
ivanovii, L seeligeri, L. welshimeri, L. innocua and L. grayi. Each isolate is numbered for 
simplicity and the corresponding species name is recorded in Table 2.2. The 5 major 
identifiable phena are indicated by black boxes numbered 1-5. The dendrogram shows that 
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distance levels are relatively close, suggesting that a large number of conserved ribosomal 
proteins amongst the species.  
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3.3 Characterisation of L. monocytogenes  using SELDI-TOF MS 
SELDI-TOF-MS is an extension of MALDI-TOF-MS in which different classes of protein 
extracts are analysed. Ultimately profiles generated using SELDI-TOF-MS may also be used 
to generate MSP dendrograms and was executed in this study. SELDI-TOF-MS was explored 
in this study as an alternate method for the characterisation of Listeria. Whilst both MALDI-
TOF-MS and SELDI-TOF-MS are able to detect proteins which may provide the basis for 
differentiation, in general former detects ribosomal proteins while the latter detects cytosolic 
proteins. As shown in the previous section, analysis of MSP dendrograms (derived from the 
analysis of MALDI-TOF-MS generated spectra) showed that results are comparable to 
dendrograms generated using 16S RNA data. Here comparability of SELDI-TOF-MS derived 
dendrograms is assessed.  
 
Before characterisation, it was necessary to select the most appropriate ProteinChip Array. 
This was undertaken by testing L. monocytogenes F2365 and L. monocytogenes NCTC 10357 
protein extracts, which were prepared from growth in BHI broth. The ProteinChips selected 
in this study were ProteinChip CM10, ProteinChip Q10 array and the ProteinChip H50 array, 
as they generally yield broader mass spectra. The chips were prepared using varing amounts 
of protein 150 - 1200 µg. This would enable the determination of the most suitable quantity 
of protein needed to obtain a larger number of peaks with high intensities. Initially 8 sets of 
stacked spectra were produced (Figure 3.20 - Figure 3.27). Using L. monocytogenes F2365 
protein sample, the least number of peaks were dectected using the ProteinChip H50 array 
prepared with acetonitrile (Figure 3.22).  The ProteinChip H50 array prepared with methanol, 
allowed detection of the largest number of peaks with the highest intensities (Figure 3.21). 
This is relative to Figures 3.20 and and Figure 3.23 which depicts proteins detected using 
ProteinChip CM10 and ProteinChip Q10 respectivley.  
 
Visual inspection of results obtained using protein extracts from NCTC 10357, also showed 
that the least number of peaks were dectected using the ProteinChip H50 array prepared with 
acetonitrile (Figure 3.26). Further inspection showed that a large numbet of peaks were 
detected across all other chips: ProteinChip CM10 (Figure 3.24), ProteinChip H50, prepared 
using methanol (Figure 3.25) and ProteinChip Q10 (Figure 3.27). However, the results 
showed that in comparison to the ProteinChip CM10 and ProteinChip Q10 array, the 
ProteinChip H50 array prepared with methanol, led to the detection of the greatest number of 
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protein peaks. For ease of comparison a separate image was generated, see Figure 3.28. This 
image is a composite of results obtained as a result of applying 600 µg of NCTC 10357 
protein extract to ProteinChip CM10 array (Figure 3.24), ProteinChip H50 array , prepared 
with  methanol (Figure 3.25) and ProteinChip Q10 array (Figure 3.27).  
 
According to the ProteinChip® instruction manuals the recommended maximum amount of 
protein that should be used is 350 μg, however, results show that for Listeria spp. this 
concentration needs to be greater and for ProteinChip H50 array in particular this is almost 
double (ca 600 μg). Also, at 600 μg the intensity of the peaks were greater, therefore using a 
higher amount of protein could offer a greater chance of detecting more peaks (Figure 3.28). 
The H50 ProteinChip array was therefore selected for further use in this study using 600 μg 
of protein extracts prepared from BHI broth and using 50% methanol as the binding buffer. 
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Figure 3.20. Ions detected on a ProteinChip CM10 array using L. monocytogenes F2365 
protein extracts. The chip allows simultaneous processing of 8 samples and the data are 
therefore presented as 8 stacked spectra. The identity of each sample is noted at the end of 
each spectrum. From top to bottom they include 750 µg, 650 µg, 550 µg, 450 µg, 350 µg, 250 
µg and 150 µg of protein and the Bio-Rad Standard was applied to the 8
th
 spot. The image 
shows peak intensity (y-axis) versus m/z (x-axis).  
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Figure 3.21. Ions detected on a ProteinChip H50 array which was prepared using methanol 
and L. monocytogenes F2365 protein extracts. The chip allows simultaneous processing of 8 
samples and the data are therefore presented as 8 stacked spectra. The identity of each sample 
is noted at the end of each spectrum. From top to bottom they include 546 µg, 450 µg, 400 
µg, 350 µg, 300 µg, 250 µg and 200 µg of protein was used to generate the spectra, and the 
Bio-Rad matrix solution was applied to the 8
th
 spot. The image shows peak intensity (y-axis) 
versus m/z (x-axis).  
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Figure 3.22. Ions detected on a ProteinChip H50 array which was prepared using acetonitrile 
and L. monocytogenes F2365 protein extracts. The chip allows simultaneous processing of 8 
samples and the data are therefore presented as 8 stacked spectra. The identity of each sample 
is noted at the end of each spectrum. From top to bottom they include 173 µg, 450 µg, 400 
µg, 350 µg, 300 µg, 250 µg and 200 µg of protein and the Bio-Rad matrix solution was 
applied to the 8
th
 spot. The image shows peak intensity (y-axis) versus m/z (x-axis). 
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Figure 3.23. Ions detected on a ProteinChip Q10 array which was prepared using and L. 
monocytogenes F2365 protein extracts. The chip allows simultaneous processing of 8 
samples and the data are therefore presented as 8 stacked spectra. The identity of each sample 
is noted at the end of each spectrum. From top to bottom they include 546 µg, 450 µg, 400 
µg, 350 µg, 300 µg, 250 µg and 200 µg of protein and the Bio-Rad matrix solution was 
applied to the 8
th
 spot. The image shows peak intensity (y-axis) versus m/z (x-axis). 
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Figure 3.24. Ions detected on a ProteinChip CM10 array which was prepared using and L. 
monocytogenes NCTC 10357 protein extracts. The chip allows simultaneous processing of 8 
samples and the data are therefore presented as 8 stacked spectra. The identity of each sample 
is noted at the end of each spectrum. From top to bottom they include 1200 µg, 1000 µg, 800 
µg, 600 µg, 400 µg, 350 µg and 250 µg of protein and the Bio-Rad matrix solution was 
applied to the 8
th
 spot. The image shows peak intensity (y-axis) versus m/z (x-axis). 
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Figure 3.25. Ions detected on a ProteinChip H50 array which was prepared using methanol 
and L. monocytogenes NCTC 10357 protein extracts. The chip allows simultaneous 
processing of 8 samples and the data are therefore presented as 8 stacked spectra. The identity 
of each sample is noted at the end of each spectrum. From top to bottom they include 984 µg, 
800 µg, 600 µg, 500 µg, 350 µg, 200 µg and 150 µg of protein and the Bio-Rad standard 
solution was applied to the 8
th
 spot. The image shows peak intensity (y-axis) versus m/z (x-
axis). 
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Figure 3.26. Ions detected on a ProteinChip H50 array which was prepared using acetonirile 
and L. monocytogenes NCTC 10357 protein extracts. The chip allows simultaneous 
processing of 8 samples and the data are therefore presented as 8 stacked spectra. The identity 
of each sample is noted at the end of each spectrum. From top to bottom they include 800 µg, 
600 µg, 500 µg, 350 µg, 150 µg, 250 µg and 984 µg of protein and the Bio-Rad standard 
solution was applied to the 8
th
 spot. The image shows peak intensity (y-axis) versus m/z (x-
axis) 
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Figure 3.27. Ions detected on a ProteinChip Q10 array which was prepared using acetonirile 
and L. monocytogenes NCTC 10357 protein extracts. The chip allows simultaneous 
processing of 8 samples and the data are therefore presented as 8 stacked spectra. The identity 
of each sample is noted at the end of each spectrum. From top to bottom they include 984 µg, 
800 µg, 600 µg, 500 µg, 350 µg, 200 µg and 150 µg of protein and the Bio-Rad standard 
solution was applied to the 8
th
 spot. The image shows peak intensity (y-axis) versus m/z (x-
axis). 
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Figure 3.28. A comparison of L. monocytogenes NCTC 10357 proteins bound to a spot on a 
ProteinChip CM10 array (top spectra), ProteinChip Q10 array (middle spectra) and a 
ProteinChip H50 arrays. The data was pulled from Figure 3.24, Figure 3.25 and Figure 3.27 
respectivley and shows peak intensity (y-axis) versus m/z ratio (x-axis). The amount of 
protein used was 600 μg. Visual inspection shows that a larger number of peaks were 
detected using the ProteinChip H50 array, whilst the ProteinChip CM10 array detected peaks 
at higher intensities. 
 
 
 
 
164 
 
A total of 30 isolates were selected for analysis on the ProteinChip H50 array. The results 
obtained were poor, in that, either insufficient peaks as seen in Figure 3.29 or no peaks were 
detected as in seen in Figure 3.30. This observation is relative to Figure 3.28 in which 
inspection of the ProteinChip H50 array shows a large numbe of peaks. This was an 
unexpected result and an investigation was carried out to access the quality of the protein 
extracts. The quality was assessed by separating all 30 of the protein samples on a 1-D SDS 
gel. The results showed that the protein extracts were not degraded as degradation would 
have appeared as smearing in the lanes (Figure 3.31 illustrates 8 of the 30 protein extracts). 
This therefore eliminated sample quality as the cause of poor MS spectra. In addition to 
demonstrating protein quality the gel also demonstrated the diversity among the species as 
there were several bands which were present in some isolates and absent in others. This result 
was a preliminary and positive indication of the diversity that may be detected in much 
greater detail. The SELDI-TOF-MS data was visualized using heat maps to enable 
comparative expression between strains (Figure 3.31).  
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Figure 3.29. Ions detected on a ProteinChip H50 array which was prepared using methanol 
and 600 μg of various L. monocytogenes protein extracts. The chip allows simultaneous 
processing of 8 samples and the data are therefore presented as 8 stacked spectra. The identity 
of each sample is noted at the end of each spectrum. From top to bottom they include isolates 
H10 162 0552, H10 112 0014, H10 178 0389, H09 348 0558, H08 476 0100, H09 012 0053, 
H10 074 0236 and H08 262 0274. The image shows peak intensity (y-axis) versus m/z (x-
axis). 
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Figure 3.30. Ions detected on a ProteinChip H50 array which was prepared using methanol 
and 600 μg of various L. monocytogenes protein extracts. The chip allows simultaneous 
processing of 8 samples and the data are therefore presented as 8 stacked spectra. The identity 
of each sample is noted at the end of each spectrum. From top to bottom they include isolates 
H10 044 0420, H10 074 0271, H09 062 0066, H10 146 0091, H10 126 0369, H10 172 0401, 
H09 170 0375 and H10 202 0622. The image shows peak intensity (y-axis) versus m/z (x-
axis). 
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Figure 3.31. One-dimensional SDS PAGE analysis of 5 µg protein extracts of Listeria and 
Brochothrix species. Lane M shows the protein marker, Lane 25 - NCTC 11288 (L. innocua), 
26 - NCTC 11846 (L. ivanovii subsp ivanovii), 27 - NCTC 11856 (L. seeligeri), 28 - NCTC 
11857 (L. welshimeri), 29 - DSM 4712 (B. campestris), 30 - DSM 20171 (B. thermosphacta), 
23 - NCTC 10890 (L. monocytogenes) and 24 - NCTC 10815 (L. grayi subsp grayi). The 
protein profiles show the diversity among the species as there were several bands which were 
present in some isolates and absent in others. An example is the protein band in the 3.5 - 10 
kDa marker region which is present in lane 29 (indicated by black arrow) and absent in lanes 
25, 26, 30 and 23.  
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It was considered that the quality of the remaining ProteinChip H50 arrays were poor as 
results from other in-house laboratory projects showed that the ProteinChip CM10 arrays 
produced good quality spectra. As a result of limited resources the ProteinChips H50 arrays 
were not replaced and analysis was continued using ProteinChips CM10 arrays and 
established in-house protocols. This involved manual spotting, using a smaller amount of 
protein (6 μg) which was harvested from isolates grown on BN agar, and a different buffer 
composition (25 mM ammonium acetate/0.01% Triton). In an initial test, extracts obtained 
from growth in BHI broth and BN agar produced good quality spectra with peak intensities 
up to 40 units (Figure 3.32). Comparison of peak intensities showed that ProteinChip CM10 
arrays produced higher mass abundance intensities than ProteinChip H50 array results 
depicted in Figure 3.21 and Figure 3.25. Spectra corresponding to isolates grown on BN agar 
produced a mass spectrum ranging from approximately 15 - 17 kDa which were absent from 
spectra corresponding to isolates grown in BHI broth (indicated by green arrows on Figure 
3.33). Based on these results the 30 isolates were retested using extracts obtained from BN 
plates. These spectra were of good quality, with the majority of peaks detected ranging from 
approximately 5 - 22 kDa (Figures 3.34 - 3.37). The results also showed that the data was 
reproducible as spectra corresponding to isolates H10 162 0552, NCTC 10357, L. 
monocytogenes F2365 and H10 146 0091 (Figure 3.33) were similar when re-analysed 
(Figures 3.34 - 3.37).  
 
Evidence of experimental control is depicted in Figure 3.38. In this figure the negative 
control is the lower spectra. A solution containing matrix only was applied to this spot of the 
ProteinCip CM10 array. Due to the absence of protein in this sample the result was as 
expected and no ions were detected. On the other hand the upper spectra of Figure 3.38 
showed that ions were detected using the molecular weight standard obtained from Bio-Rad 
which served as a positive control. 
 
As reproducible data for all 30 isolates was satisfactorily produced and with evidence of 
successful controls, the subsequent stage of using the spectra to construct a dendrogram was 
carried out. This was achieved using the spectra in Figures 3.34 - 3.37.  
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Figure 3.32. Ions detected on a ProteinChip CM10 array which was prepared by manual 
spotting using 6 μg of various L. monocytogenes protein extracts obtained from BHI broth 
and BN agar plate cultures. The chip allows simultaneous processing of 8 samples and the 
data are therefore presented as 8 stacked spectra. The identity of each sample is noted at the 
end of each spectra. From top to bottom they include isolates H10 162 0552 (from plate), 
H10 162 0552 (from broth), NCTC 10357 (from plate), NCTC 10357 (from broth), L. 
monocytogenes (from plate), L. monocytogenes (from broth), H10 146 0091 (from plate) and 
H10 146 0091 (from broth). The image shows peak intensity (y-axis) versus m/z (x-axis). 
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Figure 3.33. Ions detected on a ProteinChip CM10 array which was prepared by manual 
spotting using 6 μg of various L. monocytogenes protein extracts obtained from BHI broth 
and BN agar plate cultures. The chip allows simultaneous processing of 8 samples and the 
data are therefore presented as 8 stacked spectra. The identity of each sample is noted at the 
end of each spectra. From top to bottom they include isolates H10 162 0552 (from plate), 
H10 162 0552 (from broth), NCTC 10357 (from plate), NCTC 10357 (from broth), L. 
monocytogenes F2365 (from plate), L. monocytogenes F2365 (from broth), H10 146 0091 
(from plate) and H10 146 0091 (from broth).  The image is a zoomed version of Figure 3.32 
between the 0-35000 Da region. The image shows peak intensity (y-axis) versus m/z (x-axis). 
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Green arrows indicate ions ranging from approximately 15 - 17 kDa which are present in 
samples obtained from growth on plate which are absent from samples derived from broth. 
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Figure 3.34. Ions detected on a ProteinChip CM10 array which was prepared by manual 
spotting using 6 μg of various L. monocytogenes protein extracts obtained from BN agar plate 
cultures. The chip allows simultaneous processing of 8 samples and the data are therefore 
presented as 8 stacked spectra. The identity of each sample is noted at the end of each 
spectra. From top to bottom they include isolates H10 162 0552, H10 112 0014, H10 178 
0389, H09 348 0558, H08 476 0100, L. monocytogenes F2365, H09 012 0053, H10 074 
0236. The image shows peak intensity (y-axis) versus m/z (x-axis). 
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Figure 3.35. Ions detected on a ProteinChip CM10 array which was prepared by manual 
spotting using 6 μg of various L. monocytogenes protein extracts obtained from BN agar plate 
cultures. The chip allows simultaneous processing of 8 samples and the data are therefore 
presented as 8 stacked spectra. The identity of each sample is noted at the end of each 
spectra. From top to bottom they include isolates H08 074 0236, H10 044 0420, H08 074 
0271, H09 062 0066, H10 146 0091, H10 126 0369, H10 172 0401 and H10 170 0375. The 
image shows peak intensity (y-axis) versus m/z (x-axis). 
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Figure 3.36. Ions detected on a ProteinChip CM10 array which was prepared by manual 
spotting using 6 μg of various Listeria species protein extracts obtained from BN agar plate 
cultures. The chip allows simultaneous processing of 8 samples and the data are therefore 
presented as 8 stacked spectra. The identity of each sample is noted at the end of each 
spectra. From top to bottom they include isolates H10 202 0622, H09 406 0833, H08 490 
0250, H09 392 0041, NCTC 05214, NCTC 10890, NCTC 10815 and NCTC 11288. The 
image shows peak intensity (y-axis) versus m/z (x-axis). 
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Figure 3.37. Ions detected on a ProteinChip CM10 array which was prepared by manual 
spotting using 6 μg of various Listeria and Brochothrix species protein extracts obtained from 
BN agar plate cultures. The chip allows simultaneous processing of 8 samples and the data 
are therefore presented as 8 stacked spectra. The identity of each sample is noted at the end of 
each spectra. From top to bottom they include isolates NCTC 11846, NCTC 11856, NCTC 
11857, DSM 4712, DSM 20599, NCTC 10357, Bio-Rad standard and matrix. The image 
shows peak intensity (y-axis) versus m/z (x-axis). 
 
 
 
176 
 
 
 
Figure 3.38. Ions detected on a ProteinChip CM10 array which was prepared by manual 
spotting using Bio-Rad standard (top) and matrix (bottom). The identity of each sample is 
noted at the end of each spectra. The image shows peak intensity (y-axis) versus m/z (y-axis). 
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Analysis of Figures 3.34 - Figure 3.37 using the Ciphergen ProteinChip software, lead to the 
creation of a heat map, from which a dendrogram was deduced (Figure 3.39). The heat map is 
a visual representation of proteins which were detected in each sample. In this representation 
all protein ions are assigned a red, green or black colour code. Ions depicted in red were up-
regulated, ions depicted in green were down-regulated whilst those depicted in black were at 
the same expression level across all isolates. A visual inspection of the heat map showed 
dense patches of up-regulated and down regulated proteins. Furthur analysis of the heat map 
using the Ciphergen ProteinChip software produced the dendrogram illustrated at the top of 
Figure 3.39. The dendrogram showed that the isolates delineated into 5 clearly distinct 
clusters. Closer observation showed that the clusters did not correlate with molecular 
serotypes, or AFLP patterns. Each cluster contained a mixture of Listeria species whilst 
Brochothrix species did not cluster separately. In this study the result showed the close 
relationship amongst Listeria species and the close relationship between Listeria and 
Brochothrix.  
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Figure 3.39. Dendrogram (top) and heat map (botton) generated by analysis of Listeria and 
Brochothrix spp. SELDI-TOF-MS spectra. The heat map was generated using software 
analysis through which each detected protein ion was assigned an m/z value. These are listed 
along the right border of the heat map which is a rectangular image composed of red, green 
and black coloured squares. Each ion is assigned a red, green or black colour which indicated 
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whether in that particular sample, the protein was up-regulated (red), down-regulated (green) 
or did not have a change in expression across all isolates. The isolates are listed above the 
heat map. A dendrogram is constructed basedon the relative amounts of protein ions detected.  
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3.4 Analysis of L. monocytogenes  proteins differentially expressed at 4°C and 
37°C 
Prior to investigating proteins that are differentially expressed at 4°C and 37°C, it is 
necessary to determine a suitable time for harvesting L. monocytogenes cultures grown under 
each condition. Cultures harvested during mid to late exponential growth phase yielded 
sufficient protein for the study. For cultures grown at 4°C, it was necessary to allow sufficient 
time for cells to adapt to environmental conditions. Growth curves were established. A total 
of 7 L. monocytogenes isolates were used in this study, one of which was type strain NCTC 
10357 and the remaining 6, H10 162 0552, H08 446 0286, H08 446 0286, H09 012 0053, 
H10 146 0091, H08 074 0271 were isolates obtained from FPRU. The growth curves of 
NCTC 10357 at 4°C and 37°C were pre-determined in this study (Figures 3.1 and 3.12 
respectively). In order to determine whether similar results would be obtained for the other 6 
isolates, clinical isolate H10 162 0552 was selected as a test isolate for growth curve 
comparison.  
 
The growth curve of a  L. monocytogenes clinical isolate H10 162 0552, was confirmed as 
being similar to the type strain at 4°C and 37°C (Figures 3.40 and 3.41 respectively). From 
this data, it was deduced that growth of all L. monocytogenes isolates selected for this study 
would have a similar growth curve; such isolates were therefore harvested at similar 
absorbance values, that is,  between OD600 0.5 and 0.7 and between OD600 0.8 and 1.0 when 
grown at  4°C and 37°C respectively. This was carried out so that as previously discussed the 
majority of cells would be in exponential growth phase. 
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Figure 3.40. L. monocytogenes H1 0162 0552 growth curve at 4°C. Absorbance at OD600 (y-
axis) versus days (x-axis). The curve shows that at an absorbance between OD600 0.5 and 0.7 
cells were in their exponential growth phase. 
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Figure 3.41. L. monocytogenes H1 0162 0552 growth curve at 37°C. Absorbance at OD600 (y-
axis) versus days (x-axis). The curve shows that at an absorbance between OD600 0.8 and 1.0 
cells were in their exponential growth phase. 
 
One-dimensional gel images of protein extracts obtained from the 7 L. monocytogenes 
isolates grown at 4°C and 37°C, showed that a number of bands had different intensities 
across all biological replicates. In all 7 isolates, it was consistently observed that a protein 
band corresponding to approximately 10 kDa in size was more intense at 4°C than 37°C. 
Also, consistently present in all isolates was a protein band corresponding to approximately 
10 kDa which was present at 37°C and absent at 4°C (these bands are indicated on the gel 
images by black arrows) (Figures 3.42 and 3.43). 
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Figure 3.42. One-dimensional SDS PAGE analysis of proteins expressed in L. 
monocytogenes NCTC 10357 at 4°C and 37°C. Lanes: M-Marker; lanes 1 and 2 - 4°C and 
37°C respectively (1
st
 replicate); lanes 3 and 4 - 4°C and 37°C respectively (2
nd
 replicate); 
and lanes 5 and 6 - 4°C and 37°C respectively (3
rd
 replicate). A comparison of all three 
biological replicates showed that samples obtained from 4°C and 37°C cultured isolates both 
appear to have a unique protein band in the 10- 15 kDa marker range (indicated by black 
arrows). 
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Figure 3.43. One-dimensional SDS PAGE analysis of proteins expressed in L. 
monocytogenes H10 162 0552 at 4°C and 37°C. Lanes: M-Marker; lanes 1 and 2 - 4°C and 
37°C respectively (1
st
 replicate); lanes 3 and 4 - 4°C and 37°C respectively (2
nd
 replicate); 
and lanes 5 and 6 - 4°C and 37°C respectively (3
rd
 replicate). A comparison of all three 
biological replicates showed that samples obtained from 4°C and 37°C cultured isolates both 
appear to have a unique protein band in the 10 - 15 kDa marker range (indicated by black 
arrows).  
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The observed differences in band intensities were confirmed using the Bio-Rad Image Lab 
4.0 software which assigns an intensity value to each band. As 7 isolates were tested in this 
study, the small sample size means that the data cannot be statistically tested, however, 
compilation of the data on bar graphs showed that overall, the 10 kDa band was more intense 
at 4°C than 37°C (Figures 3.44). (One figure is shown, however, the same trend was observed 
for all isolates).   
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Figure 3.44. Intensity of the ~10 kDa protein band at 4°C and 37°C in biological replicates 1, 
2 and 3 of L. monocytogenes isolate H08 074 0271. The intensity was 32%, 35% and 81% 
greater at 4°C (blue bars) than at 37°C (red bars) for replicates 1 and 2, and 3 respectively.   
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Protein bands which showed differential expression at approximately 10 kDa (Figures 3.42 
and 3.43) were further analysed using LC-MS/MS followed by Scaffold software analysis 
and results indicated 9 that proteins were either up or down-regulated at either temperature 
(Figures 3.45 - 3.53 and Table 3.5). As expected changes in growth temperature affected 
protein expression. The most dramatic change can be seen in Figure 3.50. Here, at 4°C 
hypothetical protein lin2124 had a normalized spectrum count ranging between 1.0 and 3.5, 
whilst at 37°C the normalized spectrum count ranged between 25.0 and 67.5.  
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Figure 3.45. A bar graph showing the relative abundance of hypothetical protein lin1401 
across different protein samples. Protein samples were obtained from seven L. 
monocytogenes isolates H080740271, H084460286, H084900250, H090120053, 
H101460091, H101620552 and NCTC 10357. Each isolate was cultured at 37°C and 4°C 
giving a total of 14 biological samples on the x-axis.  The y-axis shows the normalized 
spectral count of the protein in each sample. The data indicates that overall hypothetical 
protein lin1401 was expressed at a higher level in isolates grown at 4°C. 
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Figure 3.46. A bar graph showing the relative abundance of PTS system, cellobiose specific, 
IIB component protein across different protein samples. Protein samples were obtained from 
seven L. monocytogenes isolates H080740271, H084460286, H084900250, H090120053, 
H101460091, H101620552 and NCTC 10357. Each isolate was cultured at 37°C and 4°C 
giving a total of 14 biological samples on the x-axis.  The y-axis shows the normalized 
spectral count of the protein in each sample.The data indicates that overall PTS system, 
cellobiose specific, IIB component protein was expressed at a higher level in isolates grown 
at 4°C. 
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Figure 3.47. A bar graph showing the relative abundance of hypothetical protein lin1183 
across different protein samples. Protein samples were obtained from seven L. 
monocytogenes isolates H080740271, H084460286, H084900250, H090120053, 
H101460091, H101620552 and NCTC 10357. Each isolate was cultured at 37°C and 4°C 
giving a total of 14 biological samples on the x-axis. The y-axis shows the normalized 
spectral count of the protein in each sample. The data indicates that overall hypothetical 
protein lin1183 was expressed at a higher level in isolates grown at 4°C. 
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Figure 3.48. A bar graph showing the relative abundance of 50s ribosomal protein L29 across 
different protein samples. Protein samples were obtained from seven L. monocytogenes 
isolates H080740271, H084460286, H084900250, H090120053, H101460091, H101620552 
and NCTC 10357. Each isolate was cultured at 37°C and 4°C giving a total of 14 biological 
samples on the x-axis. The y-axis shows the normalized spectral count of the protein in each 
sample. The data indicates that overall 50s ribosomal protein L29 was expressed at a higher 
level in isolates grown at 4°C. 
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Figure 3.49. A bar graph showing the relative abundance of co-chaperonin GroES across 
different protein samples. Protein samples were obtained from seven L. monocytogenes 
isolates H080740271, H084460286, H084900250, H090120053, H101460091, H101620552 
and NCTC 10357. Each isolate was cultured at 37°C and 4°C giving a total of 14 biological 
samples on the x-axis.  The y-axis shows the normalized spectral count of the protein in each 
sample. The data indicates that overall co-chaperonin GroES was expressed at a higher level 
in isolates grown at 37°C. 
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Figure 3.50. A bar graph showing the relative abundance of hypothetical protein lin2124 
across different protein samples. Protein samples were obtained from seven L. 
monocytogenes isolates H080740271, H084460286, H084900250, H090120053, 
H101460091, H101620552 and NCTC 10357. Each isolate was cultured at 37°C and 4°C 
giving a total of 14 biological samples on the x-axis. The y-axis shows the normalized 
spectral count of the protein in each sample. The data indicates that overall hypothetical 
protein lin2124 was expressed at a higher level in isolates grown at 37°C. 
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Figure 3.51. A bar graph showing the relative abundance of phosphocarrier protein HPr 
across different protein samples. Protein samples were obtained from seven L. 
monocytogenes isolates H080740271, H084460286, H084900250, H090120053, 
H101460091, H101620552 and NCTC 10357. Each isolate was cultured at 37°C and 4°C 
giving a total of 14 biological samples on the x-axis. The y-axis shows the normalized 
spectral count of the protein in each sample. The data indicates that overall phosphocarrier 
protein HPr was expressed at a higher level in isolates grown at 37°C. 
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Figure 3.52. A bar graph showing the relative abundance of anti-anti-sigma factor across 
different protein samples.. Protein samples were obtained from seven L. monocytogenes 
isolates H080740271, H084460286, H084900250, H090120053, H101460091, H101620552 
and NCTC 10357. Each isolate was cultured at 37°C and 4°C giving a total of 14 biological 
samples on the x-axis. The y-axis shows the normalized spectral count of the protein in each 
sample. The data indicates that overall anti-anti-sigma factor was expressed at a higher level 
in isolates grown at 37°C. 
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Figure 3.53. A bar graph showing the relative abundance of 30s ribosomal protein S16 factor 
across different protein samples. Protein samples were obtained from seven L. 
monocytogenes isolates H080740271, H084460286, H084900250, H090120053, 
H101460091, H101620552 and NCTC 10357. Each isolate was cultured at 37°C and 4°C 
giving a total of 14 biological samples on the x-axis. The y-axis shows the normalized 
spectral count of the protein in each sample. The data indicates that overall 30s ribosomal 
protein S16 was expressed at a higher level in isolates grown at 37°C. 
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Table 3.5 Proteins up regulated at 4°C and 37°C. Four proteins are upregulated at 4°C and 
down-regulated at 37°C, whilst 5 proteins are up-regulate at 37°C and down-regulated at 4°C. 
The table is a summary of Figures 3.45 - 3.53 which shows in more detailed the differences 
in expression levels.   
Proteins up-regulated at 4°C (down-
regulated at 37°C). 
Proteins up-regulated at 37°C 
(down-regulated at 4°C). 
Hypothetical protein lin1401 (7 kDa) 
(except H10 162 0552) 
Co-chaperonin GroES (10 kDa) 
Phosphotransferase system (PTS 
system), cellobiose specific, IIB 
component  (11 kDa) (except NCTC 
10357) 
Hypothetical protein lin2124 (7 kDa) 
(except H10 162 0552) 
Hypothetical protein lin1183 (12 kDa) 
(except H10 162 0552) 
Histidine phosphocarrier protein (HPr) 
(9 kDa) (except H10 162 0552) 
50s ribosomal protein L29 (7 kDa) 
(except H10 162 0552) 
Anti-anti sigma factor (13 kDa) 
(except H10 162 0552) 
 30s ribosomal protein S16 (10 kDa) 
(except H10 162 0552) 
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Analysis also indicated that 3 proteins were uniquely expressed at 4°C and 37°C. 
Hypothetical protein lwe06778, an 11 kDa protein, was present at 4°C and absent at 37°C in 
all isolates except the type strain where it was present at both temperatures (Figure 3.54). 
Phosphoribosyl-AMP cyclohydrolase , a 12 kDa protein, was also present at 4°C and absent 
at 37°C in all isolates except the type strain where it was absent at both temperatures (Figure 
3.55). On the other hand, hypothetical protein lmo0056, an 11 kDa protein, was present at 
37°C and absent at 4°C (Figure 3.56).  
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Figure 3.54. A bar graph showing the relative abundance of hypothetical protein lwe06778 
across different protein samples. Protein samples were obtained from seven L. 
monocytogenes isolates H080740271, H084460286, H084900250, H090120053, 
H101460091, H101620552 and NCTC 10357. Each isolate was cultured at 37°C and 4°C 
giving a total of 14 biological samples on the x-axis. The y-axis shows the normalized 
spectral count of the protein in each sample. The data indicates that hypothetical protein 
lwe06778 was soley expressed at 4°C, with the exception of thype strain NCTC 10357 where 
the protein was also present at 37°C 
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Figure 3.55. A bar graph showing the relative abundance of phosphoribosyl-AMP 
cyclohydrolase across different protein samples. Protein samples were obtained from seven L. 
monocytogenes isolates H080740271, H084460286, H084900250, H090120053, 
H101460091, H101620552 and NCTC 10357. Each isolate was cultured at 37°C and 4°C 
giving a total of 14 biological samples on the x-axis. The y-axis shows the normalized 
spectral count of the protein in each sample. The data indicates that, with the exception of 
NCTC 10357, phosphoribosyl-AMP cyclohydrolase was soley expressed at 4°C. The protein 
was not exptressed in the type strain at either temperature. 
201 
 
 
 
Figure 3.56. A bar graph showing the relative abundance of protein lmo0056 different protein 
samples. Protein samples were obtained from seven L. monocytogenes isolates H080740271, 
H084460286, H084900250, H090120053, H101460091, H101620552 and NCTC 10357. 
Each isolate was cultured at 37°C and 4°C giving a total of 14 biological samples on the x-
axis. The y-axis shows the normalized spectral count of the protein in each sample. The data 
indicates that protein lmo0056 was soley expressed at 37°C. 
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Proteins extracts from H101620552 were analysed by high resolution capillary 
electrophoresis (deltaDOT) to further establish the presence of the unique ~10 kDa protein 
bands. SDS-PAGE gel analysis of the samples confirmed the presence of a more intense 
protein band at ~10 kDa (figure not shown). These were analysed against the protein ladder 
using the GST electropherogram and EVA (Figures 3.57 and 3.58) combining the 
information in a mass calibration tool  to assign molecular weights for peaks of interest in the 
L. monocytogenes H101620552 lysate samples (Figures 3.59 and 3.60). Differences in peak 
area were calculated and showed that the area of peak A was decreased by 78% in the protein 
sample expressed at 37°C while the area of peak B was decreased by 54% in the sample 
expressed at 4°C.   
 
The SDS-CGE analysis showed that the average molecular weight of the protein 
corresponding to peak A was 12.88 kDa while the average molecular weight of the protein 
corresponding to peak B was 40.65 kDa. There was a 78% decrease in peak A at 37°C and a 
54% decrease in peak B at 4°C. High resolution capillary electrophoresis (deltaDOT) 
therefore unequivocally corroborated the findings of hypothetical protein lwe06778 and 
phosphoribosyl-AMP cyclohydrolase which were 11 kDa and 12 kDa respectively. 
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Figures 3.57. GST electropherogram depicting the separation of the molecular weight ladder. 
The plot of absorbance (y-axis) versus time in minutes (x-axis) shows the molecular weights 
of seven proteins present in the mixture: 10, 20, 35, 50, 100, 150 and 225 kDa. The ladder 
combined with the mass calibration tool built into the processing software were used to 
assign molecular weights for the peaks of interest in the lysate samples. (Image obtained from 
deltaDOT). 
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Figures 3.58. EVA trace depicting the separation of the molecular weight ladder. The plot of 
absorbance (y-axis) versus time in minutes (x-axis) shows the molecular weights of seven 
proteins present in the mixture: 10, 20, 35, 50, 100, 150 and 225 kDa. The ladder combined 
with the mass calibration tool built into the processing software were used to assign 
molecular weights for the peaks of interest in the lysate samples. (Image obtained from 
deltaDOT). 
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Figures 3.59. GST electropherogram depicting the separation of L. monocytogenes 
H101620552 protein extracts expressed at 4°C (orange and red traces) and 37°C (blue and 
green traces). Replicates of each sample were run. The plot shows absorbance (y-axis) versus 
time in minutes (x-axis). Clear differences are indicated by black arrows as peak A and peak 
B. Peak A is appears to exhibit greater expression at 4°C than at 37°C, while  Peak B appears 
to exhibit greater expression at 37°C than at 4°C. (Image obtained from deltaDOT). 
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Figure 3.60.  EVA trace depicting the separation of L. monocytogenes H101620552 protein 
extracts expressed at 4°C (orange and red traces) and 37°C (blue and green traces). Replicates 
of each sample were run. The plot shows absorbance (y-axis) versus time in minutes (x-axis). 
Clear differences are indicated by black arrows as peak A and peak B. Peak A is appears to 
exhibit greater expression at 4°C than at 37°C, while  Peak B appears to exhibit greater 
expression at 37°C than at 4°C. (Image obtained from deltaDOT). 
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4: Discussion 
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The symptoms associated with listeriosis are severe (with 20-30% of cases resulting in 
mortality). It is therefore important to be able to rapidly identify L. monocytogenes as well as 
discriminate beyond the species level, as such information is valuable for outbreak 
investigations. Subtyping information ultimately contributes to implementation of control 
measures required to reduce the risk of infection to unexposed individuals. Currently 
subtyping methods (see Section 1.2.6.3) each have limitations, consequently more recent 
technologies such as MALDI-TOF-MS, SELDI-TOF-MS and LC-MS/MS were explored in 
this study.  
 
Experiemental work particularly in proteomics is often subject to huge variables which may 
affect the validity of the data presented and subsequently result in incorrect or inconclusive 
findings. Consideration was therefore given to this fact before experimental work was carried 
out. Care was taken to implement appropriate negative and positive controls to reduce 
variables and to ensure that the resulting data was reproducible. This also ensured that all data 
was robust and that conclusions were derived confidently. The work began by devising a 
method for the effective lysis of various Listeria species. In this work, the negative controls 
were Gram stained images of unlysed cells with which the stained images of lysed cell debris 
could be compared. Reproducibility was confirmed when the same result was evident across 
all species. This will be discussed in detail later. The study then moved on to characterisation 
of Listeria using MALDI-TOF-MS and SELDI-TOF-MS derived dendrograms. In both 
instances the negative control was the matrix, in which, as expected no ions were detected. In 
the case of MALDI-TOF-MS the positive control was the BTS: a protein extract of E. coli 
supplied by Brucker. Identification of this organism was an indication that the instrument and 
identification procedure was in working condition, therefore giving credibility to the identity 
and characterisation of unknown samples.  In the case of SELDI-TOF-MS the negative 
control was also the matrix.  A separate positive control was not used as it was decided that 
the molecular weight standard supplied by Bio-Rad was sufficient. A heat map (which is a 
representation of up- and down-regulated protein) was generated from SELDI-TOF-MS 
generated spectra, care was also taken to ensure that the same amount of protein extracts 
(6µg) was used in each experiment, as this further reduces variability and provides a basis for 
comparative expression. 
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 In some experimental designs, it is not always possible to introduce a positive and a negative 
control. In such instances, where appropriate the data are made robust by conducting 
experiments with a number of biological replicates. This was the case when invesitigating 
proteins differentially expressed at 4°C and 37°C. A total of 7 isolates were tested in 
biolological triplicates using two proteomics methods 1-D SDS PAGE followed by band 
intensity measurement and 1D SDS PAGE followed by LC-MS/MS analysis. The same 
amount of protein (5µg) was used in each experiment.  The differences obsereved between 
the two conditions were consistently observed. This was the case for all biological replicates 
across all 7 isolates. This reproducibility lent additional support to findings and conclusions, 
which is discussed in further detail later.  
 
As cited by Dare, the possibility of using MALDI-TOF-MS as a characterisation tool for 
microorganisms was first reported in three separate studies: Claydon et al. (1996), Holland et 
al. (1996), and Krishnamurthy et al. (1996) (Dare 2005). Claydon and colleagues, for 
example, clearly showed the difference that existed among the partial spectra of 
Staphylococcus aureus (SA), Citrobacter freundi (CF) and Escherichia coli CJ532 NCTC 
50167 (ECC2) (Figure 4.1). These differences allowed the three genera to be identified from 
a quick visual inspection. Currently, MALDI-TOF-MS is coupled with software analysis, 
negating the need for visual inspection. 
 
Subsequently, Shah and colleagues used MALDI-TOF-MS to discriminate various 
pathogenic species (Shah et al. 2000). Since many of the pathogenic properties of a cell are 
surface-associated, they reasoned that such a targeted approach would simultaneously shed 
light on the pathpgenic potential of the strains. For Gram positive species, 5-chloro-2-
mercaptobenzothiazole (CMBT) matrix, which enables profiling based on unique surface 
proteins, was used. However, they discovered that surface-associated proteins are markedly 
affected by environmental parameters such as growth media, pH and temperature such that a 
MALDI-TOF-MS spectrum of a strain grown on blood and nutrient agar are different (Shah 
et al. 2000). CMBT was subsequently superseded by DHB and HCCA, and lead to 
improvements in identification. These matrices permit detection of ribosomal proteins which 
are abundant in the cell, stable and unique for species regardless of culture conditions 
(Welker and Moore 2010). In this study the application of HCCA matrix to formic acid 
extracted proteins yielded greater amounts of protein ions (Figures 3.14a, 3.14b, 3.16a and 
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3.16b). This yielded more confidence in microbial identification to the species level (Table 
3.4) (Culak et al. 2012).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
211 
 
 
Figure 4.1. Partial, positive ion, mass spectra of SA, CF and ECC2. Relative peptide/protein 
ion intensity (y-axis) and mass/charge (m/z) (x-axis). SA peaks are in the lowest molecular 
weight range, whilst CF is distinguishable from ECC2 due to the difference in relative 
intensity of the 1618 Da.  The spectra therefore show that each isolate has a set of ions that 
may serve as a unique fingerprint for identification amongst other bacteria (taken from 
Claydon et al., 1996). 
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In 2008, Barbuddhe and colleagues also reported the successful rapid identification of all 
species, (except newly discovered L. marthii and L. roucourtiae), and typing of L. 
monocytogenes using MALDI-TOF-MS (Barbuddhe et al. 2008). They reported that two 
different peak pairs 5,597/11,193 and 5,590/11,179 Da led to the separation of L. 
monocytogenes into lineages I and II respectively, and that a 7970 Da mass ion led to 
identification of L. monocytogenes lineage III isolates. 
 
In this study, the MSP dendrogram showed that L. grayi distantly separated from other 
Listeria species (Figure 3.18). The topography of the tree is similar to that derived by 16S 
rRNA sequencing (Figure 4.2) and highlights congruency between methods.  
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Figure 4.2. Phylogenetic tree of Listeria species, Brochothrix species, Bacillus subtilis and E. 
coli based on sequence analysis of 16S rRNA gene. Distance level (y-axis) species name (x-
axis). The dendrogram shows the relationship between Listeria species, Brochothrix species, 
B. subtilis and E.coli. All Listeria species are closely related forming one cluster, with the 
exception of L. grayi which separates into a separate phena. Brochothrix is the only genus in 
the Listereacea family along with Listeria and clusters in separate phena as did B. subtilis and 
E.coli (taken from Rijpens et al. 1998).  
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The MSP dendrogram shows that the remaining species were clustered into 5 major phena, 
each with further subdivisions (Figure 3.19). The results also show that these phena are not 
clustered according to their serotypes. This is an expected result as serotypes are based on 
flagella and somatic proteins, while the HCCA matrix used for MALDI-TOF-MS spectra 
generation allows the analysis of ribosomal proteins. As a result, it would be more 
appropriate to view these results as an emergence of a new descriptive category, referred to as 
MALDI types.  
 
Unlike sample preparation for MALDI-TOF-MS (which simply required a nominal formic 
acid extraction), a preamble to SELDI-TOF-MS analysis required selecting a suitable growth 
phase for harvesting cells from BHI broth, and devising a suitable extraction method which 
was reproducible. As previously mentioned the conserved size of the Listeria genome is 28 - 
32 Mb. Therefore, theoretically it could be expected that a protein concentration of 
approximately 28 - 32 mg/ml would be harvested using an efficient lysis method. However, 
in reality this is not possible due to the factors previously mentioned (see section 1.3.5), as a 
result the focus was to devise a reproducible method which allowed extraction of as much 
protein as possible.   
 
The first measure taken was to harvest cells from BHI broth which were in their exponential 
phase (see section 3.1.1). The impact of this would be the ability to obtain a larger quantity of 
viable and healthy cells from which a larger amount of protein may be harversted. The 
second measure taken was to investigate three cell lysis methods. Of the three lysis methods 
investigated in this study (pressure cycling, glass bead beating and enzymatic endolysin), 
results showed that lysis of Listeria spp. with endolysin was most efficient in terms of the 
amount of cells which were no longer visibly intact after incubation with the enzyme, and the 
amount of protein released. The former was evident upon examination of the cell debris, as 
generally intact cells appeared to be absent when 5 µg of endolysin was used to lyse a 100 
mg cell pellet. By contrast, intact cells were visible following glass bead beating (Figure 3.5) 
or pressure cycling. This evidence concurs with research published by Lossner and 
colleagues, in which complete lysis of L. monocytogenes WSLC1001 cells was demonstrated 
by a plot of absorbance against time. They reported that the L. monocytogenes cell suspension 
was cleared after 8-10 minutes of endolysin treatment (Figure 1.15) (Loessner, Schneider, 
and Scherer 1995). The data from the current study suggests that the amount of protein 
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extracted from L. monocytogenes F2365 cells was higher when endolysin was used in 
conjunction with glass bead beating in comparison to lysis by pressure cycling and glass bead 
beating only. However, in comparison to lysis with glass beads beating only, lysis with 
endolysin consistently resulted in the identification of fewer proteins across all three 
biological replicates (Table 3.1). For this reason, lysis with glass beads was the preferred 
method for producing protein extracts for SELDI-TOF-MS analysis, and subsequently for 
investigating proteins that were differentially expressed at 4°C and 37°C. 
 
In this study analysis of extracted proteins on a 1-D SDS gel (Figure 3.31) showed diversity 
between Listeria and Brocothrix species. The protein profiles show that several bands were 
consistently present amongst all the species. In addition, it was also evident that in B. 
campestris a protein band in the 3.5 - 10 kDa marker region was absent from L. innocua, L 
ivanovii subsp ivanovii, L. monocytogenes and B. thermosphacta. Here the huge diversity 
among the strains was also visualised through a heat map (Figure 3.39), supporting the view 
that analysis of SELDI-TOF-MS data would provide greater insight into Listeria species 
diversity. The heat map showed that a number of mass ions were differentially expressed, 
providing a visual image of areas of the mass spectrum that may be useful for biomarker 
discovery. The heat map resolved isolates into 5 phena. Members of the Brochothrix genus, 
(the only taxon belonging to the Listeriaceae family alongside the genus Listeria), did not 
cluster into a separate phenon, suggesting a large number of common cytosolic proteins 
among these genera despite their phylogenetic distance.  
 
Unlike MALDI-TOF-MS where there has been considerable development in the technology, 
SELDI-TOF-MS has remained largely unchanged since its inception by the parent company, 
Ciphergen Biosystems, and its transfer to the new company, Bio-Rad, (Hercules, CA, USA). 
The instrument (PBS ll) was superseded by the Series 4000 instrument but changes were 
mostly in the introduction of new software and not technology. The data generated is often 
compared to an SDS-PAGE gel because the software presents the mass ions into a „Gel 
View‟ image (Figure 1.14)   
 
However, SELDI-TOF-MS is more complex than SDS-PAGE in terms of resolution (Figure 
1.14) while the selective sample of the affinity chips makes it far more versatile.  The SELDI 
technology was designed to perform MS analysis of protein mixtures retained on 
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chromatographic array surfaces which are made through chemical coupling affinity 
characteristics, such as ion-exchange, hydrophobicity, metal binding etc. Compounds dock 
onto the surface through the selected affinity interactions whilst non-binding "contaminants" 
are removed by washing. The captured molecules (which are non-covalently bound) are then 
analysed by MALDI-TOF-MS which provides molecular weight information. Once 
molecular-docking is achieved, the mass spectrum is usually obtained within minutes (Shah et 
al. 2005). It produces a spectrum of complex protein mixtures based on the mass-to-charge 
ratio of the proteins and on their binding affinity to the ProteinChip surface. Differentially 
expressed proteins may be determined from these protein profiles by comparing peak 
intensities, often represented as „Heat Maps‟. Comparison of the protein peak patterns 
obtained from isolates grown under similar conditions provides a unique protein fingerprint 
pattern between bacterial strains as seen here for various strains of Listeria spp (Figure 3.39).   
 
Proteins, rather than DNA or RNA, carry out most of the cellular functions. Therefore, the 
direct measurement of protein levels and activity within the cell is the best determinant of 
overall cellular function. Moreover, since there is often a poor correlation between transcript 
and protein levels, an accurate conclusion regarding protein function based upon mRNA 
levels is currently difficult to attain. Proteomic analysis, however, is a valuable means of 
determining cellular function and can now be measured accurately. Furthermore, it can also 
play a pivotal role in mapping protein profiles in different sample groups, e.g. aggressive vs 
benign strains or the same strain grown at different temperatures to search for differential 
protein expression markers. The result of such an experiment is a list of proteins that are up- 
or down-regulated between both states. Currently, SELDI-TOF-MS can display differential 
patterns but not identify the proteins. For this, an LC-MS/MS based approach is required and 
has been used to map out differentially expressed proteins of L. monocytogenes grown at 4
o
C 
and 37
o
C.  
 
The differential expression of L. monocytogenes proteins at 4°C and 37°C is of considerable 
interest. Cacacae and colleagues used type strain NCTC 10357 (also referred to as L. 
monocytogenes EGD-e) and found that higher amounts of enzymes which play a role in 
energy production were up-regulated at 4
o
C (Cacace et al. 2010). The current study extended 
this work by the inclusion of clinical and food isolates which may be more appropriate. A 
survery of the literature shows that most studies investigating the molecular mechanisms of L. 
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monocytogenes are conducted using soley the type strain. As mentioned earlier (see section 
1.1.1) the provenance of the type strain was a diseased rabbit (Gibbons 1972). During this 
study it was hypothesised that the molecular mechanisms involved in infection of other 
animals, including the diseased rabbit, may differ from those involved in infecting the human 
population. Provided that the hypothesis is correct, the implications would be observed 
differences in the expression level of induced genes and subsequently proteins. The type 
strain could therefore be atypical and possibly an unideal model for studying molecular 
mechanisms of strains that contaminate food and infect the human population. Routine tests 
already show that the type strain is atypical.  It is non-hemolytic and lacks flagella, properties 
that are more compatible with L. innocua, therefore, in 1983, it was suggested that a more 
typical isolate NCTC 7973 should be declared the type strain (Jones and Seeliger 1983).  For  
the above reasons differential expression at 4°C and 37°C was investigated using a variety of  
isolates which included the type strain,  clinical isolates and food isolates.  It was envisaged 
that the study may reveal further evidence of the atypical nature of the type strain. The 
organisms chosen belonged to serotypes 4b, 1/2b, 1/2c and 1/2a, (as these are implicated in 
95% of hospitalisation cases (Nightingale 2010) and had AFLP patterns I, II, VII and IX 
respectively (the HPA‟s statistics show that these patterns occur most frequently in the 
respective serotypes (data not published)). A total of 7 isolates were tested; 3 clinical isolates 
and 3 food isolates, in addition to the type strain.  
 
The 1-D gel analysis was carrried out on all isolates, two of which are illustrated (Figure 3.42 
and 3.43). The results show the presence of an approximately 10 kDa protein band (indicated 
by black arrows) which was more intense at 4°C than at 37°C. The gel also shows the 
presence of a similar sized band (indicated by black arrows) which was more intense at 37°C 
than at 4°C. The Bio-Rad Image Lab 4.0 software analysis results (Figure 3.44) showed the 
presence of an approximately 10 kDa protein band which was more intense at 4°C than at 
37°C. The same 1-D gels also showed the presence of an approximately 10 kDa band which 
was more intense at 37°C than at 4°C.  
 
The differentially expressed proteins were analysed using LC-MS/MS. The Scaffold software 
which was used to sort the LC-MS/MS data, provided an output of quantification as a 
normalised spectrum count. Normalised spectrum counts refer to the number of spectra 
associated with all identified peptides that are representative of a protein. Subsequently, 
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spectrum counts are correlated with protein abundance. In this study, a number of the proteins 
identified were designated 'hypothetical‟, that is proteins which at present do not have a 
known function. Nevertheless, analysing their expression level at 4°C and 37°C has made it 
possible to putatively associate them with metabolic switches between these two phases. In 
this study 9 proteins were identified as either up- or down-regulated at 4°C and 37°C (Figures 
3.45 - 3.62 and Table 3.5), and ranged from 7 - 13 kDa in size, and therefore showed that 
they may have contributed to the protein bands observed in the 10 kDa region of the 1-D gels. 
Two of the 4 proteins up-regulated at 4°C and down-regulated at 37°C, were „hypothetical 
proteins‟. The remaining 2 were phosphotransferase system (PTS) which plays a role in 
modulating the use of carbon sources in bacteria (Domenech et al. 2012) and 50S ribosomal 
protein L29 which plays a role in protein synthesis. Of the 5 proteins up-regulated at 37°C 
and down-regulated at 4°C, one was a „hypothetical protein‟. The remaining 4 were Co-
chaperonin GroES and 30s ribosomal protein S16 which play a role in protein folding and 
synthesis respectively, an anti-anti sigma factor which participates in modulating gene 
expression in response to stress (Homerova et al. 2012) and histidine phosphocarrier protein 
(HPr) which forms part of PTS (Domenech et al. 2012).  
 
In addition to these differentially expressed proteins, 3 were identified as uniquely expressed 
at either 4°C or 37°C. Hypothetical protein lmo0056 was uniquely expressed at 37°C in all 
isolates tested (Figure 3.56). Hypothetical protein lwe06778 was only expressed at 4°C in all 
isolates except NCTC 10357, in which it was present at both temperatures (Figure 3.54). 
Phosphoribosyl-AMP cyclohydrolase was expressed solely at 4°C in all isolates except 
NCTC 10357, in which it was absent at both temperatures (Figure 3.55). This data further 
supports the view that the type strain of L. monocytogenes is atypical. The data also strongly 
supports the decision made at the beginning of the study, not to base the entire investigation 
on the type strain as done in other studies designed to study this phenomenon. The fact that 
this type strain, NCTC 10357, which closely resembles L. innocua behaves so differently 
suggests that the mechanistic changes associated with growth at 4°C and 37°C may be 
restricted to L. monocytogenes. 
 
The LC-MS/MS and Scaffold software analysis showed that the size of hypothetical protein 
lmo0056 was 11 kDa, hypothetical protein lwe06778 was 11 kDa and that phosphoribosyl-
AMP cyclohydrolase was 12 kDa. The data obtained by high resolution capillary 
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electrophoresis (deltaDot) also supports the evidence of an increased abundance of small 
molecular weight proteins at 4°C as this data showed a 12 kDa protein peak at 4°C which was 
lower at 37°C (Figure 3.59 and 3.60). 
 
As mentioned earlier, it is difficult to ascertain the role of hypothetical proteins lmo0056 and 
lwe06778. Further work, such as gene knockout studies would be necessary to elucidate their 
role, however, at present there is evidence from this study, that they may serve as possible 
biomarkers of the presence of L. monocytogenes in cold RTE foods. Hypothetical protein 
lwe06778 may serve as a cold storage biomarker, while lmo0056 may serve as a warm 
temperature indicator of the species. 
 
Phosphoribosyl-AMP cyclohydrolase, (which was uniquely expressed at 4°C), is involved in 
the histidine biosynthesis pathway, an unbranched pathway with no route to bypass any of the 
10 enzymes involved (Henriksen et al. 2010). In this pathway, ATP 
phosphoribosyltransferase (HisG) catalyses the first step resulting in the condensation of ATP 
and 5-phosphoribosyl 1-pyrophosphate (PRPP) to form phosphoribosyl-ATP. In the second 
step, the triphosphate of phosphoribosyl-ATP is then hydrolysed by phosphoribosyl-ATP 
pyrophosphohydrolase (HisE) to form phosphoribosyl-AMP. In the third step, the purine ring 
of phosphoribosyl-AMP is hydrolysed by phosphoribosyl-AMP cyclohydrolase (HisI) (the 
protein identified in this study), to form phosphoribosyl-formimino-5-aminoimidazole 
carboxamide ribonucleotide, which is denoted as phosphoribosyl-formimino-AICAR-P for 
short. In the fourth step, this product is converted to phosphoribulosyl formimino-5-amino 
imidazole carboxamide ribonucleotide denoted as phosphoribusyl-formimino-AICAR-P by 
the enzyme phospho-D-ribosyl formimino-5-amino-1-phosphoribosyl-4-imidazole 
carboxamide isomerase (His A) in a process called Amadori rearrangement. In the fifth step, 
this product is then cleaved by glutamine imidazole transferase (HisH) (which in the process 
converts a glutamine molecule to glutamate) to form 5-aminoimidazole-4-carboxamide 1-
beta-D ribofuranosyl 5‟-monophosphate (AICAR) which is used to synthesise purines and 
imidazole glycerol phosphate (referred to as imidazole acetol P or IGP). In the sixth step, IGP 
is dehydrated by imidazole glycerol phosphate dehydratase (IGPD) producing imidazole 
acetol phosphate (imidazole acetol-P), which is transaminated in the seventh step by 
histidinol phosphate amino transferase (HisC) to form L-histidinol-phosphate. In the eighth 
step, L-histidinol-phosphate is converted to L-histidinol by histidinol phosphatase (HisB). In 
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the ninth step L-histidinol-phosphate is converted to L-histidinal by histidinol dehydrogenase 
(HisD) and in the final step HisD is also responsible for converting L-histidinal to L-histidine 
(Figure 4.3) (Henriksen et al. 2010). 
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Figure 4.3. Histidine biosynthesis pathway The pathway is an unbranched with no route to 
bypass any of the 10 enzymes involved, the result of which is the synthesis of L-histidine 
(taken from Henriksen et al. 2010). 
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A survey of the literature did not offer an explanation for the up regulation of the histidine 
biosynthesis pathway at low temperatures in L. monocytogenes, however, a possible 
explanation may be as follows. Antarctic psychotropic bacteria are frequently used as models 
for studying cold adaptation, one of which is Pseudomonas syringae, which has the ability to 
grow below 0°C (Kannan et al. 1998; Regha, Satapathy, and Ray 2005). It was shown that P. 
syringae encodes hut genes that are involved in the histidine utilisation pathway at low 
temperatures (Kannan et al. 1998). Similar to antarctic psychotrophic bacteria, L. 
monocytogenes is capable of surviving below 0°C, it therefore seems plausible that L. 
monocytogenes may also have hut genes which are vital to the organism‟s survival at low 
temperatures. A survey of the literature showed that Bacillus subtilis, a close relative of 
Listeria, utilises L-histidine as a carbon and nitrogen source under nutrient limiting 
conditions. In B. subtilis, the genes responsible for L-histidine utilisation are within the hut 
operon, which consists of hutP, hutH, hutU, hutI, hutG, and hutM (Kumarevel, Mizuno, and 
Kumar 2005). By analogy, it seems plausible that at low temperatures L. monocytogenes 
switches on the expression of HisI in order to enable the biosynthesis of L-histidine, the 
utilisation of which is required as a carbon and nitrogen source under cold stress conditions. 
The ability to activate the histidine biosynthesis and histidine utilisation pathway may be vital 
to the organism‟s survival at low temperatures, as such temperatures may limit the activity of 
enzymes that would at ambient temperatures facilitate the uptake of environmental carbon 
and nitrogen sources. This hypothesis may form the basis for a future study to expand the 
present work. 
 
The results shown here could have commercial implications, utilising the hypothetical protein 
lwe06778 and phosphoribosyl-AMP cyclohydrolase as biomarkers for the presence of the 
organism in foods being preserved at refrigeration temperatures. Alternatively, inhibitors of 
these proteins may be suitable candidates for preserving cold stored food against L. 
monocytogenes. This idea may be supported in a study by Henriksen and colleagues in which 
they used flux balance analysis to identify unconditionally essential S. aureus enzymes. One 
family of proteins identified in their study was those involved in histidine biosynthesis 
(Figure 4.3), and which included phosphoribosyl-AMP cyclohydrolase. Their aim was to 
screen various compounds in order to find an inhibitory candidate, and ultimately propose an 
antibacterial treatment alternative in an era where multiple drug resistant organisms pose a 
major healthcare challenge. They performed virtual screening to identify compounds which 
223 
 
docked into the active sites of all 9 enzymes involved in histidine biosynthesis (HisG, HisE, 
HisI, HisA, HisF, HisH, HisB (IGPD), HisC and HisD (Henriksen et al. 2010).  They found 
that three enzymes HisI, IGPD and HisC had docking sites for 18 inhibitory compounds. 
Compounds HisI1, HisI2, HisI4, HisI8, HisI19 and HisI11 were selected inhibitors for HisI, 
compounds IGDP1, IGDP6, IGDP10, IGDP13, IGDP14, IGDP16 and IGDP17 were selected 
inhibitors for IGDP, and HisC5, HisC9, HisC11, HisC14, HisC16 and HisC19 were selected 
as inhibitors for HisC (Henriksen et al. 2010). Their disc inhibition assay studies showed that, 
relative to ampicillin, HisI2 showed weak inhibition, IDPG1 showed strong inhibition, 
followed by IGPD13, IGPD6 and HisC9 which showed weak inhibition (Figure 4.4). 
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Figure 4.4. Effective inhibitor molecules: HisI2, IGPD1, IGPD6 and HisC9 of enzymes 
phosphoribosyl-AMP cyclohydrolase (HisI), imidazole glycerol phosphate dehydratase 
(IGPD), and histidinol phosphate amino transferase (HisC) (taken from Henriksen et al. 
2010). 
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Evolutionarily, the histidine biosynthesis pathway is highly conserved among different 
bacterial species (Henriksen et al. 2010), and in the case of L. monocytogenes the results 
presented in this study suggests that it is activated at 4°C.  Based on the data generated by 
Henriksen and colleagues, and the findings presented in this thesis, it is suggested that HisI2, 
IDPG1, IDPG13, IDPG6 and HisC9 are likely to be inhibitors of L. monocytogenes when 
grown at 4°C.  
 
IGPD has already been used as a target to design herbicides (Ohata, Mori, and Ward 1997) 
and Henriksen‟s findings indicate that the enzyme is a potential target for MRSA patient 
therapy. It therefore seems plausible that a similar approach may be undertaken for L. 
monocytogenes during cold storage of RTE products. The implication of these findings may 
be important to public health as this could contribute to the reduction in the number or 
listeriosis cases, which has recently seen a steady increase partly due to the consumption of 
contaminated cold stored RTE foods.  
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General Conclusion 
 
This study has shown that MALDI-TOF-MS and SELDI-TOF-MS are potential tools for 
further discrimination of L. monocytogenes isolates with cluster analysis demonstrating clear 
distinction of isolates into separate phena. The data from MSP dendrogram derived from 
MALD-TOF-MS spectra strongly correlated with 16S rRNA dendrograms. Finally, the 
identification of hypothetical protein lwe06778 and phosphoribosyl-AMP cyclohydrolase 
which were both uniquely expressed at 4°C, suggest great potential as biomarkers for the 
presence of L. monocytogenes in cold stored RTE foods, with the possibility of 
phosphoribosyl-AMP cyclohydrolase being a target for arresting the growth of the organism 
in cold storage through the introduction of an inhibitor of the enzyme. 
 
Future Work 
 
The similarity between dendrograms produced by MALDI-TOF-MS and 16S rRNA is in 
accord with the view that MALDI-TOF spectra are derived from abundant ribosomal 
proteins. Currently, multilocus sequencing typing is now being carried out on ribosomal 
proteins encoding genes (rMLST). By sequential disruption of the gene of each ribosomal 
protein followed by comparative analysis of the MALDI-TOF data, it should be possible to 
begin assigning which ribosomal proteins contribute to the mass ions revelaed in the spectra 
of each species. It should therefore be possible in the near future to better define each species 
and then improve the resolution of MALDI-TOF-MS to the level of sub species and types. 
 
At the commencement of this study, the goal was to develop MALDI-TOF-MS for use at the 
species level. Today that goal has been reached and MALDI is being used at the forefront of 
clinical diagnostics. Several laboratories aim to develop the system as a typing tool. The 
advantage this would bring food safety are immence in terms of speed, accuracy and cost. 
 
The present study also focused on the differential expression of L. monocytogenes grown at 
4°C and 37°C. This was done in order to simulate the two extremes where this species may 
reside and thrive in cold stored RTE food and in infect man, respectively. As expected there 
were changes in the protein expression associated with each growth temperature. However, 
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the type of protein analysis used (LC-MS/MS) relies on the analysis of trypsin digested 
peptides to reveal protein identity (bottom-up approach). This method, while quite 
comprehensive, misses a great deal of the post-translational modifications which are now 
readily mapped by new spectrometry methods, such as top-down proteomics. Future studies 
should therefore be based on a series of temperatures using new high resolution MS/MS 
methods to follow these translational changes. This would provide detailed insight into the 
mechanism associated with these changes and may reveal new approaches to stem the rise of 
this species as a human pathogen. 
  
Relevance in Diagnostics  
 
The discovery of proteins which are uniquely expressed at 37°C and 4°C may have 
diagnostic applications and could prove to be useful in the identification of L. monocytogenes 
in different environments. Since L. monocytogenes expresses hypothetical protein lwe06778 
and phosphoribosyl-AMP cyclohydrolase uniquely at 4°C, it is envisaged that a biosensor 
could be used to detect the presence of the contaminant in cold stored RTE foods. Detection 
of the organism in this environment could be instrumental in ensuring safety against this 
foodborne pathogen. The same principle could also be applied for the detection of L. 
monocytogenes in clinical samples. In this case hypothetical protein lmo0056 which was 
uniquely expressed at 37°C would be suitable for patient diagnosis. Biosenors remain a 
viable diagnostic method. Recently Seung-Ho and Bhunia used a multiplex optic biosensor 
for the detection of L. monocytogenes, E. coli O157:H7 and Salmonella enterica in ready-to-
eat meat samples (Sueng-Ho and Bhunia 2013).  Briefly, they used specific antibody coated 
fibres to immobilse or trap the organisms, then added AF-reporter antibodies which are 
specific to the organisms. The fluorsence was then detected with a fluorometer which 
indicated the presence of the microbial contaminants. This multiplex biosensor technology 
could be developed for detection of L. monocytogenes at 4°C and 37°C.   
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Table A1. List of proteins identified in L. monocytogenes F2365 cell extracts produced using 
glass bead beating and endolysin, their corresponding accession number and number of 
unique peptides in each biological replicate.   
 
Protein 
Number 
Identified Proteins (434) Accession 
Number 
Number of Unique Peptides 
Samples:  
   A B C D E F 
1 bifunctional acetaldehyde-
CoA/alcohol dehydrogenase  
gi|168007
43 
16 17 12 14 16 11 
2 phosphopyruvate hydratase  gi|168016
11 
16 16 15 16 17 14 
3 elongation factor Tu gi|168046
90 
14 13 13 12 12 12 
4 glyceraldehyde-3-phosphate 
dehydrogenase  
gi|168016
15 
11 11 9 9 9 7 
5 formate acetyltransferase gi|469076
34 
18 18 16 16 17 14 
6 hypothetical protein lin2048  gi|168011
14 
4 4 3 3 4 2 
7 chaperonin GroEL  gi|116873
505 
14 18 9 15 13 9 
8 50S ribosomal protein 
L7/L12 
gi|116871
634 
4 4 3 4 4 2 
9 hypothetical protein lmo2556  gi|168045
94 
4 4 6 5 4 5 
10 DNA-directed RNA 
polymerase subunit beta 
gi|469064
96 
22 18 12 17 22 11 
11 chaperone protein DnaK  gi|469077
01 
11 13 13 10 11 10 
12 elongation factor Ts gi|469078
86 
11 13 8 10 11 9 
13 phosphocarrier protein HPr gi|168000 4 5 3 4 4 5 
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70 
14 50S ribosomal protein L17  gi|116873
971 
4 3 3 3 3 4 
15 fumarate reductase 
flavoprotein subunit 
gi|168024
00 
8 10 9 8 8 7 
16 elongation factor G  gi|116874
019 
9 10 10 8 9 9 
17 pyruvate carboxylase  gi|254823
658 
16 15 11 13 16 11 
18 DNA-directed RNA 
polymerase subunit beta  
gi|116871
647 
14 13 9 9 10 9 
19 30S ribosomal protein S8 gi|168018
28 
3 3 2 3 3 2 
20 pyruvate kinase  gi|470931
07 
4 8 10 7 5 6 
21 phosphotransferase system 
enzyme I  
gi|168030
43 
6 10 7 10 9 7 
22 50S ribosomal protein L4 gi|168018
41 
4 5 3 3 4 3 
23 phosphoglyceromutase gi|168044
94 
7 8 6 7 6 6 
24 triosephosphate isomerase  gi|168016
13 
5 5 4 5 5 3 
25 50S ribosomal protein L5  gi|168018
30 
4 5 5 4 4 4 
26 co-chaperonin GroES  gi|116873
506 
2 3 2 4 4 2 
27 50S ribosomal protein L23 gi|168046
68 
3 6 4 4 5 3 
28 50S ribosomal protein L29  gi|168018
34 
2 2 2 2 2 2 
29 50S ribosomal protein L21  gi|168035
82 
4 4 2 3 4 2 
30 acetolactate synthase  gi|254825
504 
6 8 6 6 6 4 
31 hypothetical protein lin2463  gi|168015
25 
7 6 10 5 5 7 
32 30S ribosomal protein S2  gi|168008
35 
5 6 6 3 4 5 
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33 50S ribosomal protein L3  gi|168046
70 
4 4 4 3 3 2 
34 6-phosphofructokinase  gi|168036
11 
5 6 5 5 5 2 
35 L-lactate dehydrogenase gi|116871
592 
2 5 4 3 1 4 
36 30S ribosomal protein S5  gi|168018
25 
3 3 3 4 4 3 
37 CD4+ T cell-stimulating 
antigen, lipoprotein  
gi|168034
28 
6 8 7 10 9 7 
38 50S ribosomal protein L1 gi|167993
58 
4 4 3 4 3 3 
39 50S ribosomal protein L15 gi|168046
51 
2 3 2 3 2 3 
40 phosphoglycerate kinase gi|116873
822 
4 4 5 5 7 5 
41 ATP-dependent Clp protease 
proteolytic subunit  
gi|254823
607 
3 3 2 3 4 2 
42 30S ribosomal protein S10 gi|168018
43 
2 3 2 2 2 2 
43 30S ribosomal protein S1  gi|254993
213 
7 7 4 6 7 4 
44 hypothetical protein lin2128 gi|168011
94 
4 3 2 3 3 2 
45 30S ribosomal protein S7  gi|168018
65 
4 3 2 4 3 1 
46 aspartyl-tRNA synthetase  gi|469077
47 
8 9 8 5 7 6 
47 acetate kinase  gi|116873
010 
8 10 5 8 8 7 
48 adenylate kinase gi|217966
190 
2 3 3 3 2 3 
49 hypothetical protein lin0859  gi|167999
33 
9 12 6 8 8 6 
50 30S ribosomal protein S11 gi|168018
17 
3 3 2 3 3 2 
51 trigger factor gi|168003
74 
5 7 4 7 6 4 
52 polynucleotide gi|254829 5 8 6 8 5 4 
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phosphorylase/polyadenylase  912 
53 transketolase  gi|226223
907 
7 7 7 7 7 5 
54 hypothetical protein lin2786  gi|168018
47 
3 4 2 2 2 2 
55 hypothetical protein 
LMOf2365_0621  
gi|469068
37 
2 3 2 2 2 2 
56 30S ribosomal protein S4  gi|116873
025 
4 3 3 4 4 1 
57 valyl-tRNA synthetase gi|254993
780 
9 10 3 7 5 3 
58 dihydrolipoamide 
acetyltransferase 
gi|469072
86 
3 3 4 2 4 2 
59 hypothetical protein lin0145  gi|167992
22 
3 3 5 3 3 5 
60 alanyl-tRNA synthetase  gi|217964
349 
9 6 3 8 5 2 
61 50S ribosomal protein L6  gi|168046
55 
5 5 5 4 4 3 
62 pyruvate dehydrogenase beta 
subunit  
gi|116872
447 
1 3 6 4 3 5 
63 dipeptidase  gi|217964
227 
8 6 9 5 7 8 
64 isoleucyl-tRNA synthetase  gi|217963
834 
7 8 5 6 3 2 
65 hypothetical protein lmo2638  gi|168046
76 
3 3 5 4 4 2 
66 glutamyl-tRNA(Gln) 
amidotransferase  
gi|254826
001 
6 7 4 4 6 5 
67 hypothetical protein lmo0219 gi|168022
65 
2 1 3 1 3 1 
68 uracil 
phosphoribosyltransferase  
gi|168045
76 
3 3 3 2 2 3 
69 hypothetical protein 
lse_0235 
gi|289433
604 
3 2 3 2 2 3 
70 6-phosphogluconate 
dehydrogenase  
gi|168004
81 
6 7 4 4 5 2 
71 enoyl-(acyl carrier protein) 
reductase  
gi|168030
10 
5 5 5 6 5 3 
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72 universal stress protein  gi|116873
009 
6 5 4 4 6 2 
73 DNA-directed RNA 
polymerase subunit alpha  
gi|168018
16 
4 5 4 5 5 3 
74 hypothetical protein lmo0223 gi|168022
69 
3 3 5 3 4 3 
75 30S ribosomal protein S6  gi|167991
16 
3 3 1 3 3 1 
76 glutamate dehydrogenase  gi|168026
03 
3 3 6 5 6 2 
77 ATP synthase F1, beta 
subunit  
gi|315283
679 
5 5 6 4 5 6 
78 D-amino acid 
aminotransferase  
gi|469078
49 
4 5 5 4 3 3 
79 hypothetical protein lin2901 gi|168019
60 
7 5 3 5 4 3 
80 prolyl-tRNA synthetase  gi|226223
920 
7 6 6 6 5 4 
81 superoxide dismutase, Mn  gi|469076
67 
4 4 3 5 5 3 
82 50S ribosomal protein L19  gi|116873
225 
2 2 1 2 2 1 
83 epitope LemA  gi|254993
263 
2 3 2 3 2 2 
84 lysyl-tRNA synthetase  gi|168022
74 
3 5 4 4 4 5 
85 glutamyl-tRNA 
amidotransferase subunit A  
gi|217964
097 
5 5 5 2 4 4 
86 hypothetical protein lmo2223 gi|168042
62 
2 2 2 2 2 3 
87 L-glutamine-D-fructose-6-
phosphate amidotransferase  
gi|226223
357 
5 7 5 4 7 4 
88 DNA polymerase III (alpha 
subunit)  
gi|226223
921 
2 5 1 4 7 2 
89 hypothetical protein lmo1603  gi|168036
43 
8 6 3 6 4 3 
90 hypothetical protein lin1027 gi|168000
96 
3 3 2 3 2 1 
91 preprotein translocase gi|168045 7 6 3 7 5 4 
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subunit SecA 48 
92 clpB protein gi|254931
681 
9 6 1 6 4 3 
93 hypothetical protein lin2510 gi|168015
72 
6 4 1 2 2 1 
94 50S ribosomal protein L14 gi|168018
32 
3 3 2 3 3 3 
95 putative manganese-
dependent inorganic 
pyrophosphatase  
gi|168034
88 
3 7 5 6 4 5 
96 F0F1 ATP synthase subunit 
alpha 
gi|168017
36 
4 5 4 4 3 4 
97 glutamyl-tRNA synthetase  gi|168022
83 
4 5 3 2 4 3 
98 hypothetical protein lin0410 gi|167994
87 
5 10 7 4 5 3 
99 glucose-6-phosphate 
isomerase  
gi|168015
28 
3 2 2 3 3 2 
100 non-heme iron-binding 
ferritin  
gi|168029
83 
3 4 2 4 3 2 
101 (3R)-hydroxymyristoyl-ACP 
dehydratase  
gi|168017
29 
3 3 1 3 3 1 
102 30S ribosomal protein S13 gi|168018
18 
2 1 1 1 3 1 
103 arginyl-tRNA synthetase gi|217963
335 
3 4 1 5 5 2 
104 50S ribosomal protein L11 gi|167993
57 
2 3 2 2 2 2 
105 hypothetical protein lin0182  gi|167992
59 
4 5 2 4 5 2 
106 hypothetical protein lmo0096  gi|168021
44 
2 2 1 2 2 1 
107 hypothetical protein lmo0891  gi|168029
32 
4 5 4 5 5 4 
108 pyruvate-formate lyase 
activating enzyme  
gi|168005
12 
3 4 1 3 2 1 
109 catalase  gi|470926
75 
2 3 2 3 3 2 
110 50S ribosomal protein L16  gi|168018 2 2 2 1 2 2 
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35 
111 DNA gyrase subunit A  gi|167990
86 
9 5 2 8 3 1 
112 tyrosyl-tRNA synthetase  gi|226224
199 
5 3 3 3 5 2 
113 50S ribosomal protein L13  gi|168046
35 
2 2 2 2 2 1 
114 hypothetical protein 
LMOf2365_0340 
gi|469065
60 
4 5 4 5 3 3 
115 cell division protein FtsZ  gi|116873
462 
6 5 3 2 3 3 
116 translation initiation factor 
IF-3  
gi|168009
63 
4 4 2 2 4 2 
117 30S ribosomal protein S3  gi|168018
36 
1 2 2 2 1 2 
118 D-alanine-D-alanyl carrier 
protein ligase  
gi|470936
68 
2 5 3 0 3 2 
119 rod shape-determining 
protein MreB 
gi|168035
88 
5 5 1 2 3 1 
120 ATP-dependent Clp protease 
proteolytic subunit  
gi|168045
06 
3 2 1 2 2 1 
121 hypothetical protein lmo1807  gi|168038
47 
4 2 3 2 2 3 
122 hypothetical protein lin2350 gi|168014
13 
4 4 3 1 4 2 
123 ABC transporter, ATP-
binding protein  
gi|469083
50 
5 3 3 4 3 4 
124 threonyl-tRNA synthetase gi|168035
99 
4 5 2 4 5 0 
125 CTP synthetase  gi|469087
30 
3 6 3 3 4 0 
126 50S ribosomal protein L9  gi|168021
01 
3 2 2 3 2 2 
127 translation initiation factor 
IF-2 
gi|168004
30 
3 3 3 4 4 2 
128 aconitate hydratase 1 gi|217964
207 
4 2 2 3 3 2 
129 rod shape-determining 
protein MreB 
gi|168045
63 
5 6 2 4 5 3 
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130 transcriptional repressor 
CodY  
gi|168003
87 
4 5 1 4 5 1 
131 hypothetical protein lin1642  gi|168007
10 
3 4 2 3 3 2 
132 naphthoate synthase  gi|168037
13 
4 4 3 3 4 2 
133 azo-dye reductase 2  gi|254828
869 
2 3 4 3 2 2 
134 ribonucleotide-diphosphate 
reductase subunit alpha  
gi|168041
94 
5 4 3 4 4 1 
135 thioredoxin reductase  gi|168045
16 
5 7 3 6 7 1 
136 catabolite control protein A gi|168036
39 
6 8 2 2 6 1 
137 hypothetical protein lin1044 gi|168001
13 
1 1 2 1 1 1 
138 recombinase A gi|116872
830 
3 4 3 3 2 2 
139 hypothetical protein lin0250  gi|167993
27 
2 2 1 1 2 2 
140 serS  gi|307572
335 
5 4 3 4 4 3 
141 transcription elongation 
factor GreA  
gi|168005
99 
2 3 2 3 1 3 
142 phosphomethylpyrimidine 
kinase 
gi|116872
050 
3 1 1 2 2 1 
143 hypothetical protein lmo1299  gi|168033
39 
3 5 4 2 3 2 
144 DNA topoisomerase IV 
subunit A 
gi|168033
27 
3 5 3 2 3 3 
145 asparaginyl-tRNA synthetase gi|168039
35 
4 2 1 4 4 3 
146 Smc protein gi|226224
407 
7 3 1 1 4 1 
147 DAK2 domain protein  gi|470930
51 
1 5 4 1 3 4 
148 leucyl-tRNA synthetase gi|300766
055 
3 3 2 4 3 1 
149 positive regulator of sigma-B gi|255026 1 2 4 2 2 2 
249 
 
activity 473 
150 malonyl CoA-acyl carrier 
protein transacylase 
gi|217964
039 
4 5 2 4 3 0 
151 50S ribosomal protein L2  gi|116873
995 
3 5 3 1 3 3 
152 hypothetical protein lmo1888  gi|168039
27 
2 3 1 2 2 1 
153 ribose-phosphate 
pyrophosphokinase  
gi|167993
15 
3 3 3 2 2 2 
154 hypothetical protein lmo1067 gi|168031
07 
4 2 1 1 3 3 
155 inorganic 
polyphosphate/ATP-NAD 
kinaseLCC5334] 
gi|116873
015 
3 1 2 1 1 3 
156 phosphoglucomutase gi|226224
475 
2 3 2 2 2 2 
157 thymidylate kinase  gi|168047
30 
4 2 1 6 5 1 
158 peptidase gi|254824
448 
4 5 3 5 3 1 
159 hypothetical protein lmo1339 gi|168033
79 
3 4 3 4 3 3 
160 hypothetical protein 
LmonocFSL_04711  
gi|255520
525 
3 3 3 3 3 2 
161 hypothetical protein lmo1544  gi|168035
84 
4 3 2 2 3 2 
162 glucosamine-6-phosphate 
deaminase 
gi|217963
543 
4 3 3 1 3 2 
163 phenylalanyl-tRNA 
synthetase 
gi|254823
524 
3 2 2 3 3 1 
164 glutamate synthase (large 
subunit) 
gi|226224
337 
3 3 0 3 4 0 
165 formate--tetrahydrofolate 
ligase  
gi|168010
56 
4 5 4 6 5 2 
166 glucose-specific 
phosphotransferase enzyme 
iia component 
gi|217964
883 
1 1 1 2 1 2 
167 ribosome recycling factor  gi|168004
19 
2 2 2 1 1 1 
250 
 
168 MTA/SAH nucleosidase  gi|254828
272 
4 3 1 4 2 1 
169 GMP synthase gi|168031
36 
1 3 2 2 1 1 
170 FeS assembly protein SufD gi|217963
486 
2 1 5 2 2 2 
171 redox-sensing transcriptional 
repressor Rex 
gi|168012
43 
1 2 1 2 2 1 
172 UDP-N-acetylmuramoyl-L-
alanyl-D-glutamate 
synthetase 
gi|469082
72 
5 4 1 1 3 0 
173 transcription-repair coupling 
factor 
gi|217965
700 
5 2 0 0 3 0 
174 DNA-binding protein gi|254851
904 
2 3 2 2 2 1 
175 phosphoglucomutase/phosph
omannomutase family 
protein  
gi|224499
832 
4 5 3 1 3 2 
176 ABC transporter, substrate-
binding protein 
gi|470944
38 
2 2 3 2 2 2 
177 serine-protein kinase RsbW  gi|469071
26 
5 4 2 3 3 1 
178 phosphoglucosamine mutase  gi|217963
721 
2 2 1 4 2 1 
179 beta-ketoacyl-acyl-carrier-
protein synthase II  
gi|315304
368 
3 4 3 3 4 2 
180 post-translocation molecular 
chaperone 
gi|226224
827 
4 4 3 4 3 3 
181 glycerol-3-phosphate 
dehydrogenase, NAD-
dependent  
gi|469081
69 
5 5 3 5 4 1 
182 ribosomal subunit interface 
protein 
gi|116873
875 
3 2 0 2 2 1 
183 DNA mismatch repair 
protein MutS  
gi|168034
43 
4 3 0 2 1 0 
184 Tetrahydrofolate 
dehydrogenase/cyclohydrola
se  
gi|226223
961 
2 3 4 2 2 2 
185 hypothetical protein lin2434  gi|168014 3 4 2 3 3 2 
251 
 
96 
186 hypothetical protein 
LmonocyFSL_13924  
gi|255024
248 
1 2 0 1 1 0 
187 hypothetical protein lin1645 gi|168007
13 
2 1 2 2 2 1 
188 GTP-binding protein LepA  gi|116872
908 
3 4 1 2 3 3 
189 dihydrolipoamide 
dehydrogenase 
gi|168001
16 
2 3 3 1 3 2 
190 dihydrodipicolinate synthase  gi|116872
868 
2 2 2 2 2 2 
191 hypothetical protein lin1010 gi|168000
79 
2 2 1 3 2 1 
192 ClpC ATPase  gi|131429
7 
6 7 3 2 3 0 
193 IspC gi|126143
318 
5 7 5 0 0 0 
194 glycyl-tRNA synthetase beta 
subunit  
gi|254932
643 
1 3 0 3 3 2 
195 pyridoxal biosynthesis lyase 
PdxS 
gi|168041
40 
4 3 2 3 3 1 
196 hypothetical protein lin2475 gi|168015
37 
1 0 2 2 1 2 
197 adenine 
phosphoribosyltransferase 
gi|289434
804 
0 1 2 2 2 1 
198 hypothetical protein lin1776 gi|168008
44 
1 1 2 1 1 1 
199 hypothetical protein lin1007 gi|168000
76 
1 3 1 0 2 1 
200 metallo-beta-lactamase 
family protein  
gi|469078
08 
3 3 1 2 2 2 
201 hypothetical protein lmo2033 gi|168040
72 
3 3 1 3 3 0 
202 hypothetical protein lin1536  gi|168006
04 
2 2 1 1 2 1 
203 alkylphosphonate utilization 
operon protein PhnA  
gi|469066
05 
1 0 2 2 3 1 
204 phosphopentomutase  gi|469081
88 
2 3 2 4 3 1 
252 
 
205 transcription elongation 
factor NusA  
gi|116872
753 
0 3 0 3 1 1 
206 thioredoxin  gi|168002
65 
1 2 1 1 1 2 
207 F0F1 ATP synthase subunit 
delta  
gi|116873
896 
2 3 0 2 2 2 
208 50S ribosomal protein L30  gi|168018
24 
1 2 0 1 1 0 
209 UTP-glucose-1-phosphate 
uridylyltransferase  
gi|469073
10 
3 2 2 1 2 2 
210 30S ribosomal protein S17 gi|168018
33 
2 2 0 2 2 0 
211 methionyl-tRNA synthetase  gi|226222
806 
2 2 2 2 3 1 
212 putative glycerol-3-
phosphate acyltransferase 
PlsX  
gi|168038
49 
4 4 1 1 4 1 
213 hypothetical protein lwe0170 gi|116871
590 
2 1 1 2 2 1 
214 50S ribosomal protein 
L25/general stress protein 
Ctc  
gi|116871
593 
1 2 2 0 1 0 
215 DNA polymerase I gi|168036
05 
3 2 1 3 1 1 
216 protein-export membrane 
protein SecDF 
gi|470941
98 
2 4 2 0 4 3 
217 ATP-dependent DNA 
helicase  
gi|168037
99 
5 6 0 2 4 0 
218 cytidylate kinase  gi|469081
72 
2 2 3 1 2 2 
219 tellurite resistance protein, 
putative 
gi|116873
409 
2 2 2 1 3 1 
220 LuxR family DNA-binding 
response regulator 
gi|116872
424 
2 2 2 3 3 2 
221 purine nucleoside 
phosphorylase 
gi|168010
36 
2 2 2 3 3 2 
222 anaerobic ribonucleoside-
triphosphate reductase 
gi|217965
627 
3 5 1 4 2 1 
223 hypothetical protein lin1505  gi|168005 3 2 2 1 2 1 
253 
 
73 
224 partition protein ParB 
homolg  
gi|168019
81 
2 3 0 2 2 0 
225 50S ribosomal protein L31 
type B  
gi|116873
913 
2 2 0 0 2 0 
226 aminopeptidase gi|116873
147 
3 3 2 3 2 1 
227 cysteinyl-tRNA synthetase  gi|315274
656 
2 1 1 2 3 1 
228 aspartate aminotransferase  gi|168039
36 
2 4 1 2 2 1 
229 PTS system, beta-glucoside-
specific, IIA component  
gi|469079
50 
2 2 0 1 2 0 
230 thermostable 
carboxypeptidase  
gi|226224
489 
4 4 2 3 3 0 
231 hypothetical protein lmo0814  gi|168028
56 
2 2 2 2 2 1 
232 3-oxoacyl-(acyl carrier 
protein) synthase III  
gi|168042
41 
2 3 1 2 3 2 
233 3-dehydroquinate 
dehydratase 
gi|255522
128 
3 3 1 2 2 0 
234 ribonucleotide-diphosphate 
reductase subunit beta 
gi|168041
93 
3 2 0 2 2 1 
235 co-chaperone GrpE gi|217964
380 
1 2 1 1 2 0 
236 hypothetical protein lin0373 gi|167994
50 
1 2 1 1 2 2 
237 Rrf2 family protein gi|469077
43 
2 2 1 3 2 0 
238 putative secreted protein  gi|116873
080 
1 2 1 2 2 0 
239 anti-anti-sigma factor 
(antagonist of RsbW)  
gi|167999
65 
1 2 1 1 1 1 
240 peptide deformylase gi|469072
83 
1 2 0 2 0 1 
241 hypothetical protein lmo0558  gi|168026
01 
1 1 0 2 1 1 
242 hypothetical protein lmo2700 gi|168047
37 
2 2 0 2 2 1 
254 
 
243 threonine synthase  gi|168017
51 
2 2 1 1 1 2 
244 hypothetical protein lmo1236  gi|168032
76 
2 1 2 1 1 2 
245 hypothetical protein 
LMOf2365_1263 
gi|469074
72 
2 2 1 2 2 1 
246 flavodoxin family protein  gi|116873
146 
1 2 1 2 2 1 
247 PTS system, cellobiose-
specific, IIB component  
gi|116873
738 
1 2 1 2 2 1 
248 DHH subfamily 1 protein gi|469078
06 
1 4 3 3 1 1 
249 hypothetical protein 
LMHCC_1728  
gi|217965
005 
1 2 1 1 0 0 
250 excinuclease ABC, A subunit gi|217963
410 
6 2 0 0 4 0 
251 hypothetical protein 
LMOf2365_1769  
gi|469079
74 
1 3 0 1 2 1 
252 hypothetical protein 
LMOf2365_1664  
gi|469078
72 
1 2 1 2 2 1 
253 ATP-dependent protease 
ATP-binding 
subunitCC5334] 
gi|116872
712 
4 4 1 1 4 0 
254 chorismate mutase  gi|168036
40 
1 2 2 2 0 0 
255 glucose-6-phosphate 1-
dehydrogenase 
gi|168011
51 
3 1 0 1 2 0 
256 hypothetical protein lmo2692  gi|168047
29 
1 1 3 1 1 0 
257 NAD-dependent DNA ligase 
LigA 
gi|469079
88 
1 1 0 0 0 2 
258 peptide chain release factor 1  gi|168017
48 
2 3 1 4 3 0 
259 transcriptional regulator, Fur 
family 
gi|470933
85 
2 1 2 1 2 2 
260 hypothetical protein lmo1283  gi|168033
23 
1 3 0 3 2 1 
261 putative lipid kinase gi|168037
93 
3 3 2 3 0 0 
255 
 
262 MEP cytidylyltransferase 2 gi|217964
827 
1 1 2 1 1 2 
263 DNA polymerase III subunit 
beta 
gi|168020
50 
1 3 0 2 0 1 
264 DNA gyrase subunit B gi|168020
54 
3 1 2 1 2 1 
265 cell division ATP-dependent 
metalloprotease  
gi|116871
603 
2 5 0 0 2 0 
266 phenylalanyl-tRNA 
synthetase, alpha subunit 
gi|217964
713 
2 4 0 3 2 0 
267 nitroreductase family protein  gi|116874
175 
2 2 2 2 1 2 
268 oligoendopeptidase F gi|217963
650 
1 1 2 1 2 1 
269 tRNA-binding domain 
protein  
gi|470940
77 
3 2 1 3 3 1 
270 hypothetical protein lin1391 gi|168004
59 
2 2 2 2 2 2 
271 glutamate racemase  gi|116872
608 
2 2 2 1 2 1 
272 CBS domain-containing 
protein 
gi|313624
857 
1 1 2 1 1 1 
273 conserved hypothetical 
protein  
gi|254853
053 
2 2 0 1 2 2 
274 glyoxalase family protein  gi|469073
32 
2 2 0 2 1 0 
275 GTPase ObgE  gi|168035
77 
2 1 2 2 1 1 
276 chorismate synthase gi|469081
61 
3 2 2 3 2 1 
277 hypothetical protein lmo0487 gi|168025
30 
1 1 1 2 1 0 
278 phosphoglycerate mutase gi|226223
186 
3 4 0 2 3 0 
279 phosphoglycerate 
dehydrogenase  
gi|226222
719 
3 2 1 3 3 2 
280 DNA-directed RNA 
polymerase subunit delta 
gi|116873
926 
1 1 1 1 1 2 
281 UDP-N-acetylglucosamine gi|226222 2 2 0 3 2 1 
256 
 
pyrophosphorylase 827 
282 lipoyltransferase and lipoate-
protein ligase family protein  
gi|469071
65 
1 3 1 1 2 1 
283 branched-chain amino acid 
aminotransferase 
gi|469072
11 
2 4 0 1 2 0 
284 acetyl-CoA carboxylase, 
biotin carboxylase 
gi|217964
497 
3 3 2 3 3 0 
285 hypothetical protein lin1225  gi|168002
94 
2 1 0 1 1 0 
286 putative lipoprotein  gi|116872
665 
2 3 3 2 1 0 
287 CBS domain-containing 
protein  
gi|116873
005 
3 2 0 1 2 1 
288 hypothetical protein lmo1463  gi|168035
03 
0 0 0 2 0 0 
289 purine nucleoside 
phosphorylase  
gi|116873
395 
1 1 2 1 1 1 
290 hypothetical protein lmo1738 gi|168037
78 
3 1 0 3 3 0 
291 ribulose-phosphate 3-
epimerase 
gi|116873
253 
1 2 1 1 0 0 
292 hypothetical protein lin1772 gi|168008
40 
2 1 2 0 0 0 
293 GTP-binding protein EngA gi|116873
379 
1 2 0 2 2 1 
294 hypothetical protein lmo0797  gi|168028
39 
1 2 1 2 1 1 
295 putative heme peroxidase gi|168012
83 
1 2 0 2 0 0 
296 DNA topoisomerase 3 (DNA 
topoisomerase III) 
gi|217966
040 
4 3 1 0 2 1 
297 hydroxy-3-methylglutaryl 
coenzyme A synthase  
gi|226224
016 
1 1 0 2 1 1 
298 hypothetical protein lmo1434  gi|168034
74 
2 2 0 2 2 0 
299 RNA methyltransferase gi|116871
624 
1 1 2 0 0 0 
300 hypothetical protein lmo2754  gi|168047
91 
1 2 0 2 1 0 
257 
 
301 hypothetical protein lmo1579  gi|168036
19 
3 3 2 3 2 1 
302 ATP-dependent protease 
ATP-binding subunit ClpX 
gi|168033
08 
1 2 0 2 1 2 
303 Rel [Listeria 
monocytogenes] 
gi|143252
25 
2 3 1 2 2 1 
304 dihydrolipamide 
acetyltransferase 
gi|469076
00 
2 1 1 2 1 1 
305 dUTPase family protein gi|469079
22 
2 1 2 1 1 1 
306 hypothetical protein lmo1745  gi|168037
85 
3 3 1 1 1 0 
307 protein kinase, putative  gi|470930
57 
0 2 1 1 1 1 
308 hypothetical protein lmo0152 gi|168022
00 
2 2 0 1 2 0 
309 UDP-N-
acetylmuramoylalanyl-D-
glutamate--2,6-
diaminopimelate ligase 
gi|255520
496 
1 1 1 2 2 1 
310 aspartate aminotransferase  gi|168042
91 
2 5 1 4 1 1 
311 hypothetical protein lin2650 gi|168017
12 
1 1 1 0 2 1 
312 hypothetical protein lmo1334 gi|168033
74 
2 1 1 1 1 1 
313 conserved hypothetical 
protein  
gi|254931
550 
1 3 0 2 0 1 
314 hypothetical protein 
LmonocFSL_03787  
gi|255520
343 
0 0 0 3 0 0 
315 hypothetical protein lmo0796  gi|168028
38 
2 3 1 0 1 0 
316 hypothetical protein lmo1621 gi|168036
61 
0 2 1 0 0 2 
317 metallo-beta-lactamase 
family protein 
gi|116872
429 
2 3 1 3 0 0 
318 menaquinone biosynthesis 
protein menD  
gi|254829
597 
1 2 0 0 3 0 
319 thiamine biosynthesis gi|217966 2 2 0 2 1 0 
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membrane-associated 
lipoprotein  
165 
320 putaive secreted, lysin rich 
protein 
gi|168023
49 
1 2 0 2 2 0 
321 hypothetical protein lin1218 gi|168002
87 
2 1 0 1 1 1 
322 hypothetical protein lin1180  gi|168002
49 
1 2 1 1 1 1 
323 conserved hypothetical 
protein  
gi|254823
789 
1 1 1 2 3 0 
324 hypothetical protein lmo1868 gi|168039
08 
1 2 0 2 0 0 
325 alcohol dehydrogenase  gi|254824
114 
2 2 0 1 1 1 
326 ArsC family protein gi|116873
789 
1 1 0 1 2 0 
327 acetyltransferase gi|469069
14 
1 0 2 0 2 1 
328 hypothetical protein 
LMHCC_0113  
gi|217963
411 
1 0 1 2 2 1 
329 hypothetical protein lmo0292 gi|168023
38 
2 2 1 2 2 2 
330 hypothetical protein lmo0534  gi|168025
77 
1 2 0 0 2 0 
331 conserved hypothetical 
protein 
gi|254853
667 
1 2 0 2 1 0 
332 Xaa-Pro dipeptidase  gi|217964
274  
0 2 0 1 1 0 
333 nucleoside diphosphate 
kinase  
gi|168039
68  
1 1 0 2 1 0 
334 dihydrodipicolinate reductase  gi|168039
46 
2 2 1 1 1 1 
335 hypothetical protein lmo0443 gi|168024
87  
1 2 2 1 1 1 
336 D-alanine--D-alanine ligase gi|217965
050  
1 1 1 2 1 0 
337 lipase/acylhydrolase family 
protein 
gi|469067
40  
1 1 1 1 1 2 
338 hypothetical protein lmo0955 gi|168029 2 3 1 1 3 0 
259 
 
95 
339 hypothetical protein lin2851 gi|168019
11 
1 1 0 1 2 1 
340 DNA-binding response 
regulator 
gi|116873
879 
1 2 0 1 2 0 
341 hypothetical protein lin2544  gi|168016
06 
1 1 3 1 2 1 
342 hypothetical protein lmo2216  gi|168042
55 
1 1 1 1 2 0 
343 FeS assembly protein SufB  gi|116873
774 
2 1 0 2 0 0 
344 tryptophan--tRNA ligase  gi|313622
777 
1 2 0 1 0 3 
345 branched-chain alpha-keto 
acid dehydrogenase E1 
subunit  
gi|116872
804 
1 1 2 2 2 0 
346 chaperone protein DnaJ gi|469077
00 
1 2 0 2 2 0 
347 hypothetical protein lmo1850 gi|168038
90 
1 1 1 2 1 0 
348 UDP-N-acetylmuramate--
alanine ligase  
gi|217964
242 
3 2 1 1 1 0 
349 transcription antitermination 
protein NusB 
gi|116872
790 
1 1 0 1 3 0 
350 thymidylate synthase gi|217963
973 
0 1 0 0 2 0 
351 amino acid (glutamine) ABC 
transporter (ATP-binding 
protein) 
gi|255520
513 
2 1 1 0 1 0 
352 acetyl-CoA acetyltransferase  gi|254824
526 
1 2 0 2 1 0 
353 peptide chain release factor 3  gi|116872
389 
1 1 2 0 0 1 
354 DNA topoisomerase IV 
subunit B  
gi|168033
26 
1 0 2 0 0 1 
355 hypothetical protein lin0344 gi|167994
21 
0 1 0 2 0 0 
356 hypothetical protein lmo0788  gi|168028
30 
2 2 0 0 2 0 
260 
 
357 glycine cleavage system 
protein H 
gi|168044
63 
2 1 0 1 1 0 
358 Ami 4b protein  gi|120549
56 
0 2 0 0 0 0 
359 PfpI family intracellular 
peptidase  
gi|116873
688 
2 1 0 1 1 0 
360 ribonuclease PH gi|168032
78 
1 2 0 2 1 0 
361 N-acetylglucosaminyl 
transferase  
gi|254854
028 
3 3 1 1 2 0 
362 hypothetical protein lmo2506  gi|168045
44 
2 1 1 0 0 1 
363 pyrophosphatase PpaX gi|469086
53 
2 0 1 0 2 0 
364 Gfo/Idh/MocA family 
oxidoreductase 
gi|469079
56 
0 3 0 1 1 0 
365 histidyl-tRNA synthetase  gi|226224
121 
2 1 0 1 2 0 
366 lactate/malate dehydrogenase 
family protein 
gi|469078
98 
2 1 0 0 1 1 
367 aspartate kinase gi|254932
887 
0 0 1 0 2 1 
368 ribosome-binding factor A  gi|116872
758 
1 2 0 2 2 0 
369 nicotinate 
phosphoribosyltransferase 
gi|168001
46 
2 4 0 3 0 0 
370 hypothetical protein lmo0509 gi|168025
52 
1 3 1 1 0 0 
371 cell-shape determining 
protein MreC 
gi|116872
976 
2 3 0 2 2 0 
372 2-amino-4-hydroxy-6-
hydroxymethyldihydropteridi
ne pyrophosphokinase 
gi|217965
687 
1 0 2 2 2 2 
373 hypothetical protein lmo0047  gi|168020
95 
1 2 0 1 1 0 
374 UDP-glucose 4-epimerase  gi|217963
421 
2 1 0 0 1 0 
375 fructose-1-phosphate kinase  gi|168043
74 
0 1 2 0 0 2 
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376 phosphotransbutyrylase gi|217964
485 
1 2 0 1 1 1 
377 hypothetical protein lmo0620 gi|168026
62 
1 0 0 1 1 2 
378 guanylate kinase  gi|116873
262 
1 2 1 1 1 0 
379 conserved hypothetical 
protein 
gi|258611
892 
2 1 0 0 1 0 
380 hypothetical protein lmo2168  gi|168042
07 
2 0 0 0 0 0 
381 hypothetical protein lmo2196  gi|168042
35 
0 2 1 3 1 0 
382 hypothetical protein lin0315  gi|167993
92 
1 1 2 0 1 2 
383 glycosyl transferase, group 2 
family protein 
gi|469073
06 
2 1 1 1 1 1 
384 S-adenosylmethionine 
synthetase  
gi|470943
12 
1 1 1 1 2 0 
385 hypothetical protein lin2297  gi|168013
61 
1 3 1 1 1 0 
386 transcriptional regulator 
LytR  
gi|254993
053 
1 4 0 0 1 0 
387 peptide chain release factor 2 gi|469086
81 
2 0 0 1 2 1 
388 ribosomal RNA small 
subunit methyltransferase B  
gi|217964
025 
2 2 0 1 1 0 
389 aminodeoxychorismate lyase  gi|217964
354 
2 1 0 0 1 0 
390 alcohol dehydrogenase, iron-
dependent  
gi|217964
116 
2 1 0 0 1 0 
391 cell division ABC 
transporter, substrate-binding 
protein FtsY  
gi|469080
34 
2 1 0 0 2 1 
392 serine/threonine protein 
phosphatase family protein  
gi|469080
53 
2 1 0 2 2 0 
393 phosphodiesterase  gi|116872
831 
1 3 0 1 2 0 
394 aspartate kinase I gi|168034
76 
1 2 0 1 1 2 
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395 glutathione peroxidase gi|290893
460 
1 1 0 1 3 1 
396 hypothetical protein 
LMOf2365_0451  
gi|469066
69 
0 2 0 0 0 0 
397 hypothetical protein lin0297  gi|167993
74 
2 0 0 0 0 0 
398 septation ring formation 
regulator EzrA  
gi|168036
34 
0 1 0 2 1 1 
399 putative metalloprotease gi|168035
05 
2 1 0 2 2 0 
400 TPR domain-containing 
protein 
gi|116872
939 
1 2 0 1 2 0 
401 thiol peroxidase gi|469078
14 
2 1 0 0 2 0 
402 conserved hypothetical 
protein  
gi|254826
165 
2 1 0 2 1 0 
403 S-adenosyl-
methyltransferase MraW 
gi|116873
471 
2 1 1 1 1 0 
404 exoribonuclease RNase-R  gi|226224
997 
3 1 0 1 0 0 
405 histidine kinase domain 
protein 
gi|217964
958 
0 1 1 1 2 0 
406 hypothetical protein lin1643 gi|168007
11 
1 2 0 1 0 1 
407 hypothetical protein lin1494 gi|168005
62 
1 0 1 0 2 0 
408 prephenate dehydratase 
(PDT)  
gi|217964
317 
0 2 1 1 0 1 
409 recombination and DNA 
strand exchange inhibitor 
protein  
gi|168032
72 
3 1 0 0 1 0 
410 peptidase, M20/M25/M40 
family  
gi|217964
888 
1 2 0 0 0 0 
411 hypothetical protein lwe0905  gi|116872
323 
1 2 0 1 1 1 
412 sugar ABC transporter ATP-
binding protein  
gi|116872
821 
0 3 0 0 0 0 
413 hypothetical protein 
LMOf2365_2003  
gi|469082
07 
1 1 0 1 2 1 
263 
 
414 DNA replication intiation 
control protein YabA  
gi|168022
12 
1 0 1 2 1 0 
415 acetyl-CoA carboxylase, 
carboxyl transferase, alpha 
subunit 
gi|217964
280 
2 2 0 2 1 0 
416 hypothetical protein lmo1487  gi|168035
27 
2 1 0 2 1 0 
417 hypothetical protein 
Lm4b_01084  
gi|226223
682 
1 2 0 0 0 1 
418 hypothetical protein 
Lm4b_01462  
gi|226224
053 
0 2 0 1 1 0 
419 GntR family transcriptional 
regulator  
gi|469070
05 
2 3 0 0 1 0 
420 hypothetical protein lin2554 gi|168016
16 
0 2 1 1 0 1 
421 pyridine nucleotide-disulfide 
oxidoreductase family 
protein  
gi|116873
753 
3 2 0 0 1 0 
422 O-methyltransferase family 
protein  
gi|217964
355 
0 0 0 0 1 2 
423 hypothetical protein lmo1873  gi|168039
13 
0 1 0 2 1 0 
424 diaminopimelate epimerase  gi|224498
531 
1 0 0 1 2 0 
425 malate dehydrogenase gi|224500
265 
0 2 0 0 0 0 
426 pyrroline-5-carboxylate 
reductase  
gi|254825
797 
1 0 2 0 0 0 
427 general stress protein 13  gi|168044
07 
2 0 0 0 0 0 
428 bifunctional glutamate--
cysteine ligase/glutathione 
synthetase  
gi|116874
133 
2 0 0 0 0 0 
429 Peptidoglycan linked protein 
(atypical IPALG motif)  
gi|226224
269 
1 2 0 0 0 0 
430 DNA polymerase III subunit 
delta 
gi|168035
21 
1 2 0 0 0 0 
431 hypothetical protein lwe1906  gi|116873
322 
1 2 0 0 0 0 
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432 DNA topoisomerase I  gi|116872
708 
0 0 2 0 0 0 
433 NADPH dehydrogenase 
NamA  
gi|168045
09 
0 2 0 0 0 0 
434 tRNA pseudouridine 
synthase A 
gi|168046
36 
0 2 0 0 0 0 
Where: 
A = Endolysin Replicate 1 
B = Endolysin Replicate 2 
C = Endolysin Replicate 3 
D = Glass Bead Beating Replicate 1 
E = Glass Bead Beating Replicate 2 
F =   Glass Bead Beating Replicate 3 
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